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The immune system 
The immune system is an organization of cells and molecules with specialized 
roles in the defense against pathogens. The immune system can be divided in 
two compartments: The first is the innate immunity (also called the natural or 
native immunity), which represents the first line of defense against invading 
microorganisms and removes antigens relatively non-specifically. The second 
is the adaptive immunity (also known as specific or acquired immunity), which 
is highly antigen-specific. Another important quality of the adaptive immunity 
that distinguishes it from innate immunity is the generation of immune 
memory resulting in an enhanced and accelerated response upon a second 
encounter with the same antigen (Chaplin, 2003; Delves and Roitt, 2000b; 
Delves and Roitt, 2000a). The cells of the innate and adaptive immune system 
are illustrated in figure 1. Broadly defined, the innate immune system includes 
all aspects of the host defense mechanisms that are encoded in the germ-line 
genes of the host. These include barrier mechanisms, soluble proteins and 
bioactive small molecules, such as complement, antimicrobial peptides and 
cytokines, produced by resident cells, and migratory cells of the immune 
system. The cellular compartment of the innate immunity encompasses 
phagocytic cells, including macrophages and dendritic cells, and effector cells, 
such as NK cells and granulocytes (Chaplin, 2003; Delves and Roitt, 2000a). 
Unlike the innate mechanisms of host defense, the adaptive immune system 
manifests exquisite specificity for its target antigens. The cells of the adaptive 
immune system are T cells that recognize foreign antigens that are presented 
by antigen presenting cells (APC) and or tissue cells, and B cells, which are 
responsible for the production of antigen-specific antibodies. Adaptive 
immunity functions through presentation of small antigenic fragments from 
infectious agents by molecules encoded in the major histocompatibility 
complex (MHC) genetic locus on the cell surface of APC (Delves and Roitt, 
2000a). There are two classes of MHC molecules. Class I molecules are 
expressed by all nucleated cells and present peptides derived from cytosolic 
microorganisms and endogenous proteins. Class II MHC molecules present 
peptides from extracellular antigens and are solely expressed on antigen 
presenting cells, like dendritic cells, macrophages and B lymphocytes. T 
lymphocytes, of the adaptive immune system, express antigen-receptors that 
recognize specific antigenic peptides in the context of either MHC class I or 
class II molecules (Watts and Powis, 1999). In response to infection, T cell 
receptor (TCR) interactions with pathogen-derived peptide-MHC complexes 
will trigger the differentiation of antigen-specific lymphocytes into effector 
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cells and memory cells (Delves and Roitt, 2000b). The effector cells are then 
instantly engaged in the immune response. Memory cells, the hallmark of the 
adaptive immunity, are long-lived cells and possess the capacity to respond 
more quickly and efficiently upon repeated exposures to the same antigen 
(Campos and Godson, 2003).  
This thesis will focus on two types of immune cells, which are indissolubly 
linked together: the dendritic cell (chapter 2 and 3) of the innate immune 
system and the T cell of the adaptive immune system (chapter 4-6).  




























Figure 1: Schematic overview of the development of immune cells. CMP: Common 
myeloid precursor, CLP: Common lymphoid precursor, DCP: DC progenitors, MCP: Mast cell 
progenitor, GMP: granulocyte-macrophage precursor. 
Dendritic cells 
Dendritic cells (DC) play a critical role in the immune system as they serve as 
a link between the innate and adoptive immune responses and are particularly 
skilled in inducing the differentiation of naïve T cells into effector cells. 
Immature DC reside in the tissues or circulate through the blood, where they 
function as the sentinels of the immune system. Immature DC are phagocytic 
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cells with a high capacity for fluid-phase endocytosis and receptor-mediated 
endocytosis. When exposed to pathogens this capacity is transiently 
enhanced. Activated DC process the captured antigens and differentiate into 
mature DC. Meanwhile, the cells migrate out of the tissue via the efferent 
lymph to the draining lymph node. Mature DC have lost their capacity to 
endocytose, but have become excellent APC, high in costimulatory molecules 
and MHC-peptide complexes and with a dendritic morphology. In the lymph 
node DC migrate into the T cell-rich area where they encounter T cells 
(Banchereau et al., 2000; Austyn, 1998).  
Origin and subsets 
DC reside in small numbers in tissues that are potential sides of pathogen 
entry. They are continuously replenished by precursors in the blood that are 
generated from hematopoietic stem cells in the bone marrow and may include 
blood precursors as well as monocytes (fig. 1). Precursors that have entered 
the tissue differentiate into tissue-specific immature DC, e. g. dermal dendritic 
cells and Langerhans cells in the skin and gut DC in the intestine. Two major 
populations of immature DC have been identified: the CD11chigh myeloid DC 
and the CD11clow plasmacytoid DC (Kapsenberg, 2003; Cella et al., 1997; 
Ardavin et al., 2001; Shortman and Liu, 2002). Many more subpopulations of 
DC have been characterized, however discussing all subclasses would go 
beyond the scope of this thesis. Most functional experiments have been 
carried out with classical myeloid DC derived from monocytes that are cultured 
with IL-4 and GM-CSF (Sallusto and Lanzavecchia, 1994). In the study 
described in chapter 2 monocyte-derived DC were used to study the 
maturation of DC.  
Activation 
Different types of signals can induce the maturation of DC. The first is the 
pathogen itself (or parts of it) that binds to pathogen recognition receptors on 
the cell surface of the DC such as toll-like receptors (TLR1-9) (Kadowaki et al., 
2001). For example, the bacterial wall substance lipopolysaccharide (LPS) 
binds to TLR4 and induces activation of DC (Chow et al., 1999; Rescigno et 
al., 1998). Secondly, mediators, that are produced by cells in the infected 
tissue can activate DC, such as cytokines, like TNFα and IL-1, and 
prostaglandins (Steinbrink et al., 2000; Jonuleit et al., 1996; Gallucci and 
Matzinger, 2001). In addition, cross-linking of CD40 molecules on the cell 
membrane of the DC can induce the maturation of DC. CD40 cross-linking 
occurs by the binding with its ligand CD40L, which is mainly expressed on 
activated T helper cells and is thought to be crucial for full maturation of DC 
and optimal activation of cytotoxic T cells (Cella et al., 1996; Schoenberger et 
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al., 1998). In chapter 2 the maturation of dendritic cells is studied using 
stimuli from each category.  
MHC class I pathway MHC class II pathway

















Figure 2. Antigen processing and presentation in MHC class I and II molecules. 
Cytosolic proteins, both self and non-self like viral proteins, are degraded by the 
proteasome. Antigenic peptides are transported via the transporter associated with antigen 
processing (TAP) into the endoplasmic reticulum (ER). In the ER antigenic fragments can 
form complexes with the MHC class I heavy chain and light chain. MHC class I-peptide 
complexes are then transported via the trans-Golgi network to the plasma membrane. 
Exogenous peptides are internalized in the endosomal/lysosomal pathway. In endosomes 
and lysosomes degradation of the antigens takes place by various proteases. MHC class II 
molecules are synthesized in the ER and are protected from endogenous peptides by the 
invariant chain. Vesicles containing MHC class II molecules fuse with late endosomes/early 
lysosomes and form the MHC class II rich compartment (MIIC). In the MIIC the invariant 
chain is replaced by antigenic peptides from the endosome. MHC class II-peptide 
complexes are then transported to the plasma membrane. DC are the only cells that are 
capable of presenting exogenous antigens in the context of MHC class I molecules, also 
called cross-presentation. The mechanisms for cross-presentation are yet poorly 
understood. Exogenous antigens may be released into the cytoplasm and processed by the 
proteasome and/or endocytosed MHC class I molecules may be loaded in the MIIC together 
with MHC class II molecules. 
Antigen capturing and processing 
Immature DC internalize antigens from its environment by fluidphase 
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endocytosis and receptor-mediated endocytosis (Lanzavecchia, 1996). DC 
express a wide range of receptors for recognition of glycoproteins, such as C-
type lectins (mannose receptor, DC-SIGN, Langerin), conserved microbial 
patterns, such as toll-like receptors, and binding of antigen-antibody 
complexes via Fc receptors, that mediate internalization of antigens 
(Geijtenbeek et al., 2004; Gallucci and Matzinger, 2001). Depending on their 
tissue localization and differentiation state, DC are specialized to respond to 
specific microbes, by expressing distinct sets of TLR and C-type lectins (Kaisho 
and Akira, 2003). Antigen capturing is maximal shortly after activation of the 
DC and is down-regulated in mature DC to ensure that primarily antigens that 
were present at the time of infection will be processed and presented to T 
cells (Granucci et al., 1999). After uptake, antigens traffic through the 
endosomal/lysosomal pathway to be degraded (Pieters, 1997). Endosomes 
containing internalized antigens fuse with the so called MHC class II rich 
compartment (MIIC) where antigens are degraded into antigenic fragments 
and loaded onto MHC class II molecules (Neefjes, 1999; Watts, 2001). DC are 
exclusive in that they can also pass exogenous-peptides on to the MHC class I 
pathway (Thery and Amigorena, 2001; Heath et al., 2004; den Haan and 
Bevan, 2001; Gromme et al., 1999), enabling them to activate both CD4+ and 
CD8+ T cells (discussed later in this chapter). More details on antigen 
presentation by MHC class I and II by DC can be found in figure 2.  
DC maturation 
The functional modifications during maturation transform immature DC with 
low T cell stimulating capacity into potent T cell stimulating mature DC (fig. 
3). In the first place, maturation of DC leads to a selective decrease of antigen 
and pathogen internalization activity and the redistribution of MHC molecules 
from intracellular endocytic compartments to the cell surface. In addition, 
mature DC show surface expression of several integrins and chemokine 
receptors, which enables them to migrate out of the tissue via the efferent 
lymph nodes to present captured antigens to T cells in the local draining 
lymph node. Mature DC increase the surface expression of costimulatory 
molecules, like CD80 and CD86, and adhesion molecules for the activation of 
T cells (Banchereau et al., 2000; van der Merwe and Davis, 2003). Maturation 
of DC also entails the re-organization of their cytoskeleton. In mature DC 
cytoskeletal rearrangements are involved in high cell motility typical for 
mature DC, the formation of dendrites and veils, and the establishment of 
stable immunological synapses with antigen-specific T cells (Banchereau et al., 
2000; Al-Alwan et al., 2001b; Al-Alwan et al., 2001a). Furthermore, mature 
DC secrete chemokines to attract T cells and cytokines to influence their 
function (Banchereau et al., 2000). DC produce distinct sets of cytokines 
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dependent on the encountered stimuli and the maturation state of the cell 
(Kapsenberg, 2003). Different cytokine profiles can polarize T helper cells to 
Th1, Th2, or T regulatory cells (see Effector T cells). For full activation of 
cytotoxic T cells, DC have to interact first with antigen-specific T helper cells 
via CD40-CD40L (Cella et al., 1996; Schoenberger et al., 1998). The DC 
system is very efficient as one single DC can influence the function of between 
300 and 1000 T cells. The study presented in chapter 2 describes the 
change in morphology of DC after activation with different stimuli and 
identifies a potential key role player in the cytoskeletal rearrangements during 
DC maturation.  





MHC I-peptide complex MHC II-peptide complex Costimulatory molecules
 
Figure 3. Functional changes during DC maturation. Immature DC are characterized 
by a high endocytic capacity, low expression of costimulatory molecules and well-developed 
MHC class II rich compartments (MIIC). After maturation the endocytic capacity and MIICs 
are lost. Instead, mature DC have high expression levels of MHC class II and costimulatory 
molecules. Furthermore, mature DC develop dendrites and veils and are highly motile. 
Moreover, CCR7, the chemokine receptor for lymph node homing, is up-regulated, while 




T cell differentiation 
Like DC, T cells are derived from hematopoietic stem cells in the bone marrow 
(Akashi et al., 2000). Early in the development precursor T cells migrate to the 
thymus, where they further differentiate into mature T cells (Delves and Roitt, 
2000b). Central in the differentiation is the production of a functional T cell 
receptor that is specific for foreign antigens. The expression of T cell antigen 
receptors (TCR) is initiated by somatic recombination of gene segments that 
code for the variable regions of the receptors. Diversity is created during this 
process, so that every T cell expresses an unique antigen receptor. 
Subsequently, T cells are selected for the recognition of self-MHC molecules, 
but not self-antigenic peptides. Naïve T cells leave the thymus and circulate 
through the peripheral blood (Spits et al., 1998; Berg and Kang, 2001). 
Through the expression of the chemokine receptor CCR7 they home to the 
lymph nodes (Sallusto et al., 1998b; Dieu et al., 1998), where they will 
interact with DC and after recognition of the right peptide-MHC complex, will 
be activated into effector or memory T cells. T cells are divided into CD4+ and 
CD8+ subsets (Chaplin, 2003; Singer et al., 1999). CD4+ T cells usually act as 
helper cells and can be further subdivided in Th1, Th2 and T regulatory cells 
(Tr; also called suppressor T cells or Th3) on the basis of their cytokine 
profiles. T helper cells recognize antigen-derived peptides presented by MHC 
class II and act primarily to regulate the cellular and humoral immune 
responses (Delves and Roitt, 2000b; Kidd, 2003). CD8+ T cells are usually 
cytotoxic and recognize antigenic peptides in the context of MHC class I 
(Delves and Roitt, 2000b).  
T cell activation 
When traveling through the T cell areas of the lymph node, T cells will 
encounter DC that present foreign antigens in the context of both MHC class 
II and I. To recognize antigen, T cells need to establish a stable contact with 
APC by the formation of an immunological synapse, where T cell receptors 
and costimulatory molecules are congregated in a central area surrounded by 
a ring of adhesion molecules (Kupfer and Kupfer, 2003). The quality and 
duration of the contact determines the outcome of the interaction; 
differentiation into effector or memory cells or the development of tolerance, 
and is dependent on three factors: (1) the level of peptide-MHC complexes 
that initiate signal transduction (2) the level of costimulatory molecules that 
amplify the signaling process, and (3) the stability of the synapse 
(Lanzavecchia and Sallusto, 2001). The efficiency of the synapse as a signal 
transducing machinery varies with the nature of the APC and the 
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developmental stage of T cell. In naive T cells, TCR are inefficiently coupled to 
down-stream signal transduction pathways and are highly dependent on 
costimulatory molecules expressed on the APC. In contrast, in effector, and 
memory T cells, TCR triggering is efficiently coupled to signal transduction 
pathways so that the cells can rapidly respond to low doses of antigen even in 
the absence of costimulation.  
Effector T cells 
The two principal subsets of T cells are the CD4+ and the CD8+ positive T 
cells. After activation the majority of the CD8+ T cells mature into cytotoxic T 
cells (CTL), that can kill autologous cells that are infected with intracellular 
bacteria or viruses. CD4+ T cells differentiate mainly into T helper cells upon 
activation (Chaplin, 2003; Delves and Roitt, 2000b). T helper cells can be 
subdivided into Th1, Th2 and Tr cells on the basis of their cytokine secretion 
profile. The Th1 pathway primarily acts against intracellular pathogens, 
particularly viruses and bacteria, by helping the activation of cytotoxic T cells 
and stimulating CTL, NK cells and macrophages. Th2 cells are believed to 
emphasize protection against extracellular pathogens, by stimulation of 
antibody production of B cells, and of mast cells, basophils and eosinophils. T 
regulatory cells (Tr) comprise of 5 to 10 percent of the total peripheral T cells 
pool and are potent immunosuppressors (Kidd, 2003). Tr are required for the 
tolerance against self and harmles environmental proteins. Furthermore, they 
prevent excessive inflammation during protective immunity.  
The array of cytokines produced by Th1 and Th2 cells varies greatly. In 
general, Th1 cells secrete far more interferon (IFN) -γ and interleukin (IL) -2 
than Th2 cells and Th2 cells produce far more IL-4 (and possibly IL-5) than 
Th1 cells (Kidd, 2003). Tr cells typically secrete large amounts of either IL-10 
or transforming growth factor (TGF) -β. T cell polarization is likely determined 
under control of APC (Kapsenberg, 2003; Moser and Murphy, 2000; Kidd, 
2003), via costimulatory molecules and the secretions of cytokines and/or 
chemokines (Kapsenberg, 2003; Kidd, 2003). However, also factors produced 
by NK cells, mast cells and eosinophils and other cells may contribute to the 
differentiation into T cells (Kidd, 2003). Not only their cytokine profile, but also 
the expression of chemokine receptors distinguishes Th1 or Th2 cells. The 
chemokine receptors CCR5 and CXCR3 are preferentially expressed on Th1 
and CCR3, CCR4, CCR8 are mainly found on Th2 cells (Zlotnik et al., 1999). 
Commitment to the Th1 or Th2 type appears to be final (Kidd, 2003). After 
activation, CD8+ and CD4+ effector/memory T lymphocytes migrate out of the 
lymph node and into the circulation. The expression of chemokine receptors 
will lead them to different tissues and eventually to the site of inflammation.  
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Skin immune system 
Skin architecture and immune cells 
With a surface of 1.5-2 m2 the skin is the largest organ of the human body. It 
has a thermoregulation and a barrier function and protects against external 
physical, chemical and biological aggressions (Wysocki, 1999). The skin 
consists of three layers, the epidermis, the dermis and the subcutaneous 
tissue or subcutis (fig. 4). The epidermis is the most superficial layer of the 
skin and provides the first barrier against the invasion of foreign substances 
into the body. The principal cells of the epidermis are the keratinocytes, which 
are arranged in continuous layers, comprising: the statum basale, stratum 
spinosum (5-15 layers of cells), stratum granulosum (1-3 layers), and the 
stratum corneum (5-10 layers). Besides keratinocytes, the epidermis contains 
melanocytes and Merkel cells (mechano receptors), but also immune cells like 
Langerhans cells (3-6%) and a small percentage of lymphocytes (<1.3%) with 
a T memory/effector phenotype. The dermis and the epidermis are separated 
by a basement membrane that supports the basal keratinocytes and regulates 
exchanges of metabolic products. Through the basement membrane immune 
cells can migrate from and into the epidermis. The dermis consists mainly of 
supportive, compressible and elastic connective tissue and contains 
fibroblasts, next to vessels, nerve endings and sweat glands. The upper layer 
of the dermis contains scattered DC, macrophages and mast cells and 
sporadic T cells. The deepest layer of the skin is the subcutis, which is mainly 
made of fatty tissue. Adipocytes are arranged in primary and secondary 
lobules, separated by connective tissue septa containing fibroblasts and also 
DC and mast cells (fig 4) (Kupper and Fuhlbrigge, 2004; Kanitakis, 2002).  
Immune function of the skin 
The first barrier against the invasion of microorganisms is a physical one 
formed by the stratum corneum, which is made of flattened, anucleate 
cornified cells that are tightly packed in a lipid matrix. The second line of 
defense are the cells resident in the skin, like keratinocytes and immune cells, 
which function as sentinels for danger signals. Infiltration of pathogens results 
in the release of mediators, such as cytokines, chemotactic proteins, and 
antimicrobial peptides (Kupper and Fuhlbrigge, 2004; Yang et al., 2004). 
These proteins can act either directly on the cause of stress, like antimicrobial 
peptides, or activate residing immune cells and/or attract leukocytes form the 
peripheral blood. In addition, stress can also directly lead to the activation of 
skin-residing DC. Both the dermis and the epidermis contain DC: the dermal 
DC and the Langerhans cells, respectively. These cells remain in the skin for 
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longer periods of time as resting cells until they are activated by stress 
factors. Sporadic cutaneous lymphocyte-associated antigen (CLA) positive 
memory T cells are found throughout the skin and probably have a role in 
immune surveillance. Inflammation will attract great numbers of effector T 
cells, neutrophils, NK cells and macrophages and increase the number of DC 






















Figure 4. Architecture of the epidermis and the upperlayer of the dermis. Immune 
cells are present throughout the skin. In the epidermis mainly Langerhans cells are found 
and sporadic T cells (not shown). In the dermis, Dermal DC are present alongside mast 
cells and T cells. The dermis is easily accessable for leukocytes via microvessels in the case 
of inflammatory stimuli. 
Langerhans cells 
Langerhans cells (LC) represent the dendritic cells of the epidermis. In LC, a 
cytosolic organelle called the Birbeck granule is found which is exclusively 
expressed in immature LC. This organelle consists of superimposed and 
zippered membranes (Birbeck et al., 1961) that are positive for the C-type 
lectin Langerin (Valladeau et al., 1999). Langerin is specifically expressed by 
Langerhans cells and not only functions as a carbohydrate receptor but is also 
involved in the biogenesis of Birbeck granules (Valladeau et al., 2000). The 
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function of these granules is still poorly understood, but there are indications 
that they are actively involved in receptor-mediated endocytosis and 
participate in the antigen-processing/presenting function of LC (McDermott et 
al., 2002). The importance of Birbeck granules in the immune system can be 
questioned as in 1994 an healthy white man was identified whose LC 
completely lacked this organelle (Mommaas et al., 1994). Based on 
morphological criteria, the expression of characteristic LC markers such as 
MHC class II and CD1a, and antigen-presenting capacity, these LC appeared 
otherwise normal and functional, suggesting that Birbeck granules are not a 
prerequisite for normal LC function. In the Birbeck granule deficient person no 
labeling was detected with antibodies that are now known to recognize 
Langerin. Chapter 3 describes the identification of a genetic defect that may 
cause the lack of Birbeck granules and the absence of antibody staining in the 
Langerhans cells of this person.  
Homing of T lymphocytes in the skin 
Homing 
For homing of circulating leukocytes, they have to extravasate through a 
series of steps through the endothelium of blood vessels in the relevant organ 
site and migrate into the tissue (Fig. 5) (Thomsen et al., 2003). Homing to 
specific tissues is controlled by the combined expression of different 
chemokine receptors and specific adhesion molecule receptors. The earliest 
step in the recruitment of leukocytes is the tethering and rolling on selectins 
expressed by post-capillary venules. In addition, endothelial cells express high 
levels of adhesion molecules and can bind chemokines on their cell surface. 
Chemokine-binding to receptors on leukocytes is critically involved in 
activating integrins on the leukocyte, resulting in increasing avidity to 
vascular-endothelial-integrin ligands (Cinamon et al., 2001a; Thomsen et al., 
2003). Subsequently, integrin-binding to its ligand on the endothelium leads to 
the arrest of leukocytes. For transendothelial migration leukocytes are 
dependent on chemokines bound to the vessel wall (Cinamon et al., 2001a).  
Homing to the skin is established by the co-expression of CLA with specific 
chemokine receptors. CLA on the T cells will interact with E-selectin on the 
dermal post-capillary venules and initiate rolling and tethering of the cells. 
Chemokine binding to receptors on the T cell activates lymphocyte function-
associated antigen-1 (LFA-1), which will interact with intercellular adhesion 
molecule (ICAM) -1 on the endothelial cell. The interaction with integrins and 
endothelial-bound chemokines will then lead to the arrest of the T cell and to 
transmigration into the tissue. T cells are then further directed along the 


















Figure 5. Schematic overview of the recruitment of leukocytes from 
microvessels into the tissue. Circulating leukocytes bind to adhesion molecules and 
chemokines bound to surface receptors on the endothelial cells of the inflamed tissue. 
Leukocytes then transmigrate through the endothelial layer and the basement membrane 
into the surrounding tissue. Chemokine gradients will then lead the cells to its destination. 
The arrest of leukocytes in the microvessel and the attraction of these cells in the tissue 
may be regulated by different chemokines and receptors (modified from Thomsen et al. 
2003). 
Chemokines and receptors 
Although selectins and integrins are important in the arrest of leukocytes at 
specific sites to allow transmigration, it is essentially the chemokines that 
specifically target leukocytes to tissues and sites of inflammation. Nowadays, 
more than 45 chemokines have been identified in humans, binding to at least 
18 different receptors. Chemokines are small proteins involved in the 
recruitment and homing of leukocytes. These proteins are subdivided into four 
families based on the relative position of conserved cysteine residues: CC, 
CXC, CXXXC, and XCL, with the CC and CXC groups being the far most 
common ones (Zlotnik and Yoshie, 2000; Murphy et al., 2000). Chemokines 
are produced by tissue cells and leukocytes and act through corresponding 
groups of CCR, CXCR, CX3CR and XCR receptors of the seven-transmembrane, 
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G protein-coupled receptor family. Several chemokines can bind the same 
receptor and one chemokine can bind to several receptors creating multiple 
combinations and, therefore, multiple biological outcomes. Functional 
consequences of chemokine receptor activation are not limited to locomotion. 
Granule exocytosis, gene transcription, mitogenic effects and apoptosis are 
also affected by chemokines (Thelen, 2001; Whiting et al., 2004). In addition, 
chemokine receptors may be expressed by cells other then leukocytes, 
including endothelia, stromal cells, smooth muscle cells, epithelia and neurons 
(Rollins, 1997). Thus, in addition to localization of cells of the immune system 
to particular compartments, chemokines may be involved in other aspects of 
tissue homeostasis.  
The chemotactic function of chemokines can be classified into two categories: 
constitutive and inducible chemokines. Constitutive chemokines are involved in 
the development of lymphatic tissues, basal leukocyte trafficking and immune 
surveillance. Inducible chemokines are produced upon infection or other stress 
signals and regulate the recruitment of leukocytes to sites of inflammation 
(Zlotnik et al., 1999). The production of inducible chemokines is stimulated by 
early pro-inflammatory cytokines, such as IL-1 and TNF-α, bacterial products, 
such as lipopolysaccharide, and viral infection (Baggiolini, 1998). In addition, 
IFN-γ and IL-4, products of Th1 and Th2 lymphocytes, respectively, can 
induce the production of chemokines (Garcia-Zepeda et al., 1996a; Garcia-
Zepeda et al., 1996b), thereby reinforcing the type 1 or type 2 immune 
response.  
Skin homing, CLA+ T cells typically co-express CCR4. Its ligands CCL17 
(thymus and activation-regulated chemokine, TARC) and CCL22 (macrophage-
derived chemokine, MDC) are associated with T cell migration into the skin. 
Both ligands are constitutively expressed on cutaneous venules and are 
produced during inflammatory conditions by skin fibroblasts and keratinocytes 
(Yu et al., 2002; Horikawa et al., 2002; Chong et al., 2004). The expression of 
CCR4 ligands, E-selectin and ICAM1 by endothelial cells is constitutive and is 
up-regulated upon inflammation. CCL27 (formerly known as cutaneous T cell-
attracting chemokine; CTACK) is constitutively produced by keratinocytes, but 
can also be induced upon stimulation with tumor necrosis factor α (TNF-α) 
and IL-1β (Homey et al., 2000; Homey et al., 2002) and selectively recruits 
CLA+ memory T cells to the skin (Morales et al., 1999). Also, CCL27 appears to 
be involved in local retention of CCR10+/CD4+ T cells, likely memory T cells, to 
the skin (Moed et al., 2004). Leukocytes that have been recruited to the site 
of inflammation can also stimulate the chemoattraction of more immune cells 
by the secretion of cytokines that promote the production of chemokines by 
surrounding tissue cells (fig. 5). For example, IFN-γ, produced by Th1 cells, 
can stimulate keratinocytes to produce a range of products, including the 
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chemokines CXCL9, CXCL10, and CXCL11 (Boorsma et al., 1998; Albanesi et 
al., 2000). The secretion of these chemokines then results in the recruitment 
leukocytes that express the chemokine receptor CXCR3 (Kupper and 
Fuhlbrigge, 2004). CXCR3 expression and/or its ligands are associated with 
atopic dermatitis, contact dermatitis, mycosis fungoides, psoriasis and other 
types of skin inflammation (Shimada et al., 2004; Serra et al., 2004; 
Yamaguchi et al., 2003; Kallinich et al., 2003; Flier et al., 2001; Tokuriki et al., 
2002).  
CXCR3 
CXCR3 is expressed mainly on activated T cells (both CD4+ and CD8+ T cells), 
but can also be found on B cell plasmablasts and NK cells (Inngjerdingen et 
al., 2001; Loetscher et al., 1998). Expression of CXCR3 on CD4+ T cells is 
associated with a Th1 phenotype, although it is also expressed by a small 
subset of Th2 cells (Kim et al., 2001). The ligands of CXCR3, CXCL9 
(monokine induced by IFN-γ, MIG), CXCL10 (IFN-γ-inducible protein 10, IP10) 
and CXCL11 (IFN-inducible protein 9, IP-9; IFN-γ-inducible T cell α-
chemoattractant, ITAC) are produced under the influence of IFN-γ, secreted 
by Th1 cells. In the skin, large amounts of CXCL9-11 are secreted by 
fibroblasts in the dermis and keratinocytes in the epidermis when stimulated 
with IFN-γ (Villagomez et al., 2004; Boorsma et al., 1998; Albanesi et al., 
2000). Secretion of CXCL9-11 is associated with infiltrates of Th1 cells and 
CTL in both normal inflammation and in inflammatory diseases and is often 
found in type 1 immune responses.  
CXCR3 and its ligands CXCL9-11 are not restricted to inflammatory skin 
diseases, but are also found during inflammation in a wide range of other 
tissues, including liver, brain and intestine. Expression of CXCR3 ligands and 
infiltration of CXCR3+ cells have been demonstrated in rheumatoid arthritis 
(Qin et al., 1998; Patel et al., 2001), multiple sclerosis (Balashov et al., 1999), 
hepatitis C–infected liver (Shields et al., 1999), and artherosclerosis (Mach et 
al., 1999). The association of CXCR3 with a wide range of immune disorders 
makes it an attractive target for therapeutic applications. Blocking of CXCR3-
ligand interactions in inflammatory disorders may attenuate cell-mediated 
immune reactions by preventing recruitment of CXCR3+ CTL and Th1 cells. In 
addition, blocking CXCR3 or its ligands, may delay graft rejection (Hancock et 
al., 2001; Meyer et al., 2001; Baker et al., 2003; Belperio et al., 2002). On the 
other hand, expression or injection of CXCR3-ligands in tumors may enhance 
anti-tumor reactivity. For the development of therapies specifically acting on 











































Figure 6. Schematic overview of a selection of signal transduction pathways 
activated by chemokine receptors. Chemokine receptor triggering leads to the 
activation of Gi-proteins. The βγ subunits subsequently activate PI3Kγ and PLCβ2 and β3. 
Activation of PLC results in the formation of inositol-1,4,5-triphosphate (IP3) and 
diacylglycerol (DAG). DAG is a potent activator of protein kinase C (PKC), while IP3 binds to 
the IP3 receptor on intracellular Ca2+ stores, resulting in the release of calcium into the 
cytosol. This release subsequently induces the influx of calcium via store operated calcium 
(SOC) channels. Some subsets of PKC are also activated by increased levels of calcium. The 
α subunit of the Gi protein activates Src-like kinases, which in turn can activate PI3K and 
mitogen activated protein kinases (MAPKs), like the MEK1/2-p44/p42 pathway. Activation of 
PI3K leads to activation of Akt.  
Signal transduction  
A great number of activities of the cell are regulated by ligands binding to 
receptor on the plasma membrane. The outcome of receptor triggering 
depends on the signal transduction pathways that are linked to the receptor. 
Signaling can lead to direct effects, such as activation of integrins, cytokine 
secretion and/or activation of cytoskeletal rearrangements, and indirect effects 
by activation of gene transcription (Thelen, 2001; Whiting et al., 2004). 
Knowledge of transcription pathways used by certain receptors and their 
effects may reveal leads for the development of specific intervention therapies 




The family of chemokine receptors belongs to the seven-transmembrane 
domain, G-protein coupled receptors. They signal predominantly via Gi 
proteins and regulate Ca2+ fluxes. After activation, the α and βγ subunits of 
the Gi-protein each activate a cascade of signaling events. This paragraph will 
describe the some of the best studied signal transduction pathways that are 
involved in chemokine signaling and are depicted in figure 6. Following 
receptor triggering, the βγ subunits of Gi activate phosphatidylinositol-3-kinase 
(PI3K) -γ and phospholipase C (PLC) β1 and β2 isoenzymes. Several studies 
show crucial roles for PI3K in leukocyte migration. Activation of PLC leads to 
the formation of inositol-1,4,5-triphosphate (IP3) and a transient rise in the 
concentration of intracellular calcium. This increase in intracellular calcium has 
been widely used to test the responsiveness of chemokine receptors to 
different chemokines. Another product of PLC is diacylglycerol (DAG), which is 
a potent activator of protein kinase C (PKC). Some subsets of PKC are also 
activated by increased levels of calcium. The α subunit of the Gi protein 
activates Src-like kinases, which in turn can activate PI3K and mitogen 
activated protein kinases (MAPKs) (Thelen, 2001).  
CXCR3-triggering also elicits Ca2+ mobilization in CXCR3-transfected cells 
(Loetscher et al., 1996; Tensen et al., 1999) and in peripheral blood T cells 
and NK cells (Rabin et al., 1999). Furthermore, binding of CXCL10 to CXCR3 
on pericytes obtained from human liver activates the PI3K/Akt pathway and 
the ras/raf/Mek/p44/p42 pathway, probably via Src. In these pericytes, PI3K 
and MEK are involved in CXCR3-mediated migration (Bonacchi et al., 2001). 
Which signal transduction pathways are used by CXCR3 on activated T cells 
and how they are involved in CXCR3-mediated effects is largely unknown. In 
chapter 4 the functional importance of the PI3K/Akt pathway and the 
MEK/p44/p42 pathway in T cell migration is studied. In chapter 5 the 
characteristics and importance of Ca2+ mobilization following CXCR3-triggering 
is determined. Stimulation of CXCR3+ cells not only induces chemotaxis, but 
also stimulates proliferation of T cells and the production of IFN-γ by activated 
CD4+ T cells (Whiting et al., 2004). Knowledge of all signal transduction 
pathways involved in CXCR3-signaling and their functional importance may 
facilitate the development and evaluation of new therapeutic agents that are 
aimed at CXCR3+ T cells. Development of these agents may be focused on 
neutralization of CXCR3 ligands, by administration of blocking antibodies (Xie 
et al., 2003), or on the receptor itself, either by blocking the ligand binding 
site or by intervening in the relevant ligand-induced signaling pathways. In 
collaboration with the dept. of Pharmacochemistry, Free University, 
Amsterdam an antagonist for CXCR3 is now being developed and tested in 
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Abstract 
Upon activation, tissue residing immature dendritic cells (DC) start to migrate 
towards the draining lymph node and mature into efficient antigen-presenting 
cells. During maturation DC loose their capacity to endocytose antigens, 
change their surface expression of adhesion molecules, chemokine receptors, 
and costimulatory molecules, and change morphology. We employed 2D-PAGE 
and mass spectrometry to identify additional differentially expressed proteins 
in immature and mature DC. Human monocyte-derived DC were matured with 
LPS and protein expression profiles were compared before and after 
maturation. One of the proteins differentially expressed between immature 
and mature DC was identified as the actin-binding protein cofilin. We show 
here that cofilin is dephosphorylated in response to several maturation stimuli 
(i. e. CD40 ligand, LPS or a combination of TNF-α and prostaglandin E2). 
Moreover, dephosphorylated cofilin translocated towards the 
plasmamembrane during maturation. Importantly, this correlated with an 
increase in filamentous actin and the appearance of veils, suggesting a role 
for cofilin in cytoskeletal rearrangements during maturation.  
Introduction  
Dendritic cells are professional antigen-presenting cells that have a central 
role in the initiation of both innate and adaptive immune responses {reviewed 
in (Banchereau et al., 2000; Cella et al., 1997; Gallucci and Matzinger, 2001; 
Hartgers et al., 2000)}. DC are essential for the induction of efficient T cell 
responses as they are the only cell type able to prime naive T cells and to 
cross-present exogenous peptides in MHC class I molecules. The majority of 
DC in the periphery are in an immature state. Immature DC are poor T cell 
stimulators and reside in non-lymphoid tissues or circulate through the 
peripheral blood. They are specialized in the uptake of antigen and function as 
the sentinels of the immune system. After the encounter with inflammatory 
signals, such as LPS, DC enhance their uptake of foreign antigens and activate 
the machinery involved in processing and presenting them (Granucci et al., 
1999). Simultaneously, DC start to mature and migrate towards the draining 
lymph node, where they interact with T cells and initiate an immune response. 
During maturation, DC undergo many phenotypical and morphological 
changes. Mature DC have lost the ability to capture antigen and have up-
regulated MHC class II and costimulatory molecules. Inflammatory stimuli also 
induce a change in the expression of chemokine receptors and adhesion 
molecules that are involved in migration. Furthermore, changes in morphology 
of the cell, such as the formation of veils and dendrites, may augment the 
establishment of DC-T cell contacts and improve the DC-T cell interaction. 
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Differences between immature and mature DC have been studied extensively. 
Most studies focus on mRNA expression patterns, with techniques such as 
DNA microarrays (Ahn et al., 2002; Granucci et al., 2001; Huang et al., 2001; 
Le Naour et al., 2001; Pulendran et al., 2001). However, these techniques do 
not provide information on protein expression, activity and post-translational 
modifications.  
We have now compared protein expression profiles acquired by two-
dimensional (2D) polyacrylamide gel electrophoresis (PAGE) to identify novel 
proteins putatively involved in the differentiation from immature to mature 
DC. With this approach, several proteins were found to be differentially 
expressed between immature and mature monocyte-derived DC. By mass 
spectrometry one of these proteins was identified as cofilin, an actin-binding 
protein involved in the turnover and severing of actin filaments {reviewed in 
(Bamburg, 1999; Chen et al., 2000; Holt and Koffer, 2001; Weber, 1999)}. 
Cofilin is inactivated by phosphorylation on its serine at position 3, which 
blocks its activity by interfering with the binding to actin (Agnew et al., 1995; 
Moriyama et al., 1996). We show here that cofilin phosphorylation is regulated 
during DC maturation. Furthermore, we observed translocation of cofilin to the 
cell membrane concomitant with an increase in the concentration of 
filamentous actin (F-actin) near the cell membrane, suggesting a role for 
cofilin in cytoskeletal rearrangements during DC maturation.  
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Materials and methods  
Antibodies and reagents  
Purified antiserum against phosphorylated cofilin used for fluorescence 
microscopy was prepared as described previously (Toshima et al., 2001). The 
antiserum against phosphorylated cofilin usedf or immunoblot detection was 
generously donated by J. R. Bamberg (Colorado State University, Fort Collins, 
CO). Anti-cofilin and -profilin were purchased from Cytoskeleton, rhodamine-
phalloidin, and secondary antibodies labeled with fluorochromes were 
obtained from Molecular Probes (Leiden, The Netherlands), goat anti-rabbit 
peroxidase-conjugated secondary antibody was from Pierce (Rockford, IL) 
Antibodies against CD40, CD80, CD83 and HLA-DR and isotype controls 
labeled with FITC or phycoerythrin were from Becton Dickinson (Alphen a/d 
Rijn, The Netherlands). Human cofilin was obtained from Tebu-bio 
(Heerhugowaard, The Netherlands).  
DC culture  
Monocytes were purified from human PBMC by positive selection with CD14 
microbeads (Miltenyi Biotec, CLB, Amsterdam, The Netherlands). Monocytes 
(>95% pure) were cultured in RPMI 1640 with 2 mM L-glutamine, 100 U/ml 
penicillin and 100 mg/ml streptomycin and 10% FCS (all from Gibco-BRL, GB), 
800 U/ml GM-CSF (Leukomax; Novartis Pharmaceuticals, East Hanover, NJ), 
and 500 U/ml IL-4 (PeproTech, Rocky Hill, NJ). After 6 days, cells developed 
into typical immature DC being CD14-, CD1a+, CD11c+, CD80-, CD86low, HLA-
DRintermediate, and CD83- (data not shown). For maturation, DC were 
incubated with 10 mg/ml LPS from Escherichia coli (Sigma-Aldrich, 
Zwijndrecht, The Netherlands) for 24 or 48 h. After 24-h stimulation with LPS, 
DC showed a typical mature phenotype, being CD1ahigh, HLA-DRhigh, CD80high, 
CD86high, and CD83+. Alternatively, DC were matured with L-cells transfected 
with human CD40L (Garrone et al., 1995) (L-CD40L) in a 1:4 ratio to DC or 
with a combination of 100 nM prostaglandin E2 (PGE2; Sigma) and 50 ng/ml 
TNF-α (R and D systems, Abingdon, GB) (Lee et al., 2002). Mouse fibroblast 
L-cells, non-transfected (L-orient) or stably transfected with CD40L (L-CD40L) 
were grown in RPMI, 10% FCS and penicillin/streptomycin. For co-culture 
experiments, L-cells were irradiated (80 Gy) before addition to the DC culture. 
Expression of HLA-DR, CD86, CD83, and CD40 was analyzed by flow 
cytometry (FACScan, BD Biosciences, Mountain View, CA). Relative expression 
was determined by the ratio MFIt=x/MFIt=0.  
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Two-dimensional polyacrylamide gel electrophoresis  
Cell pellets, consisting of 1 × 106 cells, were lysed directly in 500 µl of 8 M 
urea containing 2% (w/v) CHAPS, 0.5% (v/v) IPG buffer pH 3-10 (Amersham 
Pharmacia Biotech, Roosendaal, The Netherlands) and 10 mM dithioerythritol 
(DTE). After 60 min the samples were centrifuged to sediment insoluble cell 
components. Lysates were then applied onto isoelectric focusing immobiline 
DryStrips with a linear gradient from pH 3 to 10 (Amersham Pharmacia 
Biotech). After rehydration of the IPG-strips for 12 h, proteins were focused 
for 50,000 Vh at room temperature. Prior to the second dimension, strips were 
equilibrated in 2% w/v DTE, followed by 2.5% w/v iodoacetamide, both in 6.0 
M urea, 2% SDS, 30% glycerol in 50 mM Tris-HCl (pH 6.8) for 15 min. After 
this procedure, the strips were placed on top of a 12% polyacrylamide gel 
(2.6% C piperazine diacryl, 375 mM Tris/HCl pH 8.8) and electrophoresed 
overnight. Proteins were visualized using silver staining as described 
previously (Aizawa et al., 1997).  
Protein identification by mass spectrometry  
Protein spots of interest were excised out of the 2D gels. Gel pieces were 
successively washed with distilled water, 50% acetonitrile in water and 100% 
acetonitrile. After freeze-drying, the gel pieces were equilibrated by incubating 
with 0.1 M DTT in 0.1 M sodium bicarbonate for 45 min at 56° C and 55 mM 
iodoacetamide in 0.1 M sodium bicarbonate for 30 min at room temperature. 
The gel slices were then washed with 50% acetonitrile in 0.1 M sodium 
bicarbonate and 100% acetonitrile in succession. Tryptic digestion was 
performed overnight at 37° C with 10 ng/ml trypsin (Promega Benelux, 
Leiden, The Netherlands) in 50 mM sodium bicarbonate. Peptides were 
extracted by first adding 50 ml of 0.1% TFA for 15 min and then 50 ml 
acetonitrile for another 15 min. The supernatant was then transferred to a 
glass tube for mass spectrometry and the procedure was repeated. The 
supernatant was dried down in a speedvac and samples were analyzed by 
mass spectrometry.  
Mass spectrometry  
Electrospray ionization mass spectrometry was performed using a Q-TOF1 
hybrid mass spectrometer (Micromass, Manchester, GB). Precursor ions were 
selected with the quadrupole window set to 2-Daand fragments were collected 
with high efficiency with the orthogonal time of flight mass spectrometer. The 
collision gas applied was argon (pressure 4 × 10-5 mbar) and the collision 
voltage ~30 V. The program PeptideSearch was used for pattern searches  
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(http://www. mann. embl-heidelberg. de/GroupPages/PageLink/peptide-
search/Services/PeptideSearch/FR_PeptidePatternFormG4.html) (Mann and 
Wilm, 1994).  
Western blotting  
Immature and mature cells were resuspended in lysis buffer (50 mM Tris/HCl 
pH 7.5, 10 mM EDTA, 80 mM KCl, 1% NP40), supplemented with protease 
and phosphatase inhibitors [10 mg/ml leupeptin, 10 mg/ml aprotinin, 50 mM 
PMSF, sodium orthovanadate and serine/threonine phosphatase inhibitor 
cocktail I (1:100), all obtained from Sigma]. After at least 30 min on ice, 
insoluble fragments were removed by centrifugation (850 × g, 4° C). Proteins 
were separated on 10% SDS-PAGE and transferred onto nitrocellulose 
membranes. Nonspecific binding was blocked by incubating the membranes 
with 3% w/v non-fat dry milk and 0.05% Tween-20 in TBS (TBST). 
Membranes were incubated with the first antibody in the appropriate dilution 
for 1 h at room temperature or overnight at 4° C. After incubation, 
membranes were rinsed with distilled water and washed three times in wash 
buffer (0.25 % non-fat dry milk in TBST). Secondary antibody conjugated to 
horseradish peroxidase was added to the membranes in 3% non-fat dry milk 
in TBST in the appropriate dilution. After 1 h of incubation at room 
temperature membranes were washed three times and developed using an 
enhanced chemiluminescence kit (Tebu-bio).  
Scanning electron microscopy  
Immature and mature DC were fixed in 1.5% glutaraldehyde in 0.1 M 
cacodylate buffer for at least 60 min. Cells were then allowed to attach to 
poly-L-lysine coated coverslips for 1 h. Cells were postfixed in the same 
fixative for another 0.5 h. After a short rinse in PBS, specimens were 
dehydrated in ascending concentrations of ethanol (50-100%). Samples were 
then critical point dried, mounted on aluminum stubs and coated with a layer 
of gold in a sputtering device (Emitech, Ashford, GB). Specimens were viewed 
with a JSM 6700F scanning electron microscope (Jeol, Peabody, MA) at 2.5 
kV.  
Fluorescence microscopy  
Immature and mature DC were fixed by adding an equal volume of 4% 
paraformaldehyde in PBS to the culture for at least 15 min. Cells were spun 
onto slides and air-dried before staining. Cells were permeabilized with 0.1% 
Triton X-100 and then blocked with 1% BSA in PBS. Cells were incubated with 
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phalloidin-rhodamine or with primary antibody, followed by Alexa-fluor-labeled 
secondary antibody. Coverslips were mounted with glycerol, containing 100 
ng/ml DAPI. Specimens were viewed on a Leica fluorescence microscope.  
Actin polymerization assay  
Cells were cultured in 24- or 28-well culture plates and stimulated with 
different stimuli as indicated. After 24-48 h of stimulation cells were 
resuspended in the culture medium and fixed by adding an equal volume of 
4% paraformaldehyde in PBS for at least 15 min. Cells were permeabilized in 
0.1% Triton X-100 in PBS for 10 min, washed with 0.25% BSA in PBS and 
blocked in 1% BSA in PBS for 5 min, prior to incubation with 0.5 mM 
rhodamine-phalloidin in 1% BSA in PBS for 1 h at room temperature. After 
three washes cells were resuspended in 0.25% BSA/PBS. MFI was measured 
by flow cytometry (FACScan). Relative F-actin was determined by the ratio 
MFIt=x/MFIt=0.  
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Results  
Cofilin expression is regulated during maturation  
Monocyte-derived DC cultured with LPS were used to study the differences in 
protein expression in immature and mature DC. LPS-stimulated DC exhibited a 
typical mature phenotype compared to non-stimulated cells, as evidenced by 
the expression of maturation markers (CD80, CD86, CD83; data not shown), 
and by their morphology (fig. 1). Membrane morphology of DC changed from 
microvilli in immature cells (fig. 1a) into veils in mature cells (fig. 1b, c) with 
the magnitude of the veils increasing with time of LPS exposure. Protein 
expression profiles of immature DC and mature DC were analyzed by 2D-
PAGE. Proteins in the cell lysates from these cells were first separated on the 
basis of isoelectric point and molecular weight (fig. 2A). Protein spots of 
interest (down- or up-regulated during DC maturation) were excised and 
analyzed by mass spectrometry. Based on the combined information of 
peptide fingerprints and the sequence of selected peptides, one of the 
proteins that was down-regulated after 24 h of LPS, was identified as the 18-
kDa actin-binding protein cofilin. The intensity of the cofilin spot was 
decreased in mature cells compared to immature cells, and was located in the 
gel at about pH 6.5. Upon phosphorylation of an N-terminal serine, cofilin is 
known to be deactivated. The theoretical isoelectrical point of non-
phosphorylated cofilin is 8.2 (www. expasy. org). We hypothesized that the 
cofilin isolated from the gel might be the phosphorylated form, as 
phosphorylation of proteins can cause a shift to a more acidic isoelectric point. 
Indeed, a fragment was found within the tryptic digest of cofilin that 
corresponded to the expected mass of the phosphorylated N terminus of 
cofilin. The identity of this fragment was confirmed by MS/MS analysis (fig. 
2B). When commercially available cofilin was analyzed with 2D-PAGE two 
forms of cofilin could be detected: one at pH 6.5 and one at ca. pH 8 (data 
not shown). The latter could not be distinguished in gels derived from whole 
cell lysates, as the resolution of the 2D gels was not adequate in the region 
from pH 8 to 10. Overall, our results clearly show that in response to LPS, 




Figure 1. Immature versus 
mature DC. Scanning electron 
micrograph of immature and 
mature DC. Monocyte-derived DC 
were cultured without (a) or with 
LPS for 24 h (b) or 48 h (c). Cells 
were fixed and allowed to adhere 
to poly-L-lysine-coated coverslips 
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Figure 2. A. Two-dimensional PAGE of cell lysates of immature and mature DC. Monocyte-
derived DC were cultured with or without LPS for 24 h. Proteins were separated by 
isoelectric focusing (pH range 3-10, linear) and SDS-PAGE. Inserts show magnifications of 
one of the differentially expressed proteins. The spot indicated with the arrow was 
identified as cofilin by mass spectrometry. B. MS/MS spectrum of phosphopeptide from 
cofilin. The spot indicated with an arrow in (A) was digested with trypsin and analyzed by 
mass spectrometry. In addition to several non-phosphorylated peptides from cofilin, a 
fragment of 1225.5 [M+H]+ was identified. MS/MS analysis of this fragment revealed that it 
corresponded to the N-terminal tryptic fragment of cofilin, starting with an acetylated 
alanine (Ac-A) followed by a phosphorylated serine (pS, judged by neutral loss of H3PO4 
from b3 and a3 ions). 
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Cofilin is dephosphorylated after LPS exposure  
To confirm that cofilin was dephosphorylated during maturation and to study 
the time course in which this occurs, we studied the level of phosphorylation 
of cofilin in DC at different time points during maturation with an antibody 
specific for the phosphorylated form of cofilin. Monocyte-derived DC were 
stimulated with LPS, lysed at different time points ranging from 5 min to 24 h 
and analyzed by Western blot (fig. 3). In immature DC a basal level of 
phosphorylated cofilin was detected. Stimulation with LPS increased the level 
of cofilin phosphorylation within 5 min after stimulation, which then gradually 
decreased. After 24 h of LPS stimulation, when DC reached the mature 
phenotype, the level of phosphorylated cofilin was nearly undetectable, while 
no or little change was seen in the total expression of cofilin. In addition, 
levels of profilin, an actin-binding protein responsible for filament assembly, 
did not change during maturation. These results confirm that cofilin is 
dephosphorylated during maturation, and suggest a role for cofilin in 































































Figure 3. Effect of LPS-induced maturation on cofilin phosphorylation in DC. 
Immature monocyte-derived DC were stimulated with LPS for various times from 5 min to 
24 h. Cells were lysed at indicated time points and analyzed by Western blot, with antisera 
specific for cofilin, phosphorylated cofilin (P-cofilin) and profilin. The ratio of phosphorylated 
cofilin versus total cofilin was calculated and normalized for the expression of profilin. 
Results given are representative for four experiments with cells from four different donors. 
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Figure 4. A. Phenotypic analysis of immature DC and DC matured with LPS, PGE2/TNF-α 
or CD40L for 24 or 48 h. Expression of HLA-DR, CD40, CD83 and CD86 was measured by 
FACS analysis. Diagrams present data from three donors and show the relative expression, 
calculated as described in materials and methods. Error bars show the SEM. B. Different DC 
maturation stimuli induce cofilin dephosphorylation. Immature monocyte-derived DC were 
stimulated with either LPS, PGE2/TNF-α, L-Orient, or L-CD40L for 24 or 48 h. Cell lysates 
were analyzed by Western blot, with antisera specific for cofilin and phosphorylated cofilin 
(P-cofilin). Results given are representative for experiments with five to eight different 
donors. 
Cofilin dephosphorylation corresponds with DC maturation  
To investigate whether the dephosphorylation of cofilin was a general effect of 
DC maturation, we studied the effect of other known inducers of DC 
maturation. In addition to LPS, cells were stimulated either with a combination 
of prostaglandin E2 (PGE2; 100 nM) and TNF-α (50 mg/ml) (PGE2/TNF-α) (Lee 
et al., 2002) or by cross-linking of CD40 by co-cultured DC with irradiated L-
cells transfected with human CD40 ligand (L-CD40L) (Garrone et al., 1995) for 
24 and 48 h. Untransfected L-cells (L-Orient) were used as a control. DC 
stimulated with LPS, PGE2/TNF-α or CD40L-expressing cells showed typical 
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mature morphology (e. g. clustering, dendrite formation) in culture within 24 
h (data not shown), while unstimulated cells or cells co-cultured with L-Orient 
resembled immature DC (e. g. absence of clusters of cells, no dendrite 
formation). This was confirmed by phenotypic analysis (fig. 4A). DC cultured 
with LPS or with CD40L-expressing cells were highly positive for HLA-DR, 
CD86, CD40 and CD83. DC stimulated with PGE2/TNF-α, however, showed an 
intermediate phenotype: CD86 and CD83 positive, but low expression of HLA-
DR and CD40 (fig. 4A).  
Similar to maturation with LPS both CD40 ligation and stimulation with 
PGE2/TNF-α induced dephosphorylation of cofilin (fig. 4B). The degree of DC 
maturation as measured by FACS analysis correlated with the degree of cofilin 
dephosphorylation, CD40 ligation and LPS being more effective than 
PGE2/TNF-α. The degree of dephosphorylation of cofilin increased with the 
time of maturation for all three stimuli. Thus, in addition to LPS, also CD40L 
and PGE2/TNF-α induced activation of cofilin, and the level of 
dephosphorylation paralleled the degree of DC maturation.  
Cofilin relocalizes during maturation  
Next, we investigated whether cofilin indeed interacts with the DC 
cytoskeleton, by studying the localization of cofilin in immature and mature DC 
by immunofluorescence microscopy (fig. 5a-d). In immature DC, cofilin was 
localized throughout the cytoplasm and excluded from the nucleus (fig. 5a). 
Phosphorylated cofilin was also found in the cytoplasm, but was more 
concentrated towards the plasma membrane (fig. 5c). In mature cells the 
expression of phosphorylated cofilin was strongly diminished or absent (fig. 
5d). In contrast, staining for total cofilin (fig. 5b) demonstrated higher 
expression near the cell membrane and in membrane protrusions of mature 
cells, while cofilin was absent from the cytoplasm. Thus, during DC maturation 
cofilin was dephosphorylated and the active form was concentrated below the 
plasma membrane and in veils, suggesting a translocation of cofilin towards, 
and interaction with, the actin cytoskeleton underneath the cell surface.  
F-actin is increased in mature DC  
Finally, we studied the dynamics of the actin cytoskeleton during DC 
maturation. Cofilin can bind to actin and is involved in actin depolymerization, 
polymerization and rearrangement of the actin cytoskeleton. The actin 
cytoskeleton is mainly localized below the plasma membrane and is  










Figure 5. Effects of LPS-induced maturation on the localization and 
phosphorylation state of cofilin and on F-actin in DC. Monocyte-derived DC were 
stimulated for 24 h with LPS. Immature (iDC; a, c, e) and mature (mDC; b, d, f) DC were 
fixed and spun onto slides. Cells were stained for cofilin (a, b) or phosphorylated cofilin (P-
cofilin) (c, d) with specific antisera, followed by a secondary antibody labeled with Alexa594. 
Arrows indicate cells with very low expression of phosphorylated cofilin. Actin-filaments 
were visualized with rhodamine-phalloidin (e, f).  
responsible for the shape, stability and motility of the cell surface. As cofilin is 
activated and translocated towards the cell membrane, it may be associated 
with and alter the amount of F-actin in the cell. Therefore, F-actin was 
visualized with rhodamine-labeled phalloidin for immunofluorescence 
microscopy. In immature DC, F-actin could be detected below the cell 
membrane (fig. 5e). After 24 h of LPS stimulation, the amount of F-actin was 
increased and seemed more concentrated at the cell membrane (fig. 5f). The 
increase in F-actin was even more pronounced after 48 h of LPS treatment. 
Levels of F-actin during DC maturation were quantified by staining actin 




































fluorescence intensity (MFI) by flow cytometry (fig. 6). The amount of F-actin 
increased during DC maturation independent of the stimulus used: LPS, 
CD40L-expressing cells or PGE2/TNF-α. Co-culture with L-Orient control cells 
did not increase the F-actin content. Again, LPS and CD40 ligation were more 
effective in inducing an increase in F-actin (p<0.01, 48 h) than PGE2/TNF-α 
(p=0.052, 48 h). Scanning electron microscopy revealed that after 48 h of 
stimulation with L-CD40L DC had an appearance similar to DC matured with 
LPS (not shown). Co-culturing with L-orient did not induce morphological 
changes. Thus, simultaneously with the dephosphorylation and translocation 
of cofilin, the amount of F-actin increased during DC maturation and this was 
paralleled by the appearance of veils.  
 
Figure 6. Maturation induces an increase in F-actin content of DC. DC were 
stimulated with LPS, L-Orient, L-CD40L, or PGE2/TNF-α and fixed with paraformaldehyde 
after 24 or 48 h. After staining with phalloidin-rhodamine, the amount of F-actin was 
measured by FACS analysis. The diagram represents data from 5 to 11 different donors and 
shows the relative F-actin, calculated as described in materials and methods. Error bars 
show SEM (Student's t-test; *; *; p<0.01, *; p=0.05).  
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Discussion  
During maturation of DC a large number of genes and proteins are being 
regulated to establish the transition of the immature into the mature 
phenotype. In this study, we have used 2D-PAGE followed by mass 
spectrometry to compare protein expression profiles of immature and mature 
monocyte-derived DC. One of the differentially expressed proteins identified 
with this technique was cofilin, which appeared to be dephosphorylated during 
DC maturation. Stimulation with LPS induced translocation of the 
dephosphorylated (activated) form of cofilin towards the F-actin-rich area 
below the cell membrane. This shift correlated with an increase in F-actin and 
in the concentration of actin filaments at the cell membrane. Cofilin 
dephosphorylation was dependent on the degree of maturation, induced by 
LPS, CD40-cross-linking or PGE2/TNF-α, and correlated with an increase in F-
actin, suggesting a role for cofilin in rearrangements in the actin cytoskeleton. 
Moreover, this was paralleled by the appearance of veils appearing during DC 
maturation.  
Cofilin is a small phosphoprotein of 18.5 kDa {reviewed in (Bamburg, 1999; 
Chen et al., 2000; Holt and Koffer, 2001; Weber, 1999)}, which can bind to 
both F-actin as well as free actin monomers (G-actin) and binds preferentially 
to actin-ADP. Binding of cofilin to F-actin increases the dissociation of actin 
monomers and can sever actin filaments. Hereby, cofilin can enhance the 
turnover of the actin cytoskeleton and increase the number of actin filaments 
and, thereby, increase the amount of potential sites of actin polymerization. 
The actin cytoskeleton is vital for the stability of the cell membrane and 
membrane-dependent processes such as migration (Albrecht-Buehler, 1977; 
Huttenlocher et al., 1996); reviewed in (Vicente-Manzanares et al., 2002), 
motility (Chen et al., 2000; Shutt et al., 2000), phagocytosis (Chen et al., 
2000; Diakonova et al., 2002; Nishita et al., 2002) and division (Chen et al., 
2000; Nagaoka et al., 1995). Moreover, in DC the actin-cytoskeleton is 
essential for the formation of its characteristic dendrites and veils and the 
immunological synapse (Al-Alwan et al., 2001b; Badour et al., 2003; Dustin 
and Cooper, 2000; Sechi et al., 2002; Thome, 2003; Vicente-Manzanares et 
al., 2002; Wetzel et al., 2002). Cofilin is capable of increasing the rate of actin 
depolymerization and polymerization, and the turnover of actin filaments. A 
role for cofilin has been described in processes involving the formation of 
membrane protrusions and podosomes, which have a part in phagocytosis, 
membrane ruffling, lamellipod extension and cell motility (Aizawa et al., 1996; 
Chan et al., 2000; Diakonova et al., 2002; Nishita et al., 2002; Svitkina and 
Borisy, 1999; Zebda et al., 2000). In line with this, cofilin may play a role in a 
great number of DC characteristics involving actin reorganization, such as 
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morphology, endocytosis, migration, 'capturing' and adherence of T cells and 
the formation of the immunological synapse. We show here that cofilin activity 
is regulated during DC maturation. Our study is the first to imply the 
involvement of a direct effector of actin rearrangements in dendritic cell 
maturation.  
An actin-binding protein of a different category, fascin has been shown to be 
specifically expressed in mature DC and not in mature DC (Al-Alwan et al., 
2001a; Ross et al., 2000). Fascin is an actin-bundling protein and is involved 
in the formation of long dendrites. The combined expression of active cofilin 
and fascin may contribute to the formation of the characteristic veils of 
mature DC; cofilin by increasing F-actin turnover and enabling rearrangements 
of the actin cytoskeleton and fascin by the formation of stable F-actin bundles. 
As DC are very motile cells, it is to be expected that cofilin activity is crucial to 
maintain motility of the cell and possibly also of its veils, enabling a highly 
flexible manner of antigen presentation.  
Cofilin activity is regulated by phosphorylation via LIM kinases (Agnew et al., 
1995; Moriyama et al., 1996). Cofilin is dephosphorylated by serine protein 
phosphatases. A specific phosphatase of cofilin, slingshot, has been identified 
only recently (Ambach et al., 2000). Additionally, the protein phosphatases 
PP1/PP2A can associate with and activate cofilin (Niwa et al., 2002). How 
these phosphatases are regulated is not well understood. We observed an 
initial rise in phosphorylated cofilin shortly after DC stimulation. Similarly, 
Nishita et al. (Nishita et al., 2002) showed cofilin phosphorylation in T cells as 
quickly as 1 min after stimulation with SDF-1a. This transient rise in 
phosphorylated cofilin may be involved in the initiation of the actin 
cytoskeleton reorganization to enable clustering of membrane-bound 
molecules involved in signaling (Samstag et al., 1996). After the initial rise in 
phosphorylation upon LPS-induced DC maturation cofilin was 
dephosphorylated and translocated towards the membrane. Maturation in DC 
may, thus, be accompanied by the activation of (one of) these 
serine/threonine phosphatases. We tried to inhibit the activity of PP1/PP2A 
with thephosphatase inhibitor okadaic acid, which has been described to 
inhibit dephosphorylation of cofilin (Ambach et al., 2000; Djafarzadeh and 
Niggli, 1997). During incubation with okadaic acid, the cell membranes were 
blebbing and after several hours cells were fragmented. After 16 h of okadaic 
acid (at 50 nM), most of the cells were disintegrated (data not shown). 
Possibly, this is the effect of inhibition of cofilin activity, causing instability of 
the cell membrane by affecting the actin cytoskeleton. However, it cannot be 
excluded that apoptotic cell death is induced, since okadaic acid is also an 
inducer of apoptosis (Samstag et al., 1996).  
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Cofilin dephosphorylation upon stimulation was also observed in T cells, 
neutrophils and polymorphic mononuclear leukocytes after aspecific activation 
(Ambach et al., 2000; Djafarzadeh and Niggli, 1997; Lee et al., 2000; Okada 
et al., 1996). These and other studies have demonstrated that after 
dephosphorylation cofilin translocates to the plasma membrane (Adachi et al., 
2000; Chan et al., 2000; Djafarzadeh and Niggli, 1997; Nagaoka et al., 1996; 
Shevchenko et al., 1996), or, more specifically, to the actin cytoskeleton (Lee 
et al., 2000) and is essential for the formation of membrane protrusions like 
podosomes and filopodia (Adachi et al., 2000; Aizawa et al., 1997; Nagaoka et 
al., 1996). As mentioned before, cofilin activation can result in either 
depolymerization, polymerization or in a neutral turnover (tread milling) of F-
actin. Several reports have demonstrated a positive effect of cofilin activation 
on actin polymerization in both cell-free (Ichetovkin et al., 2002) and cell-
based studies (Aizawa et al., 1996; Aizawa et al., 1997; Chan et al., 2000; 
Kleijmeer et al., 2001; Zebda et al., 2000). Non-phosphorylated cofilin 
appeared to be essential for lamellipod extension, membrane ruffling and cell 
movement. Moreover, active cofilin is essential for polarization of cells and 
direction of lamellipodia during migration (Dawe et al., 2003). Translocation of 
dephosphorylated cofilin to the cell membrane can thus have a profound 
effect on the actin cytoskeleton. Consistent with these data, we found an 
increase in both F-actin and active cofilin in the F-actin-rich area below the cell 
membrane during DC maturation. Moreover, cofilin dephosphorylation 
correlated with both the increase in F-actin and the appearance of veils on 
mature DC. The decrease in phosphorylated cofilin was stronger after 48 h 
than after 24 h of DC maturation, as was the appearance of veils. Collectively, 
our results indicate that cofilin is involved in the morphological transformation 
of DC during maturation.  
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Abstract 
A heterozygous mutation in the Langerin gene corresponding to position 837 
in the Langerin mRNA was identified in a person deficient in Birbeck granules. 
This mutation results in an amino acid replacement of Tryptophane by 
Arginine at position 264 in the CRD domain of the Langerine protein. 
Expression of mutated Langerin in human fibroblasts induces tubular like 
structures that are negative for BG specific antibodie staining and do not 
resemble the characteristic stratified structure of BG.  
Introduction 
Birbeck granules (BG) are cytoplasmic organelles that are only found in 
Langerhans cells (LC). The function of BG, first described in 1961 (Birbeck et 
al., 1961), is still not completely understood, although most studies point 
towards an active role in receptor-mediated endocytosis and participation in 
the antigen-processing/presenting function of (McDermott et al., 2002). 
Recent studies demonstrated a crucial role for the C-type lectin Langerin, in 
the biogenesis of BG. Expression of human or mouse cDNA encoding 
Langerin, an endocytic receptor exclusively present in Langerhans cells, into 
fibroblasts results in the formation of BG (Valladeau et al., 2000; Valladeau et 
al., 2002).  
About 10 years ago we were the first and thus far only group that identified a 
healthy white man whose LC completely lack presence of BG as determined by 
electron microscopic studies (Mommaas et al., 1994). The absence of BG in 
these LC was documented further by the lack of staining with a BG-specific 
antibody (DCGM4). Considering the role of Langerin in the formation of BG 
and the fact that DCGM4 recognizes Langerin (Valladeau et al., 1999), we 
hypothesized that alterations/mutations in the Langerin gene might be 
responsible for the lack of BG in this index person.  
To test this hypothesis we performed DNA sequence analysis of all Langerin 
encoding exons from the index person lacking BG. We identified a hitherto 
unknown mutation resulting in an amino acid substitution (W > R) at position 
264 in a conserved (carbohydrate recognition) domain of the Langerin protein. 
Expression of a wild type Langerin construct in dermal fibroblast resulted in 
BGs positive for DCGM4. Expression of the mutant Langerin construct, 
identical to wild type except for the single base pair substitution, resulted in 
irregular tubular structures, negative for DCGM4. From these data we 
conclude that W264 in the Langerin protein is essential for BG biogenesis.  
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Materials and methods 
PCR 
All polymerase chain reactions (PCR) were carried out using custom primers 
and Platinum Taq from Invitrogen (Breda, the Netherlands) in a PTC-200 
Thermal cycler (MJ Research, Waltham, MA).  





























A GGGGACAAGTTTGTACAAAAAAGCA GGCTTCAGGATGACTGTGGAGAAGGA 
Coding region 
AS GGGGACCACTTTGTACAAGAAAGCTG GGTGTCACGGTTCTGATGGGACATAGG 
1051 
A CCAGGATAAGGGTGAGCACT 




Mutation 3’ overlap 
AS CGTTGGAGCTCAAAGAGTGA 
264 
Table I. PCR-primers used in this study.  
 
Sequencing of the Langerin gene 
DNA was isolated from peripheral blood lymphocytes of the index person 
lacking Birbeck granules (Mommaas et al., 1994) and controls (obtained with 
informed consent) using the QIAamp DNA mini kit (Qiagen, Hilden, Germany). 
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Individual Langerin encoding exons were amplified by PCR (touchdown 
protocol, annealing temperature 65˚ C to 50˚ C over 15 cycli followed by 20 
cycli at 50˚ C) using 6 primer sets (See table I) developed on the human DNA 
and mRNA sequences deposited in the Genbank under # AC007395 and 
NM_015717. PCR products were purified and directly sequenced from both 5' 
and 3' ends using an ABI 3700 automatic sequencer (Applied Biosystems, 
Foster City, CA).  
Heterologous expression of mutant and wild type Langerin cDNA 
In default of a frozen skin biopsy from the index person enabling mRNA 
extraction, wild type and mutant Langerin expression constructs were created 
as follows. cDNA synthesized from mRNA isolated from normal skin (obtained 
from plastic surgery with written informed consent from the donor) was used 
as a template for a Langerin specific PCR (Primers S1/AS1, see Table I; 
annealing at 50˚ C; 35 cycli). The resulting 1049 bp PCR product was cloned 
in pTOPO (Invitrogen) and sequenced. The identified mutation at position 837 
(numbering according to NM_015717) was introduced in the Langerin cDNA 
sequence by overlap extension mutation PCR (Horton et al., 1990) using two 
mutation primers (See table I) in combination with the S1/AS1 primers at the 
5' and 3' end and the pTOPO plasmid containing wild type Langerin cDNA as 
template. PCR products were cloned in pTOPO and sequenced.  
Next, the coding region of both the wild type and mutant Langerin cDNA were 
amplified with PCR primers containing flanking sequences for Gateway cloning 
and pTOPO (harboring wild type or mutant sequences) as template. Resulting 
PCR products were cloned in the Gateway Cloning vectors (Invitrogen) 
pDEST53, linking Green Fluorescent Protein (GFP) to the N-terminus of 
Langerin, and pDEST 12.2. All Gateway constructs were sequenced to confirm 
the position of the insert and the absence of PCR errors.  
Human primary dermal fibroblasts (cultured in DMEM, supplemented with L-
glutamine (2mM, Gibco BRL, Breda, The Netherlands), 5% FCS 
(Hyclone/Perbio, Etten Leur, the Netherlands) and penicillin/streptomycin 
(Gibco BRL) were transfected with Gateway constructs containing the wild 
type or mutant Langerin cDNA using the Amaxa nucleofector (Amaxa, 
Cologne, Germany). The transfections were performed according to the 
Human Dermal fibroblast Nucleofector Kit (Amaxa) and protocol. The cells 
were cultured for a maximum of 40 hrs in a 37° C/ 5% CO2 incubator and 




For electron microscopy, cells were fixed in 2% paraformaldehyde and 0.1% 
glutaraldehyde in 0.1 M PHEM buffer for 2 hours at room temperature. Part of 
the cells was processed further for routine electron microscopy and the other 
part for immuno-electron microscopy. For routine electron microscopy cells 
were post-fixed in 1% osmiumtetroxide in 0.1M phosphate buffer for 30 
minutes at 4°C, dehydrated in a graded ethanol series and embedded in epon 
LX112. Ultrathin sections were stained with uranylacetate and lead salts. For 
immuno-electron microscopy, cells were pelleted in 12% gelatin, 
cryoprotected in 2.3M sucrose and snapfrozen in liquid nitrogen. Ultrathin 
cryosections were incubated with either mouse monoclonal anti-Langerin IgG1 
(formerly known as DCGM4; Beckman Coulter, Mijdrecht, the Netherlands) 
(1/100), followed by a rabbit anti-mouse immunoglobulins as bridging 
antibody (DAKOcytomation, Heverlee, Belgium)(1/200) and 15 nm protein A-
gold (1/200) or rabbit polyclonal anti-GFP IgG (Molecular Probes Europe, 
Leiden, the Netherlands)(1/200) followed by 15 nm protein A-gold. After 
incubation, the sections were embedded in methylcellulose and stained with 
uranylacetate. All specimens were viewed with a Philips 410 electron 
microscope (Philips, Eindhoven, The Netherlands). 
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Results and discussion 
PCR and sequence analysis of Langerin encoding exons  
PCR analysis of all Langerin encoding exons demonstrated no large differences 
in terms of deletions/insertions between the DNA of the index person and the 
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Figure 1. Analysis of the Langerin gene. A. Representative example of a PCR analysis 
using Langerin specific primers for exon 1-6 and as template genomic DNA of the index 
person lacking Birbeck granules (a), control DNA (b) or no template (c). Obtained PCR 
products were analyzed on a TBE based agarose gel and stained with ethidium bromide. M 
denotes DNA marker (Generuler 100 bp ladder; Fermentas, St. Leon-Rot, Germany), size in 
base pairs is given on the left. B. Fragment of a sequence chromatogram of a PCR product 
representing exon 5 of the index person lacking Birbeck granules. A double sequence (T/C) 
is detected at positions 837 and 880. Corresponding amino acids are given on top using 
single letter abbreviation. C. Alignment of a conserved domain within the type II C-type 
lectin family of proteins. Arrow indicates conserved tryptophane residue (W) at position 264 
within this family. 
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control DNA (Fig. 1A). DNA sequence analysis of all obtained PCR products 
revealed that the exons encoding Langerin in our index person were 
heterozygous at four positions: 281, 837, 880 and 989. Two of these 
mutations were silent (pos. 281 C/T and 989 A/G), while the other two 
resulted in an amino acid change in the Langerin protein (Fig. 1B). 
Heterozygosity at pos 880, however, was also found in the control DNA (See 
Fig. 1B right panel) and in the cDNA of the second control that was used as a 
basis to create the Langerin expression constructs. Moreover, until recently, 
this nucleotide was indicated as a known SNP in Genbank; this annotation was 
removed after a recent update (July 2004). Heterozygosity at pos. 837 is of 
particular interest since it encodes a variant Langerin containing the basic 
residue Arginine (R) in stead of the aromatic amino acid Tryptophane (W) in a 
highly conserved region of the Langerin protein and related type II C-type 
lectins (Fig. 1C). As this mutation was located in the carbohydrate recognition 
domain (CRD), we reasoned that this mutation (W264R) might have functional 
consequences for the Langerin protein.  
Expression of wild type and mutant Langerin cDNA 
Expression of wild type Langerin with or without GFP in human fibroblasts 
resulted in the mass formation of Birbeck granules, as was revealed by 
transmission electron microscopy (Fig. 2), indicating that GFP did not interfere 
with the formation of Birbeck granules. Birbeck granules in GFP-wild type 
Langerin transfected cells were strongly positive for anti-GFP (Fig. 3A) and 
moderate positive for DCGM4-labeling (Fig. 3B). In contrast, expression of 
GFP-mutant Langerin did not induce the formation of BG demonstrating the 
a b
 
Figure 2. Detection of Birbeck granules in Langerin expressing fibroblasts by 
electron microscopy. Fibroblasts transfected with wildtype Langerin (A) of wildtype GFP-
Langerin (B) show typical structures reminiscent of Birbeck granules.  






Figure 3. Immuno-electron microscopic analysis of GFP-Langerin expressing 
fibroblasts. A-B. Typical anti-GFP (A) or DCGM4 (B) immunostaining of fibroblasts 
transfected with GFP- wild type Langerin construct. C. Representative example of an anti-
GFP staining of fibroblasts transfected with the GFP-mutant Langerin construct. Antibodies 
were detected with 15 nm protein A-gold.  
functional consequences of the W264R conversion. Although lacking Birbeck 
granules, transfection of human fibroblasts with the GFP-mutant Langerin 
induced the formation of an assembly of GFP-positive tubular membrane 
structures seemingly consisting of lipid bilayers, but lacking the stratified 
organization found in Birbeck granules (Fig. 3C). The membrane structures 
induced by the mutant Langerin were negative for DCGM4 labeling, although 
expression of the protein was confirmed by staining for GFP. These results 
suggest that the W264R mutation is either located in the epitope recognized 
by DCGM4 or that it causes a conformational change preventing the binding of 
the antibody. Furthermore, these data demonstrate that the W264R amino 
acid replacement prevents the formation of the typical structure of Birbeck 
granules. Nonetheless, this mutant Langerin is still able to induce the 
formation of lipid bilayer membrane structures. The mechanisms by which this 
mutation prevents the formation of the superimposed and zippered 
membranes typical for Birbeck granules are currently under investigation and 
will expand our understanding of the role of Langerin in the formation of BG 
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Abstract  
The chemokines CXCL9, 10 and 11 exert their action via CXC chemokine 
receptor-3 (CXCR3), a receptor highly expressed on activated T cells. These 
IFN-γ-induced chemokines are thought to be crucial in directing activated T 
cells to sites of inflammation. As such, they play an important role in several 
chronic inflammatory diseases, including ulcerative colitis, multiple sclerosis, 
artherosclerosis and delayed type hypersensitivity reactions of the skin. In this 
study, we first demonstrate that in COS-7 cells heterologously expressing 
CXCR3, CXCL11 is a potent activator of the pertussis toxin sensitive (PTX) 
p44/p42 MAPK and Akt/phosphatidylinositol-3-kinase (PI3K) pathways. Next, 
we show that these signal transduction pathways are also operative and PTX 
sensitive in primary human T cells expressing CXCR3. Importantly, abrogation 
of these signaling cascades by specific inhibitors did not block the migration of 
T cells towards CXCR3 ligands, suggesting that MAPK and Akt activation is not 
crucial for CXCR3-mediated chemotaxis of T cells. Finally, we demonstrate 
that CXCR3 targeting chemokines control T cell migration via PTX sensitive, 
phospholipase C pathways and phosphatidylinositol kinases other than class I 
PI3Kγ.  
Introduction 
Chemokines are a group of small, secreted and heparin-binding proteins that 
are not only active as chemotactic factors but also as end-point effectors of 
immune protective functions. These proteins are classified into CXC, CC, C and 
CX3C chemokines, based on the position of characteristic structure 
determining cysteine residues within their N-terminal part (Baggiolini, 2001; 
Luster, 1998; Murphy et al., 2000; Zlotnik et al., 1999). They are produced 
locally in the tissues and exert their action on leukocytes by binding to specific 
G protein–coupled receptors (GPCRs), embedded within the membrane of 
their respective target cells. Typically, the binding of a chemokine to its 
cognate GPCR triggers the activation of multiple signal transduction pathways, 
including a transient intracellular rise in Ca2+ (Baggiolini, 1998). To date about 
50 different chemokines and at least 18 different receptors have been 
identified (Zlotnik et al., 1999).  
For several chemokines it has been shown that receptor binding also activates 
the p44/p42 MAPK (extracellular signal-regulated kinase) pathway in multiple 
cell types (Boehme et al., 1999; Knall et al., 1997; Tilton et al., 2000; Dubois 
et al., 1996; Ganju et al., 1998; Coffer et al., 1998). Blockade of MAPK 
activation inhibited eotaxin-induced eosinophil rolling in vivo and chemotaxis 




CD4+ T cells (Vlahakis et al., 2002) pointing towards a crucial role of MAPK 
activation in leukocyte migration.  
The chemokines CXCL9, 10 and 11 (formerly known as resp. Mig, IP-10 and 
IP-9/I-TAC) exert their action via CXC chemokine receptor-3 (CXCR3), a 
receptor highly expressed on activated T cells (Loetscher et al., 1996; Qin et 
al., 1998). These IFN-g induced chemokines, are thought to be crucial in 
directing activated T cells to sites of inflammation, where they play an 
important role in Th1 mediated immune responses. Expression of the CXCR3 
targeting chemokines have been demonstrated in several chronic 
inflammatory diseases, including ulcerative colitis (Uguccioni et al., 1999), 
multiple sclerosis (Balashov et al., 1999; Sorensen et al., 1999), hepatitis C-
infected liver (Mach et al., 1999), artherosclerosis (Shields et al., 1999), 
delayed type hypersensitivity skin reactions and chronic skin inflammations 
(Flier et al., 1999; Flier et al., 2001). However, to date little is known about 
the intracellular events following agonist binding to CXCR3, except for Ca2+ 
mobilization, in T cells (Loetscher et al., 1996; Rabin et al., 1999; Tensen et 
al., 1999; Cole et al., 1998).  
In this study we have delineated several signaling pathways of CXCR3 ligands, 
in particular of CXCL11, which appears to be the most potent agonist in all 
assays used. We show that CXCR3 ligands are able to activate the p44/p42 
MAPK and Akt/phosphatidylinositol-3-kinase (PI3K) signaling cascades in 
CXCR3-transfected COS-7 cells and primary human T cells. Chemotaxis of T 
cells, however, is not mediated by these kinases, but controlled via Gi and 
phospholipase C dependent pathways and phosphatidylinositol kinases other 
than class I PI3Kγ.  
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Materials and methods 
Materials 
Cell culture media and supplements were obtained from GIBCO BRL. CXCL10 
(IP-10) was obtained from Peprotech (Rocky Hill, NJ, U. S. A) and CXCL11 (IP-
9/I-TAC) was from R & D systems Inc. (Minneapolis, MN, U. S. A.). The MEK 
inhibitors PD98059 and U0126 were obtained from New England Biolabs, Inc. 
(Beverly, MA, USA) and Promega (Leiden, The Netherlands) resp. The PLC 
inhibitor U73122, its inactive analog U73343, phosphatidylinositol kinase 
inhibitors wortmannin and LY294002 and pertussis toxin were obtained from 
Sigma (Sigma-Aldrich Chemie B. V. Zwijndrecht, The Netherlands). hCXCR3 in 
pcDNA III was a gift from Dr. B. Moser (Loetscher et al., 1996).  
Cell culture and transfection  
COS-7 cells were grown at 5% CO2 at 37˚C in Dulbecco’s modified Eagle’s 
medium supplemented with 5% fetal calf serum, 2 mM L-glutamine, 50 IU/ml 
penicillin, and 50 mg/ml streptomycin. Transfection of COS-7 cells was 
performed with DEAE-dextran. The total amount of DNA in transfected cells 
was kept constant by addition of the empty vector. Transfected cells were 
maintained in serum-free medium. Isolations, activation and culturing of 
human T lymphocytes were performed as described previously (Tensen et al., 
1999).  
Chemotaxis assays  
The assay for chemotaxis was performed in 24-well plates (Costar, 
Cambridge, MA) carrying Transwell permeable supports with 5-µm 
polycarbonate membrane. Cultured T cells were washed once, and 
resuspended at 5 × 106 cells/ml in RPMI 1640 containing 0.25% BSA. Medium 
alone or supplemented with chemokine was placed in the lower compartment, 
and cells were loaded onto the inserts at 0.5 × 106/100 µl for each individual 
assay. Chambers were incubated for 120 min in a 5% CO2 -humidified 
incubator at 37° C. After the incubation period, numbers of T cells migrating 
to the lower chamber were counted under a microscope using a 
hemocytometer. Viability was checked with trypan blue exclusion. All 
conditions were tested in at least in triplicate; statistic evaluation was 




If not stated otherwise, IL-2–expanded activated T cells were serum starved 
overnight in medium supplemented with 400 U/ml IL-2 and 0.2% BSA. The 
cells were washed twice and resuspended in HBSS containing 20 mM Hepes, 
pH 7.4 (2 × 107 cells/ml). Aliquots of 2 × 106 cells for immunoblotting were 
incubated for 10 min at 37° C and then stimulated with the appropriate 
agonist at indicated time intervals. Incubations were terminated by 
centrifugation and pelleted cells were lysed as described under Western blot 
analysis. COS-7 cells were serum-starved and stimulated as indicated in the 
figures.  
Western blot analysis  
Transiently transfected COS-7 cells (48 h after transfection) and IL-2-
expanded activated T cells were lysed in RIPA buffer (phosphate-buffered 
saline containing 1% Nonidet P-40, 0.1% SDS, 0.5% sodium deoxycholate, 1 
mM phenylmethylsulphonylfluoride, 1 mM sodium orthovanadate and 2 mg/ml 
of aprotinin and leupeptin), sonicated, separated by SDS polyacrylamide gel 
electrophoresis, and blotted to polyvinylidene difluoride membrane. Antibodies 
recognizing p44/p42 MAPK, Akt, phospho-Akt (S473) (New England Biolabs, 
Inc, Beverly, MA, USA) were used in combination with a goat anti-rabbit 
horseradish peroxidase-conjugated secondary antibody (Biorad, Hercules, CA, 
USA). The antibody recognizing phospho-p44/p42 MAPK (T202/Y204) (New 
England Biolabs, Inc, Beverly, MA, USA) was used in combination with a goat 
anti-mouse horseradish peroxidase-conjugated secondary antibody (Bio-Rad, 
Hercules, CA, USA). Protein bands were detected with ECL chemiluminescence 
and directly quantified using an Image station (NEN Life Science Products, 
Inc, Boston, MA, USA).  
Actin polymerization assay 
Cells were washed three times in RPMI 1640 and resuspended in assay 
medium (RPMI 1640 with 0.1% BSA [BSA, fraction V, Sigma]) in a 
concentration of 1 × 106 cells/ml. Prior to the experiment, the cells and 
chemokine were kept at room temperature for 10 minutes. Chemokine was 
subsequently added to the cell suspension (10 nM). At indicated time points, 
100 ml of cell suspension was transferred to 100 ml of fixation solution (4% 
paraformaldehyde [PFA]). Cells were incubated in the fixation solution for at 
least 15 minutes. Thereafter, the cells were centrifuged and resuspended in 
100 ml of permeabilization reagent (0.1% Triton-X 100). After 10 minutes of 
incubation in this solution, cells were washed, blocked with 1% BSA (5 min), 
washed and incubated with 0.5 mM rhodamine-phalloidin (Molecular Probes, 
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Leiden, The Netherlands) to visualize the F-actin. After 30 minutes, the cells 
were centrifuged and resuspended in PBS with 0.25% BSA. Mean fluorescence 
intensity was measured by FACS analysis (FACScan; BD Biosciences, Alphen 




CXCR3 agonists induce activation of p44/p42 MAPK in CXCR3- 
transfected COS-7 cells 
We first examined the relative potencies of CXCR3 agonists CXCL11 and 
CXCL10 to activate the p44/p42 MAPK signaling pathway. To this end, the 
human CXCR3 receptor was transiently expressed into COS-7 cells. Exposure 
of CXCR3-expressing COS-7 cells to (30 nM) CXCL11 (IP-9) for different 
periods of time resulted in a time-dependent increase in endogenous MAPK 
activity as detected by an increase in phosphorylation of p44/p42 MAPK, 
measured using an antibody recognizing the phosphorylated form of p44/p42 
MAPK (fig. 1A). A maximal transient increase in phosphorylation of p44/p42 
MAPK was observed after 15 min exposure of cells to CXCL11 at a 
concentration of 30 nM (fig. 1A). The other well-known CXCR3 agonist 
CXCL10 (IP-10) also induced an increase in phosphorylation of p44/p42 MAPK, 
albeit to a lesser extent (fig. 1B).  
As expected, incubation of cells expressing CXCR3 with the specific MEK 
inhibitors U0126 (10 mM) or PD98059 (10 mM, data not shown) led to a 
complete abolishment of basal and CXCL11-induced phosphorylation of 
p44/p42 MAPK, confirming the involvement of the Raf-MEK pathway (fig. 1C). 
CXCR3 belongs to the class of Gi-coupled receptors, which are known to 
activate p44/p42 MAPK in COS-7 cells (Crespo et al., 1994; Luttrell et al., 
1996) through the release of Gβγ subunits leading to activation of PI3K and 
Ras (Koch et al., 1994). In order to examine the involvement of the Gi-
signaling pathway in CXCR3-mediated signaling to p44/p42 MAPK, cells were 
treated with pertussis toxin (PTX, 100 ng/ml) for 48 hrs. Pretreatment of cells 
with PTX resulted in a partial reduction of CXCR3-induced increase in MAPK 
phosphorylation (fig. 1D). Involvement of PI3K was examined by pretreatment 
of cells for 30 min with wortmannin (100 nM). Pretreatment of cells with 
wortmannin led to a complete inhibition of basal and CXCL11-induced 
phosphorylation of MAPK (fig. 1E).  
CXCR3 agonists induce activation of p44/p42 MAPK in T lymphocytes  
As previously shown, T lymphocytes treated for 10 days with IL-2 express 
CXCR3 (Loetscher et al., 1996; Tensen et al., 1999). In IL-2 expanded, 
activated T cells, CXCL11 induced a time- (data not shown) and 
concentration-dependent increase in phosphorylation of p44/p42 MAPK (fig. 
2A). A maximal increase in phosphorylation of p44/p42 MAPK, ranging from 2 
to 5 fold increase, was observed after 5-15 min stimulation of cells with 
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CXCL11, varying with the T cell donor. Analogous to the observations made in 
CXCR3-expressing COS-7 cells, the activation of p44/p42 MAPK by CXCL11 
appeared to be transient, since no increase in phosphorylation of MAPK was 
detected after 60 min exposure of cells to CXCL11 (data not shown). A 
whereas CXCL9 and in particular CXCL10 were less potent in phosphorylating 






















































































































Figure 1. CXCR3 agonists stimulate activation of p44/p42 MAPK in CXCR3-
transfected COS-7 cells A. COS-7 cells transiently transfected with CXCR3 (2.0 mg 
plasmid/106 cells) were stimulated for different periods of time with 30 nM CXCL11. 
Phosphorylation of p44/p42 MAPK was determined by Western blot analysis using specific 
anti-phosho-p44/p42 (P-p44/p42) antibodies. Phosphorylation was quantified by 
chemiluminescence and corrected for total MAPK (T-p44/p42) expression on stripped blots. 
B. CXCR3-expressing COS-7 cells were incubated with CXCL10 and -11 (30 nM) for 15 min 
before lysis of the cells. C-E. Involvement of Raf-MEK- (C), Gi- (D) and PI3K- (E) signaling 
pathway in CXCL11 (15 min, 30 nM) -induced p44/p42 MAPK phosphorylation. CXCR3-
expressing COS-7 cells were grown in serum-free medium in the presence of U0126 (10 
mM, 30 min; C) or PTX (100 ng/ml, 48 h; D) or wortmannin (wort; 100 nM, 30 min; E) 
before lysis and Western blot analysis. A representative experiment out of at least two 




















































































































Figure 2. CXCR3 agonists stimulate activation of p44/p42 MAPK in T 
lymphocytes. A-B. Activated IL-2 expanded blood T cells were incubated for 15 min with 
various concentrations of CXCL11 (A), CXCL10 (B) or CXCL9 (B) before lysis of the cells. 
Phosphorylation of p44/p42 MAPK was determined by Western blot analysis using specific 
anti-phosho-p44/p42 (P-p44/p42) antibodies. Phosphorylation was quantified by 
chemiluminescence and corrected for total MAPK (T-p44/p42) expression on stripped blots. 
C-E. Involvement of Raf-MEK- (C), Gi- (D) and PI3K- (E) signaling pathway in CXCL11-
induced p44/p42 MAPK phosphorylation. T cells were grown in serum-free medium in the 
presence of U0126 (10 mM, 30 min; C) or PTX (100 ng/ml, 48 h; D) or wortmannin (wort; 
100 nM, 30 min; E) and exposed to CXCL11 (15 min, 30 nM) before lysis and Western blot 
analysis. A representative experiment out of at least two independent experiments is 
shown. 
In activated T cells, CXCR3-mediated activation of p44/p42 MAPK appeared to 
be mediated by the Raf-MEK pathway, as the MEK inhibitor (U0126) 
completely inhibited the CXCL11-induced increase in MAPK phosphorylation 
(fig. 2C). The CXCL11-induced phosphorylation of p44/p42 MAPK in T cells 
appeared to be Gi- and partially PI3K mediated, as preincubation of cells with 
PTX (48 h, 100 ng/ml, fig. 2D) resulted in a complete, and preincubation of 
cells with wortmannin (30 min, 100 nM, fig. 2E) led to a partial attenuation of 
the CXCL11-induced phosphorylation of p44/p42 MAPK.  



























































































Figure 3. CXCR3 agonists stimulate activation of Akt in CXCR3-transfected COS-7 
cells A. COS-7 cells transiently transfected with CXCR3 (2.0 mg plasmid/106 cells) were 
stimulated for different periods of time with 10 (A1), 30 (A2) and 100 (A3) nM CXCL11 and 
phosphorylation of Akt was determined by Western blot analysis using specific anti-phosho-
Akt (P-Akt) antibodies. Phosphorylation was quantified by chemiluminescence and corrected 
for total Akt (T-Akt) expression on stripped blots. B. CXCR3-expressing COS-7 cells were 
incubated with 30 nM CXCL11 or CXCL10 for 15 min before lysing the cells. C-D. Involvement 
of Gi- (C) and PI3K- (D) signaling pathway in CXCL11-induced Akt phosphorylation. CXCR3-
expressing COS-7 cells were grown in serum-free medium in the presence of PTX (100 ng/ml, 
48 h; C) or wortmannin (wort) (100 nM, 30 min; D) and exposed to CXCL11 (15 min, 30 nM) 
before lysis and Western blot analysis. A representative experiment out of at least two 
independent experiments is shown. 
CXCR3 agonists phosphorylate Akt in CXCR3-transfected COS-7 cells 
The serine/threonine kinase Akt is known to be critical for cell survival, 
proliferation and gene expression (Chan et al., 1999). In addition, Akt has 
been shown to be implicated in cell migration (Haugh et al., 2000; Morales-
Ruiz et al., 2000; Servant et al., 2000). Exposure of CXCR3-expressing COS-7 
cells to CXCL11 resulted in a marked and sustained increase in 
phosphorylation of endogenous Akt in COS-7 cells, as evidenced by 
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immunoblotting with a phosphospecific antibody (fig. 3A). CXCL11 induced a 
time- and concentration-dependent phosphorylation of Akt, reaching a 
maximal effect with 10 nM after 15 to 30 min exposure (fig. 3A). CXCL11 
induced a marked increase in phosphorylation of Akt at 30 nM, while at this 
concentration CXCL10 only induced a marginal increase in phosphorylation of 
Akt. Involvement of Gi-signaling pathways in the CXCR3-induced signaling to 
Akt was determined by treatment with PTX. As can be seen in fig. 3C, PTX 
treatment resulted in a marked inhibition of CXCL11-induced phosphorylation 
of Akt. To study the role of PI3K (a known key player in the activation of Akt 
(Burgering and Coffer, 1995)), CXCR3-expressing cells were treated with PI3K 
inhibitor wortmannin (30 min, 100 nM). As expected, inhibition of PI3K 



















































































Figure 4. CXCR3 agonists stimulate activation of Akt in T lymphocytes A-C. T cells 
were stimulated for different periods of time with 10, 30 and 100 nM CXCL11 (A1-3), 
CXCL10 (B1-3), CXCL9 (B1-3) or CXCL12 (C) and phosphorylation of Akt was determined by 
Western blot analysis using specific anti-phosho-Akt (P-Akt) antibodies. Phosphorylation 
was quantified by chemiluminescence and corrected for total Akt (T-Akt) expression on 
stripped blots.  
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CXCR3 agonists phosphorylate Akt in T lymphocytes 
Also in activated T cells, CXCL11 generated a time- and concentration-
dependent increase in phosphorylation of Akt (fig. 4A1-3). At low 
concentrations of CXCL11 (10 nM) a maximal increase in phosphorylation of 
Akt was detected after 30 min incubation. Remarkably, at higher 
concentrations of CXCL11 (30 and 100 nM) already after 1 min exposure of 
cells a marked increase in Akt phosphorylation was observed. Akt 
phosphorylation levels remained at an elevated level for up to at least 60 min 
when cells were exposed to 30 nM, while at higher concentrations of CXCL11 
(100 nM) a gradual decrease to basal levels was observed. Again, the ability 
of CXCL10 to induce an elevation of Akt phosphorylation was less pronounced 
when compared to CXCL11 at the different concentrations (fig. 4B1-3). CXCL9  
ED
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Figure 4 continued. D-E. Involvement of Gi- (D) and PI3K- (E) signaling pathway in 
CXCL11-induced Akt phosphorylation. T cells were grown in serum-free medium in the 
presence of PTX (100 ng/ml, 48 h; D) or wortmannin (wort; 100 nM, 30 min; E) and 
exposed to CXCL11 (1 min, 30 nM) before lysis and Western blot analysis. A representative 




appeared to exert a similar increase of Akt phosphorylation compared to 
CXCL11 after 1 min exposure (fig. 4B1-3). However, CXCL9 was not able to 
induce a sustained elevated level of Akt phosphorylation. As a control, 
activated T cells were also exposed to CXCL12 (SDF-1α), which binds to its 
cognate receptor CXCR4 on these cells. As previously shown by Tilton et al. 
(Tilton et al., 2000), CXCL12 (SDF-1α) induced a sustained increase in 
activation of Akt (fig. 4C). CXCL11-mediated phosphorylation of Akt appeared 
to be Gi-dependent as treatment of cells with PTX abrogated the CXCL11-
induced increase in phosphorylation of Akt (fig. 4D). In addition, PI3K 
appeared to be involved as preincubation of cells with wortmannin markedly 
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Figure 5. CXCL11–induced F-actin formation in primary human T cells and the 
effect of inhibitors. At 10, 30, 60 and 300 seconds after 10 nM CXCL11 stimulation 
(indicated in the panels), the levels of F-actin were determined by FACS analysis. 
Significantly lower F-actin levels were found after pre-treatment with PTX, U73122 and high 
concentrations of wortmannin. No effects were observed with the MEK inhibitor U0126 and 
the inactive analog of U73122 (U73433; data not shown). Data shown are the average of 
independent experiments with T cells from seven different donors. Error bars represent 
SEM. Asterisks indicate values significantly different from CXCL11-induced actin 
polymerization without inhibitor (Student’s T-test; * p < 0.05, ** p < 0.005). 
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CXCR3-mediated actin polymerization and chemotaxis of T 
lymphocytes 
Finally, the role of MEK-1, PI3K/PI4K, phospholipase C and Gi protein, was 
determined in CXCR3-induced actin polymerization and CXCR3-mediated 
chemotaxis of T cells. Addition of CXCL11 to CXCR3-expressing primary T cells 
induced a rapid and marked onset of F-actin polymerization (fig. 5). CXCL11-
stimulated actin polymerization was not inhibited by pretreatment with the 
MEK inhibitor U0126 (fig. 5). Moderate inhibition of CXCL11-mediated actin 
polymerization was found after 30 seconds when cells were pretreated with 
300 nM wortmannin, or earlier (10 seconds) when pretreated with higher MEK 
inhibitor U0126 (fig. 5). Moderate inhibition of CXCL11-mediated actin 
polymerization was found after 30 seconds when cells were pretreated with 





























































































Figure 6. CXCR3-mediated chemotaxis of activated, primary human T-
lymphocytes and the effect of inhibitors. The chemotactic activity of activated IL-2 
expanded, blood derived human T cells towards 30 nM CXCL11 was determined by the 
Transwell migration system. Migration is reduced by pre-treatment with PTX, the PLC 
inhibitor U73122 and high concentrations of the kinase inhibitors wortmannin and 
LY294002. No significant effects on chemotactic activity were found with the inactive 
analog of U73122 (U73433), and the MEK inhibitors U0126 and PD98059. Data shown are 
the average of experiments with T cells from at least five different donors, except for the 
different LY294002 concentrations (n = 4). Chemotaxis is expressed as percentage of cells 
migrating in comparison to 30 nM CXCL11 (set at 100% for each individual donor). Error 
bars represent SEM. Asterisks indicate values significantly different from CXCL11-induced 
chemotaxis without inhibitor (Student’s T-test; ** p < 0.001).  
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concentrations of wortmannin (3 mM). Complete inhibition, however, was 
achieved after pretreatment with pertussis toxin and the PLC inhibitor U73122 
(5 mM). The inactive analog of U73122, U73343, had no effect (not shown). 
The role of MEK-1 and p44/p42 MAPK in CXCR3-mediated T cell migration was 
studied using the MEK inhibitors PD98059 and U0126 (fig. 6). Neither 
PD98059, nor U0126 caused inhibition of CXCL11-induced chemotaxis. Low 
concentrations of wortmannin, selective for class I PI3K inhibition, did not 
block CXCR3-mediated T cell migration (fig 6). However, at high 
concentrations of wortmannin (>1 µM) significant inhibition of CXCR3-
mediated T cell migration was observed. Similar results were obtained with 
the structurally distinct PI3/PI4K inhibitor LY294002. At concentrations 
selective for class I PI3K inhibition no effects were detected, while increased 
concentrations induced partial inhibition of CXCL11-induced T cell migration. 
Finally, CXCL11-induced migration was completely blocked by pertussis toxin 
pretreatment and the selective inhibitor of phospholipase C (U73122), while 
the inactive analogue of U73122 (U73343) had no effect (fig. 6). This 
confirmed the crucial role of Gi proteins and PLC in CXCR3-mediated migration 
of human primary T cells. None of the inhibitors except for the specific PLC 
inhibitor U73122 affected chemokinesis (data not shown). 
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Discussion 
T cell migration into sites of inflammation is a complex process in which 
several cell surface molecules, e. g. adhesion molecules, integrins and their 
ligands, act together. Soluble mediators, mainly chemokines, are central in 
both activating and directing T cell subsets to target tissues. However, the 
signaling pathways involved in the regulation of these processes are still 
poorly defined. CXCR3 is predominantly expressed on activated T cells and 
activation by CXCL9, 10 and 11 leads to Ca2+ mobilization (Loetscher et al., 
1996; Rabin et al., 1999; Tensen et al., 1999; Cole et al., 1998) and 
chemotaxis in T cells (Tensen et al., 1999). Recently, CXCL9 was shown to 
stimulate also the p44/p42 MAPK pathway in melanoma cells (Robledo et al., 
2001) and both CXCL9 and -10 were reported to activate the Ras/ERK, Src, 
and the PI3K/Akt pathways (Bonacchi et al., 2001) in tissue-specific pericytes. 
However, CXCR3-signaling events in T cells as well as the relative effects of 
CXCL9, -10 and -11 on activation of the p44/p42 MAPK- and Akt-signaling 
pathways on cells heterologously expressing CXCR3 are thus far unknown.  
CXCR3 induces activation of the p44/p42 MAPK and Akt/PI3K 
pathways in T cells 
In CXCR3-transfected COS-7 cells and in activated primary human T cells, 
CXCL11, -10 and -9 induce activation of the p44/p42 MAPK- as well as the 
Akt-signaling pathways. However, considerable differences exist between 
these CXCR3 activating chemokines, with CXCL11 being a more potent ligand 
than CXCL9 and CXCL10. The potencies of CXCL9 and in particular CXCL10 to 
phosphorylate p44/p42 MAPK and Akt are lower than that observed for 
CXCL11 at different time points. These observations are in agreement with the 
reduced affinities reported for CXCL9 and -10 compared to -11 for CXCR3, 
with CXCL11 being unique as it interacts with two receptor states of CXCR3 
(Cox et al., 2001). In both model systems, CXCR3 agonists activate p44/p42 
MAPK and Akt in a Gi and PI3K sensitive manner. It should be noted that the 
efficacy of chemokines is subject to T cell donor variability, while their rank 
order of potency remains the same. As signaling induced by the different 
chemokines in CXCR3-expressing COS-7 is similar to those in activated T cells, 
CXCR3-expressing COS-7 cells may function as a useful alternative model 
system.  
CXCR3 induces sustained activation of Akt in T cells  
Interestingly, CXCR3 activation by CXCL11 leads to sustained phosphorylation 
of Akt in T cells which is similar to that previously observed for CXCL12 (SDF-
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1α) and CXCR4, but distinct from other chemokine receptors. In case of 
CXCR4, persistent activation of Akt by CXCL12 was explained by the fact that 
CXCL12 and CXCR4 are involved in homeostasis rather than inflammation; 
sustained activation could protect CXCR4+ cells from undergoing apoptosis, a 
process that is critical for the activation of T cells (Tilton et al., 2000). Our 
data not only reveal that persistent activation of the Akt-signaling pathway is 
not an exclusive property of the CXCL12/CXCR4 signaling pathway, but also 
demonstrate that sustained activation strongly depends on the concentration 
of the chemokine present in the environment of the receptor. At low 
concentrations of CXCL11 activation of Akt is sustained, whereas at higher 
concentrations CXCL11-mediated activation of Akt is transient. Loss of Akt 
activation might in turn be the signal for chemokine-induced apoptosis as 
recently demonstrated for CXCL12 and CD4+ T cells (Loetscher et al., 1996). 
In a physiological context (e. g. inflammation) such processes might not only 
regulate and guide the migration of CXCR3-bearing T cells, but also be the 
trigger for T cell apoptosis in case of local high expression of CXCL11. 
Disturbance of such a balance might contribute to the presence of high 
numbers of CXCR3-positive T cells in certain inflammatory diseases e. g. 
chronic skin inflammations (Flier et al., 2001).  
CXCR3-mediated T cell migration is not dependent on the PI3K/Akt 
or the p44/p42 MAPK pathway 
Both the PI3K/Akt and the p44/p42 MAPK pathways have been reported to be 
involved in chemokine-induced migration of various cell types (Boehme et al., 
1999; Loetscher et al., 1996; Qin et al., 1998; Vlahakis et al., 2002). 
Additional evidence for PI3Kγ as an important intermediary signal for 
chemotaxis came from genetic studies using PI3Kγ knock-out mice (Hirsch et 
al., 2000; Li et al., 2000; Sasaki et al., 2000). In our study the potent 
inhibitors of MEK1/2 (PD98059 and U0126) were unable to block CXCR3-
mediated transmigration of T cells and CXCR3-induced actin polymerization. 
The inhibitors of PI3K showed a moderate attenuation of CXCR3-mediated 
transmigration of T cells and actin polymerization at relatively high 
concentrations. Both MEK1/2 and PI3K inhibitors were active in blocking the 
CXCL11-mediated phosphorylation of MAPK-p44/p42 and Akt at low 
concentrations.  
Although wortmannin and LY294002 have been used extensively to study the 
physiological role of (class I) PI3Ks in various cellular responses (including 
chemotaxis) contradictory results have been obtained. For example, treatment 
with these PI3K inhibitors inhibited chemotaxis in some studies (Cox et al., 
2001; Coffer et al., 1998) but not in others (Thelen, 2001; Neptune and 
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Bourne, 1997). These studies should be interpreted with caution, as it was 
shown that at higher concentrations (above 100 nM wortmannin or 10 µM 
LY294002) these compounds inhibit other signaling enzymes, including class 
II PI3K and Phosphatidylinositol-4-kinases (PI4K) (Fruman et al., 1998). As in 
our transmigration and actin polymerization assays only a moderate inhibition 
of T cell migration and actin polymerization is obtained with relative low and 
PI3K specific concentrations, we conclude that it is more likely that class II 
PI3K, PI4K or related enzymes other than PI3Kγ are involved in CXCR3-
mediated T cell migration. To date limited information is available on the role 
of PI4K in cell migration. However, in neutrophils, a close association of PI4K, 
α3β1 integrin, and transmembrane-4 superfamily (TM4SF) protein (CD151) 
was demonstrated (Yauch et al., 1998). From this observation, a functionally 
important role of this complex (including PI4K) in cell migration was 
suggested.  
Our data on the possible involvement of class II PI3K or PI4K are in contrast 
with the general concept that chemotaxis is regulated via PI3Kγ (Rickert et al., 
2000; Stephens et al., 2002; Weiner, 2002). This apparent discrepancy might 
result (aside from the fact that PI3K inhibitors at high concentrations also 
inhibited class II PI3K and PI4K; See above), also from the conception that 
signals involved in the regulation of cell migration act in a species, cell and 
chemokine/chemokine receptor dependent fashion (like the different roles of 
p44/p42 MAPK). The most convincing data pointing towards a crucial role for 
PI3Kγ in chemotaxis used PI3Kγ knock-out mice and tested 
CCR5/CXCR4/CXCR2 mediated migration of neutrophils/macrophages (Hirsch 
et al., 2000; Li et al., 2000; Sasaki et al., 2000). At this point one cannot 
exclude that CXCR3-mediated chemotaxis of human T cells is coordinated and 
regulated in a different way involving class II PI3K or PI4K rather than PI3Kγ.  
An important role for MAPK in leukocyte migration came from studies in which 
blockade of MAPK activation by the MAPK kinase inhibitors lead to a decrease 
in eotaxin-induced eosinophil chemotaxis in vitro as well as inhibition of actin 
polymerization (Boehme et al., 1999). Similar observations were made for 
CXCL12-induced migration of CD4+ T cells (Vlahakis et al., 2002). These 
pathways are clearly not employed in case of CXCR3-mediated T cell 
migration. Two structurally different MAPK inhibitors (PD98059 and U0126) 
were not able to inhibit CXCR3-induced actin polymerization assays or CXCR3-
mediated in vitro transmigration, while fully inhibiting phosphorylation of 
p44/p42 MAPK. At this point a role for MAPK in the overall process of 
transendothelial T cell migration cannot be excluded. Recently, it was shown 
for eosinophils that under flow conditions CCR3-mediated MAPK-signals cause 
these cells to rapidly decrease their VCAM-1-mediated adherence while 
enhancing their ICAM-1 binding (Tachimoto et al., 2002). In analogy, 
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recruitment of T cells into sites of inflammations might require CXCR3-
mediated MAPK activation for proper adherence during transendothelial 
migration. In addition, CXCR3 activation of MAPK pathways might be of 
importance for T cell function and development. As it was shown that MAPK-
signaling is involved in T cell proliferation (DeSilva et al., 1998), the observed 
CXCL11-induced p44/p42 MAPK activation might induce long-term effects on T 
cells.  
CXCR3-mediated T cell migration is dependent on Gαi, PLC and PI-
Kinase signaling  
The crucial role of G-proteins in chemotaxis of lymphocytes is well known. It is 
commonly accepted that all chemokine receptors couple to Gi although some 
chemokine receptors can also couple to Gαq, Gα11, Gα14 and Gα16 proteins 
(Wu et al., 1993; Kuang et al., 1996; Soede et al., 2001). As pretreatment of 
T cells with pertussis toxin completely blocks CXCR3-mediated chemotaxis, it 
can be concluded that CXCR3 is primarily coupled to Gαi. The preference of 
CXCR3-coupling to Gαi over Gα16, was also demonstrated in a CHO-cell line 
overexpressing human Gα16 (Tensen et al., 1999). PTX treatment of these 
cells completely abrogates CXCL11-induced Ca2+ signaling, demonstrating that 
CXCR3 couples to endogenously Gαi and not to Gα16.  
The presence of the PLC-signaling pathways in T cells and the ability of 
chemokines to activate this system was previously demonstrated for 
CXCL8/CXCR2 (Bacon et al., 1995). Moreover, PLCβ activation of 
heterologously expressed chemokine receptors was shown for CCR1 and -2 
(Kuang et al., 1996). The major role of PLC as determinant of chemokine-
mediated chemotaxis of T cells (as described in this manuscript), however, is 
hitherto not recognized. Strikingly, the PLC pathway was thus far considered 
to play a role in down-modulation of chemotaxis (Li et al., 2000) rather than 
being crucial for T cell chemotaxis. The fact that the specific inhibitor of PLC 
attenuated chemokinesis, further stresses its pivotal role in T cell motility. It 
remains to be determined, which downstream signaling moieties of PLC are 
responsible for the control of the chemotactic process. Calmodulin kinase, 
myosin light chain kinase, Rho Kinase or other small GTPases are potential 
candidates, which are currently under investigation.  
In summary, our experiments indicate that both PI3Kγ (resulting in Akt 
phosphorylation) and MEK1/2 (resulting in p44/p42 MAPK phosphorylation) 
are functionally active in translating CXCR3-triggered signals in human T-
lymphocytes. However, these signals are not directly involved in CXCR3-
mediated T cell migration, which is primarily regulated in a manner dependent 
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The chemokines CXCL9, -10 and -11 are inflammation-induced chemokines 
and attract activated T cells via CXC chemokine receptor-3. We have 
previously shown that MAPK p44/p42 and Akt are activated via MEK1/2 and 
phosphatydylinositol-3-kinase, respectively, by agonist binding to CXCR3, but 
are not essential for CXCR3-mediated actin polymerization and migration in 
primary human T cells. In view of the importance of phospholipase C in 
CXCR3-regulated downstream signaling in T cells and its known role in inositol 
1,4,5-trisphosphate-mediated intracellular calcium mobilization, we studied in 
detail the CXCR3-mediated calcium mobilization in relation to T cell migration, 
actin polymerization and downstream kinase activation. We demonstrate that 
in CHO cells transfected with human CXCR3 CXCL11-induced calcium 
mobilization CXCL11 occurred via store operated calcium channels. However, 
biological responses following CXCL11-stimulation of human peripheral T cells, 
such as actin polymerization, chemotaxis and phosphorylation of downstream 
kinases, were independent of entry of extracellular calcium. In contrast, T cell 
migration was dependent on CXCL11-induced release of calcium from 
intracellular stores. In addition, in the absence of intracellular calcium both 
actin polymerization and chemotaxis were severely diminished or abolished, 
while phosphorylation of the downstream kinase Akt, but not of p44/p42, was 
decreased. These novel observations expand our current understanding of the 
role of CXCR3 in T cell biology and trafficking.  
Introduction 
In T lymphocytes calcium (Ca2+) plays a fundamental role as a second 
messenger in a wide variety of cellular responses, including T cell activation 
(van Leeuwen and Samelson, 1999), cytokine production (Kuklina and 
Shirshev, 2001), proliferation (Kotturi et al., 2003), and cell death (Medema 
and Borst, 1999). The cytosolic [Ca2+] is maintained at relatively low levels by 
intracellular Ca2+-binding proteins and by sequestration of Ca2+ in intracellular 
membrane-bound compartments such as the endoplasmic reticulum and 
mitochondria. After ligand binding to cell surface receptors, like chemokine 
receptors, intracellular [Ca2+] can rapidly and transiently increase ([Ca2+]i). 
The information encoded in the transient [Ca2+]i is converted by Ca2+-binding 
proteins into specific biochemical changes involving Ca2+-activated protein 
kinases, Ca2+-dependent enzymes (Berridge et al., 2000; Berridge et al., 2003; 
Clapham, 1995) and transcription factors (Venkatesh et al., 2004; Lewis, 
2003) Both calcium release from intracellular stores and influx through calcium 
channels contribute to [Ca2+]i, but influx dominates quantitatively and is 
required for subsequent gene expression (Negulescu et al., 1994).  
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Receptor-mediated calcium responses can be initiated by G protein coupled 
receptors (GPCR), such as chemokine receptors, or tyrosine kinase (-coupled) 
receptors, such as antigen-receptors in T and B cells, but are always induced 
via phospholipase C (PLC). Agonist-induced activation of PLC hydrolyses a 
minor membrane phospholipid, phosphatidylinositol 4,5-bisphosphate (PIP2), 
into diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). Following 
binding of IP3 to its receptor (IP3R) on intracellular calcium stores, calcium is 
released into the cytosol. Depletion of the intracellular Ca2+ stores induces the 
influx of extracellular Ca2+ via so-called store-operated Ca2+ channels (SOC). 
The only SOC described for T cells is the Ca2+ release activated Ca2+ channels 
(CRAC). Although SOC channels have been extensively studied, their 
molecular identity has not been identified to date. Neither is there a 
consensus about the mechanism by which the SOC channels are activated. It 
is generally believed that coupling between the release of calcium from 
intracellular stores and the influx of extracellular calcium does not occur via 
Ca2+-binding to the calcium-channels in the plasma membrane. Alternative 
mechanisms for store operated calcium entry have been described of which 
two now are the most accepted: the conformational coupling model and the 
diffusible messenger hypothesis. For detailed reviews see Putney et al. 
(Putney, Jr. et al., 2001), Lewis (Lewis, 2001), and Prakriya and Lewis 
(Prakriya and Lewis, 2003).  
The functional importance of calcium responses in lymphocytes has been 
studied for activation, proliferation and gene transcription. However, its role in 
lymphocyte migration remains unclear. We studied the nature of [Ca2+]i 
following triggering of the chemokine receptor CXCR3 and its functional 
importance in biological processes involving T cell migration. CXCR3, highly 
expressed on activated T cells (Loetscher et al., 1996; Qin et al., 1998), is a 
Gαi coupled seven-transmembrane receptor, which elicits calcium increases 
after activation by one of its ligands, CXCL9, -10 or -11 (formerly known as 
Mig, IP-10 and IP-9/I-TAC, respectively) (Scandella et al., 2002; Tilton et al., 
2000; Kansra et al., 2001; Loetscher et al., 1996; Tensen et al., 1999). We 
have previously shown that agonist-induced activation of CXCR3 initiates 
multiple signal transduction pathways, including phosphorylation of MAPK 
p44p/p42 (via MEK 1/2) and Akt (via phosphatidylinositol-3-kinase; PI3K). 
CXCR3-mediated actin polymerization and migration were completely 
dependent on Gαi and phospholipase C (PLC) (Smit et al., 2003). Importantly, 
we demonstrated that CXCR3-mediated actin polymerization and migration of 
human primary T cells is not dependent on PI3K or MEK1/2. Here, we 
describe the nature of the [Ca2+]i in CXCR3-mediated signaling and 
determined its role in actin polymerization, migration and the activation of 
downstream kinases in human primary T cells and transfected cell lines.  
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Material and methods 
Materials 
Cell culture media and supplements were obtained from GibcoBRL (Carlsbad, 
CA). CXCL11 (IP-9/I-TAC) was from R & D systems Inc. (Minneapolis, MN). 
The MEK inhibitors PD98059 and U0126 were obtained from New England 
Biolabs Inc. (Beverly, MA) and Promega (Leiden, The Netherlands), 
respectively. The PLC inhibitor U73122, its inactive analog U73343, the 
phosphatidylinositol kinase inhibitors wortmannin and LY294002, pertussis 
toxin, thapsigargin, nifedipine, amiloride, latrunculin A, BAPTA-AM and 
Cytochalasin D were obtained from Sigma (Sigma-Aldrich Chemie B. V. 
Zwijndrecht, The Netherlands). Monoclonal antibodies against Akt, phospho-
p44/p42 and p44/42 and polyclonal antibody against phospho-Akt (ser473) 
were purchased from New England Biolabs.  
Cell culture 
CHO cells heterologously expressing human CXCR3 were cultured as described 
previously (Tensen et al., 1999). Peripheral blood mononuclear cells (PBMC) 
were isolated from human peripheral blood by Ficoll density centrifugation. For 
the isolation of T lymphocytes, PBMC were passed through a nylon wool 
column. Monocytes were then removed by plastic adherence. T cells were 
activated by culturing in RPMI-1640 with 2 mM L-glutamine, 100 U/ml 
penicillin, 100 µg/ml streptomycin and 10% FCS (all from GibcoBRL) in the 
presence of 1 µg/ml phytohaemaglutinin (HA17, Murex Biotech Ltd, Dartford, 
UK) for 3 days and 200 U/ml IL-2 (Eurocetus, Amsterdam, The Netherlands) 
for an additional 7-14 days (Loetscher et al., 1996). The purity of T cells and 
CXCR3-expression were monitored by FACS analysis (FACScan; BD 
Biosciences, Alphen a/d Rijn, The Netherlands). The CXCR3 monoclonal 
antibody (1C6) was from BD Biosciences; Anti-CD3 antibody was purchased 
form Sanquin (Amsterdam, The Netherlands). The percentage of 
CXCR3+/CD3+ cells was typically about 95%.  
Intracellular calcium assay 
CHO-cells expressing human CXCR3 suspended in HEPES buffer (20 mM 
HEPES, 138 mM NaCl, 5.5 mM Glucose, 6 mM KCl, 1 mM MgSO4, 1.1 mM 
CaCl2, 1 mM NaH2PO4 and 0.1% BSA; pH7.4) were loaded with 2 µM of the 
calcium sensitive dye, Fura-2-AM (Molecular Probes, Leiden, The Netherlands) 
for 45 min at 37 °C. After incubation, excess dye was removed by washing the 
cells in HEPES buffer, and the cell suspension was placed in a stirred quartz 
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cuvette. Cytosolic calcium was measured using a Photon Technology 
International (Monmouth Junction, NJ) spectrofluorometer. Fluorescence was 
measured at 37°C at excitation wavelengths of 340 and 380 nm and an 
emission wavelength of 510 nm. Maximum and minimum calcium binding was 
determined by lysing the cells with 0.1% Triton and quenching with 25mM 
ethylene glycol bis ([beta]-aminoethyl ether)-N, N, N ', N '-tetraacetic acid 
(EGTA), respectively. 
Actin polymerization assay 
Cells were resuspended in RPMI-1640 or HEPES buffer with 0.25% BSA 
(fraction V, Sigma) in a concentration of 4 × 106 cells/ml. Prior to the assay 
cells were either incubated with 20 µM BAPTA-AM for 30 minutes and washed, 
to chelate intracellular calcium or washed and resuspended in Ca2+ free HEPES 
buffer. Cells were then stimulated with 10 nM CXCL11. At indicated time 
points, 25 µl of cell suspension was transferred to 25 µl of fixation solution (4 
% paraformaldehyde [PFA]). Cells were fixed for at least 15 minutes. 
Thereafter, cells were washed and resuspended in 50 µl of permeabilization 
reagent (0.1% Triton-X 100). After 10 minutes, cells were washed, blocked 
with 1% BSA (5 min), washed and incubated with 0.5 µM rhodamine-
phalloidin (Molecular Probes) to visualize filamentous actin (F-actin). After 45 
minutes, cells were centrifuged and resuspended in PBS with 0.25% BSA. 
Mean fluorescence intensity was measured by FACS analysis.  
Chemotaxis assays  
The assay for chemotaxis was performed in 24 well plates (Costar, Cambridge, 
MA) carrying Transwell permeable supports with 5 µm pore size polycarbonate 
membrane. T cells were cultured overnight at 4 × 106 cells/ml in RPMI-1640 
containing 0.25% BSA. Prior to the assay cells were either incubated with 20 
µM BAPTA-AM for 30 minutes and washed, to chelate intracellular calcium or 
resuspended in Ca2+ free HEPES buffer or pretreated with 0.5 mM EGTA to 
remove extracellular Ca2+. Medium alone or supplemented with chemokine 
was placed in the lower compartment, and cells were loaded onto the inserts 
at 0.4 × 106/100 µl. Chambers were incubated for 120 minutes in a 5% CO2, 
humidified incubator at 37°C. After the incubation period, numbers of T cells 
migrated to the lower chamber were counted under a microscope using a 
hemocytometer. Viability was checked with trypan blue exclusion. All 
conditions were tested at least in triplicate; statistical evaluation was 




If not stated otherwise, IL-2-expanded activated T cells were serum starved 
overnight in medium supplemented with 0.25% BSA in 2 × 107 cells/ml. 
Aliquots of 8-10 × 106 T cells were preincubated with BAPTA-AM for 30 
minutes and washed three times. Other aliquots were pretreated with 0.5 mM 
EGTA, 1 µM latrunculin A or 2.5 µM cytochalasin D 5 minutes prior to 
stimulation. Cells were stimulated with 10 nM CXCL11 for 1 or 15 minutes or 
with 2.5 µM thapsigargin for 5 minutes. Following stimulation, cells were 
pelleted and frozen immediately.  
Western blot 
Cell pellets were resuspended in lysisbuffer (50 mM Tris/HCl pH 7.5, 10 mM 
EDTA, 80 mM KCl, 1% NP40), supplemented with protease and phosphatase 
inhibitors (10 µg/ml leupeptin, 10 µg/ml aprotinin, 50 µM PMSF, 1 mM sodium 
orthovanadate and serine/threonine phosphatase inhibitor cocktail I (1:100), 
all obtained from Sigma). After 30 minutes on ice, lysates were sonicated and 
insoluble fragments were removed by centrifugation (850 × g, 4° C). Proteins 
were separated on 10% SDS-PAGE and transferred onto nitrocellulose 
membranes. Non-specific binding was blocked by incubating the membranes 
with 3% w/v non-fat dry milk and 0.05% Tween-20 in TBS (TBST). 
Membranes were incubated with the first antibody in the appropriate dilution 
for 1 h at RT or overnight at 4°C. After incubation, membranes were rinsed 
with distilled water and washed three times in wash buffer (0.25% non-fat dry 
milk in TBST). Secondary antibody conjugated to horseradish peroxidase was 
added to the membranes in 3% non-fat dry milk in TBST in the appropriate 
dilution. After one hour of incubation at RT membranes were washed three 
times and developed using an enhanced chemiluminescence kit (Santa Cruz 
Biotechnology, Heerhugowaard, The Netherlands).  
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Results 
Characterization of CXCR3-induced [Ca2+]i 
Calcium influx in CHO cells heterologously expressing CXCR3 is mediated via 
store operated channels 
To study the characteristics of CXCR3-mediated Ca2+ mobilization as well as 
testing the effectiveness of inhibitors and stimulators, we started with CHO 
cells stably expressing human CXCR3 [CHO-CXCR3 (Tensen et al., 1999)]. We 
previously demonstrated that CXCL11 is the most potent stimulator of Ca2+ 
mobilization (Smit et al., 2003; Tensen et al., 1999) which correlated with the 
highest potency in Akt and MEK activation compared to CXCL9 and -10 (Smit 
et al., 2003). Therefore, all experiments were performed with 10 nM CXC11.  
We first studied the contribution of release of intracellular Ca2+ and influx of 
extracellular Ca2+ to the CXCR3-mediated [Ca2+]i. Under normal test 
conditions, CHO-CXCR3 showed a quick rise in intracellular calcium levels after 
encountering agonist, peaking within several seconds and returning to base 
line levels within 40-60 seconds (figure 1A). The removal of calcium from the 
extracellular medium, either by chelation with EGTA or by using calcium-free 
buffer, abrogated the [Ca2+]i almost completely. However, a small increase in 
calcium was still detected, most likely representing calcium release from 
intracellular stores (figure 1A). Thapsigargin, an inhibitor of the re-uptake of 
calcium into intracellular stores, induced a rise in intracellular Ca2+. Depletion 
of intracellular stores with thapsigargin prevented [Ca2+]i induced by CXCR3 
agonists (figure 1C), indicating that the mobilization of Ca2+ from intracellular 
stores is essential for the influx of extracellular calcium in CHO cells 
heterologously expressing CXCR3. These results suggest the involvement of 
store operated calcium channels (SOC) in CXCR3-mediated [Ca2+]i in CHO 
cells. The cell-permeable calcium chelator BAPTA-AM (20 mM) used to study 
the role of intracellular Ca2+ in biological responses (see below) completely 
abrogate the Ca2+ signal (figure 1B). 
A second type of Ca2+ channels is the voltage-dependent Ca2+ channel 
(VDCC). In CHO cells expressing CX3CR1, VDCC are involved in CX3CL1 
(fractalkine)-induced [Ca2+]i (Kansra et al., 2001), while T cell activation and 
proliferation is associated with L-type VDCC (Kotturi et al., 2003). Neither 
inhibition of the L-type VDCC with nifedipine (10 mM) nor inhibition of the T 
type VDCC with amiloride (100 mM) could block chemokine induced Ca2+ 
influx in CHO-CXCR3 cells (figure 1D). Thus, CXCR3-mediated Ca2+ influx in 
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Figure 1. Capacitive Ca2+ entry in CHO-CXCR3 stimulated with CXCL11 and 
thapsigargin. CHO cells transfected with the human CXCR3 loaded with FURA-2AM were 
stimulated with 10 nM CXCL11 (A-D) and 2.5 µM thapsigargin (C). A. Cells were washed 
and resuspended in HEPES buffer with or without Ca2+ prior stimulation. B. Cells were 
pretreated with 20 µM BAPTA-AM, washed and resuspended in HEPES buffer before 
stimulation. C. Cells were first stimulated with thapsigargin (2.5 µM) and subsequently with 
CXCL11. D. Cells were incubated with an inhibitor of L-type (nifedipine, 10 µM) or T type 
(amiloride, 100 µM) voltage-dependent Ca2+ channels before stimulation with CXCL11. 
Intracellular concentration of Ca2+ is represented by the ratio of fluorescence intensity at 
340 and 380 nm.  
CXCR3-induced [Ca2+]i is dependent on PLC and not on PI3K or MEK1/2 
Gi-coupled receptors induce the activation of PLC resulting in the production 
of DAG and IP3. Upon binding to its receptor, IP3 triggers the opening of Ca2+ 
channels and the release of Ca2+ from the intracellular stores. We previously 
showed that CXCR3-mediated T cell migration is completely dependent on PLC 
(Smit et al., 2003). To examine the role of PLC in the calcium response after 
agonist binding we incubated CHO-CXCR3 cells with the PLC inhibitor U73122 
and studied its effect on CXCL11-induced [Ca2+]i. As expected, U73122 
CXCR3-mediated calcium signaling in human T cells 
87 
completely blocked CXCL11-induced calcium mobilization, while its inactive 
homologue U73433 had no effect (figure 2A). In CHO cells transfected with 
CX3CR1, inhibition of PI3K, but not of MEK reduced the CX3CL1 (fractalkine)-
induced Ca2+ influx (Kansra et al., 2001). We verified whether this was also 
true for CXCL11-stimulated CHO-CXCR3. Incubation with PI3K-inhibitors 
wortmannin (200 nM) and Ly294002 (50 mM) did not prevent the CXCL11-
induced [Ca2+]i in these cells (figure 2B). In addition, inhibition of MEK with 
U1026 (10 mM) had no effect on the CXCR3-mediated calcium response 
(figure 2C). Thus, CXCL11-induced [Ca2+]i in CHO cells was dependent on PLC, 




















































[Ca2+]i and actin polymerization in human primary T cells 
To determine the functional importance of [Ca2+]i, we examined the role of 
calcium signaling in biological responses following the encounter of CXCR3-
chemokines by activated T cells. Human peripheral T cells were isolated from 
healthy donors, activated with PHA and expanded in the presence of 
recombinant human IL-2 as described previously, resulting in >95% 
CXCR3+/CD3+ cells (Tensen et al., 1999). One of the initial responses 
following chemokine receptor triggering is a fast and transient increase in  
 
Figure 2. Ligand-induced Ca2+ influx is 
PLC-dependent and independent of 
down-stream kinases. CHO-CXCR3 
loaded with FURA-2/AM and stimulated with 
10 nM CXCL11. A-C. Cells were pretreated 
with PLC inhibitor U73122 or its inactive 
analogue U73433 (both 5 µM, 1 hour) (A), 
inhibitors of PI3K (wortmannin, 200 nM; 
Ly294002, 50 µM, 1 hour) (B), MEK 























































Figure 3. Role of Ca2+ in CXCL11-induced actin polymerization and migration in 
human activated T cells. Human primary T cells were cultured with PHA and IL-2 for 10 
days. Cells were resuspended in buffer with or without Ca2+ or pretreated with 2.5 µM 
thapsigargin or 20 µM BAPTA-AM, before stimulation. A. Activated T cells were stimulated 
with 10 nM CXCL11 and fixed with paraformaldehyde at indicated time points. F-actin 
content of the cells was determined by staining with phalloidin-rhodamin. Fluorescence 
intensity was measured by FACS analysis. The graphs represent data from 4 to 15 different 
donors and show the relative F-actin, calculated as described in material and methods. 
Error bars show the standard error of the mean (Student’s t-test). B-D. The chemotactic 
activity of activated human T cells towards 30 nM CXCL11 was determined in a Transwell 
migration system. The effect of Ca2+ mobilization in T cell migration was determined by 
performing the assay in Ca2+-free HEPES buffer or by chelation of Ca2+ with 0.5 mM EGTA 
(B), depleting intracellular Ca2+ stores by pretreating the cells with thapsigargin (C) or by 
chelating intracellular Ca2+ by incubating the cells with BAPTA-AM before the start of the 
assay (D). Chemotaxis is expressed as percentage of cells migrating in comparison to 30 
nM CXCL11 (set at 100 % for each individual donor). The figures show data from 3 to 8 
different donors. Error bars represent the standard deviation. Asterisks indicate values 
significantly different from CXCL11-induced chemotaxis under normal conditions (control) 
(Student’s t-test; ** p< 0.01).  
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filamentous actin. This response could be measured by labeling stimulated 
cells with phalloidin, which binds only to filamentous actin (F-actin) and not to 
monomeric actin. Thapsigargin and BAPTA-AM were used to discriminate 
between the mechanism of Ca2+ release from intracellular stores (and possible 
other signaling events that are generated via this mechanism) and the 
physical presence of cytosolic Ca2+, respectively. Under normal conditions, a 
fast increase in F-actin was detected after stimulation with CXCL11, peaking 
within 30 seconds and returning to starting levels within 1 to 5 minutes. In the 
absence of extracellular calcium, the basal level of F-actin in the cell was 
increased and actin polymerization in response to CXCL11 was enhanced 
(p<0.001) (figure 3A). The level of F-actin in the cell was also increased by 
the thapsigargin-induced release of Ca2+ from intracellular stores (p<0.01). 
CXCL11-induced actin polymerization was still effective in thapsigargin-treated 
cells with an optimum in F-actin equal to control cells. Thus, thapsigargin- 
treatment of the cells prior to CXCL11-stimulation did not prevent the CXCR3-
mediated response. On the other hand, chelation of intracellular Ca2+ by 
incubating cells with 20 mM BAPTA-AM severely reduced the level of F-actin in 
the cells. Furthermore, actin polymerization in response to CXCL11 was 
decreased, yet not completely abolished (figure 3A). Taken together, these 
results suggest that both the process of calcium release from intracellular 
stores and influx of extracellular Ca2+ are not necessary for the CXCL11-
induced initiation of the transient increase in F-actin. However, intracellular 
Ca2+ concentrations are essential for the stability of the cytoskeleton in non-
stimulated cells and for efficient actin polymerization in stimulated cells. 
CXCR3-mediated [Ca2+]i and migration of human primary T cells 
We then studied the involvement of calcium in migration of human primary T 
cells, using a Transwell system. Spontaneous migration was not decreased in 
the absence of intra-or extracellular Ca2+ nor by emptying of calcium stores, 
indicating that basal cell motility was not affected. The migration of activated 
human T cells was not affected by the absence of extracellular Ca2+ (figure 
3B). However, depletion of intracellular stores with thapsigargin (figure 3C) or 
chelation of cytosolic calcium by BAPTA-AM (figure 3D) abrogated migration 
towards CXCL11. Viability of the cells (determined by trypan blue exclusion) 
was not affected by any of the treatments described. Thus, although 
extracellular Ca2+ is not required, Ca2+ release from intracellular stores and the 
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Figure 4. The role of Ca2+ mobilization and the cytoskeleton on CXCL11-induced 
phosphorylation of down-stream kinases p44/p42 and Akt. Activated human T cells 
were stimulated with CXCL11 for 1 and 15 minutes (A, C) or with thapsigargin for 5 
minutes (B). Cells were lysed and analyzed by Western blot, with antibodies specific for 
phosphorylated p44/p42 (P-p44/p42) or phosphorylated Akt (Ser473) P-Akt. Membranes 
were subsequently stripped and reprobed with antibodies against total p44/p42 (T-
p44/p42) and total Akt (T-Akt). A, B. Phosphorylation of p44/p42 and Akt was studied in 
normal medium, after chelation of extracellular Ca2+ with 0.5 mM EGTA or after depletion 
of intracellular Ca2+ with 20 µM BAPTA-AM. Results given are representative for 2 
independent experiments with cells from 6 different donors. C. Pretreatment of CHO-CXCR3 
cells with 2.5 µM cytochalasin D or 1 µM latrunculin A for 30 minutes does not influence 
CXCL11-induced Ca2+ mobilization. D. CXCL11-induced actin polymerization was abrogated 
activated human T cells in the presence of agents that disturb the actin cytoskeleton 
(cytochalasin D, 2.5 µM, latrunculin A, 1 µM, 5 minutes) E. Phosphorylation of p44/p42 and 
Akt was not affected in activated human T cells pretreated with 2.5 µM cytochalasin D or 1 
µM latrunculin A.  
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Activation of down-stream kinases: dependency on Ca2+ and the 
actin cytoskeleton 
Ca2+ signaling and phosphorylation of p44/42 and Akt  
Next, we studied the role of [Ca2+]i in the CXCR3-induced activity of 
MEK/p44/p42 and PI3K/Akt. Stimulation of T cells with CXCL11 resulted in 
phosphorylation of both p44/p42 and Akt (figure 4A). Phosphorylation was 
measured as early as one minute after stimulation and was decreased, but still  
detectable, after 15 minutes. In the absence of extracellular Ca2+, CXCL11-
induced phosphorylation of both p44/p42 and Akt was not changed. Chelation 
of intracellular calcium by BAPTA-AM had little or no effect on p44/p42 
phosphorylation (figure 4A). However, Akt phosphorylation was partially 
diminished in the absence of intracellular calcium. Thus, CXCL11-stimulated 
phosphorylation of Akt, but not of p44/p42 was partly dependent on 
intracellular Ca2+, while phosphorylation of both p44/p42 and Akt were 
independent of the influx of extracellular Ca2+.  
Phosphorylation of p44/p42 can also be induced in response to non-
physiological calcium mobilizing agents such as thapsigargin and ionomycin 
(Qin et al., 1998). We observed that in primary human T cells thapsigargin-
induced [Ca2+]i resulted in the phosphorylation of p44/p42 (figure 4B). 
Phosphorylation of p44/p42 was prevented, in the absence of extracellular 
Ca2+. Remarkably, chelation of intracellular calcium with BAPTA-AM had no 
effect (figure 4B). Thapsigargin-mediated Ca2+ mobilization had no effect on 
Akt phosphorylation. Taken together, these results suggest that [Ca2+]i, alone, 
does not activate Akt. However, for agonist-induced-activation of Akt, Ca2+ is 
necessary for an optimal response, perhaps by the action of Ca2+-activated 
proteins. The opposite is true for p44/p42, which was activated by 
thapsigargin-induced [Ca2+]i, but can also be phosphorylated in response to 
chemokines in the absence of Ca2+.  
Activation of p44/p42 and Ca2+ mobilization through CXCR3 does not require 
receptor internalization or an intact cytoskeleton 
We then studied the role of the cytoskeleton in [Ca2+]i and the activation of 
p44/p42. The actin cytoskeleton may be involved in coupling the Ca2+ release 
from intracellular stores to the opening of calcium channels in the plasma 
membrane. We examined the role of the cytoskeleton in [Ca2+]i signaling via 
CXCR3 in CHO-CXCR3 cells by disrupting the cytoskeleton with latrunculin A or 
cytochalasin D. Incubation of CHO-CXCR3 cells with 2.5 mM cytochalasin D or 
1 mM latrunculin A had no effect on the CXCL11-mediated Ca2+ response 
(figure 4C), indicating that the cytoskeleton had no active role in coupling 
between intracellular Ca2+ release and Ca2+ entry.  
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Several reports suggest the requirement of receptor endocytosis for the 
activation of kinases, such as JNK (McDonald et al., 2000) and MEK/p44/p42 
(Daaka et al., 1998; DeFea et al., 2000; Kranenburg et al., 1999). After 
treatment of human primary T cells with cytochalasin D or latrunculin A, the 
actin polymerization response to CXCL11 was absent (figure 4D). Incubation 
with latrunculin A for 5 minutes even caused a nearly complete 
depolymerization of the actin cytoskeleton. We then studied the influence of 
disruption of the actin cytoskeleton on CXCR3-mediated phosphorylation of 
p44/p42 in human primary T cells. Disruption of the actin cytoskeleton, had 
no effect on the phosphorylation of p44/p42 (figure 4E), indicating that 
CXCR3-internalization is not required for activation of the MEK/p44/p42 
pathway.  
 
Figure 5. CXCR3-mediated Ca2+ 
mobilization, T cell migration and actin 
polymerization is PKC-independent. A. 
CHO-CXCR3 loaded with FURA-2/AM and 
stimulated with 10 nM CXCL11. Cells were 
pretreated with PKC (Bis I, 10 µM, 30 
minutes). Intracellular concentration of Ca2+ 
is represented by the ratio of fluorescence 
intensity at 340 and 380 nm. B, C. Human 
primary T cells were cultured with PHA and 
IL-2 for 10 days. Activated T cells were 
stimulated with 10 nM CXCL11 and fixed 
with paraformaldehyde at indicated time 
points. (B) and chemotaxis assay (C). B. F-
actin content of the cells was determined by 
staining with phalloidin-rhodamin. 
Fluorescence intensity was measured by 
FACS analysis. The graph represents data 
from 4 different donors and shows the 
relative F-actin, calculated as described in 
material and methods. Error bars show the 
standard error of the mean (Student’s t-
test). C. The chemotactic activity of 
activated human T cells towards 30 nM 
CXCL11 was determined in a Transwell 
migration system. Chemotaxis is expressed 
as percentage of cells migrating in 
comparison to 30 nM CXCL11 (set at 100 % 
for each individual donor). The figure shows 
data from 3 different donors. Error bars 
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Discussion 
Signaling by chemokine receptors occurs via Gi proteins, resulting amongst 
others in an increase in intracellular [Ca2+] (Scandella et al., 2002; Tilton et 
al., 2000; Kansra et al., 2001; Loetscher et al., 1996). Ca2+ is an important 
signal in a wide variety of cellular responses, including cell proliferation, 
differentiation, and survival. Despite the fact that [Ca2+]i in T cells have been 
broadly studied (Prakriya and Lewis, 2003; Putney, Jr. et al., 2001; Lewis, 
2001), its functional importance in relation to chemokine receptors remains 
largely unknown. In this study, we investigated the role of [Ca2+]i in the signal 
transduction and biological effects of T lymphocytes following agonist binding 
to the chemokine receptor CXCR3, a receptor highly expressed on activated T 
cells (Loetscher et al., 1996; Sallusto et al., 1998a; Qin et al., 1998).  
CXCR3-triggered increase in intracellular Ca2+ in CHO-CXCR3 cells was 
mediated via store-operated Ca2+ channels. Incubation of cells with 
thapsigargin, the inhibitor of sarcoplasmatic/endoplasmatic reticulum calcium 
ATPase (SERCA) pumps on the endoplasmic reticulum (Lytton et al., 1991), 
blocks the re-uptake of Ca2+ into the intracellular stores and results in a rise in 
intracellular Ca2+ and the depletion of intracellular stores. Treatment of CHO-
CXCR3 with thapsigargin prevented CXCL11-induced [Ca2+]i. Moreover, in the 
absence of extracellular Ca2+ only a small increase in Ca2+ was detectable 
likely representing release of Ca2+ from intracellular stores. It is generally 
believed that these influxes of Ca2+ occur via CRAC channels. However, some 
studies report the involvement of voltage-dependent Ca2+ channels, such as L-
type Ca2+ channels in [Ca2+]i following TCR/CD3-stimulation (Kotturi et al., 
2003) or T type Ca2+ channels in CX3CR1-induced [Ca2+]i (Kansra et al., 
2001). We showed that, at least in CHO-cells, these channels were not 
involved in the CXCR3-mediated rise in intracellular Ca2+. Furthermore, in 
contrast to other reports (Ribeiro et al., 1997) ligand–induced store operated 
Ca2+ entry in CHO-CXCR3 following the encountering of CXCL11 was not 
affected by disruption of the cytoskeleton. We also observed that in contrast 
to the related chemokine receptor CX3CR1 (Kansra et al., 2001), PI3K does 
not play a role in chemokine-induced Ca2+ mobilization, suggesting that 
mechanisms involved in chemokine signal transduction are receptor-specific.  
Human activated T cells migrated effectively to CXCL11 both in the presence 
and in complete absence of extracellular Ca2+, indicating that CXCR3-mediated 
T cell migration was independent of the influx of Ca2+. Similar results were 
reported recently for the CCR7-mediated migration of monocyte-derived 
dendritic cells (Scandella et al., 2002). Although the depletion of intracellular 
Ca2+ stores did not greatly affect CXCR3-mediated actin polymerization, T cell 















































Figure 6: Schematic overview of a selection of components involved in the signal 
transduction pathways activated by CXCR3-ligand binding. Following ligand binding 
to CXCR3 the Gi protein is activated. The βγ subunits of the G-protein then activate PLCβ 
and PI3K. PLCβ hydrolyses PIP2 into DAG and IP3. DAG activates PKC, while IP3 binds to its 
receptor on the intracellular Ca2+ stores, which causes the release of Ca2+ into the cytosol. 
The depletion of the intracellular stores activates store operated calcium (SOC) channels in 
the plasma membrane. Subclasses of PKC can also be activated by increased Ca2+ levels. 
The scheme is not meant to be complete. L: ligand. Lines composed of more than one 
arrow signify pathways in which more kinases /enzymes lie in between the indicated 
kinase/enzyme and the target. Broken lines represent possible connections and 
involvement of the indicated proteins. 
polymerization responses are not fully representative of migratory responses. 
In contrast, the presence of intracellular Ca2+ was both essential for optimal 
CXCL11-induced actin polymerization and crucial for CXCR3-mediated T cell 
migration. Chemokine-induced local increases in Ca2+ could be necessary for 
polarization of T cells (Sanchez-Madrid and del Pozo, 1999) and migration 
towards a chemokine gradient. Intracellular Ca2+ signals have been associated 
with cell polarization in eosinophils, neutrophils and fibroblasts (Brundage et 
al., 1991; Mandeville and Maxfield, 1997; Hahn et al., 1992). We 
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demonstrated also that T cell migration was completely abrogated when 
cytosolic Ca2+ was chelated by BAPTA-AM indicating that Ca2+ itself is 
necessary for the migration of T cells. Although intracellular Ca2+-levels seems 
to be essential for cytoskeletal rearrangements, via the activity of Ca2+ 
dependent actin binding proteins such as gelsolin (Arora and McCulloch, 
1996), α-actinin (Bhatt et al., 2002) and myosin II (Eddy et al., 2000), the 
requirement of intracellular Ca2+ mobilization in CXCR3-controlled migration 
might be typical for T cells. Previous work showed that CXCR3-mediated 
migration of malignant B cells (Trentin et al., 1999) or transfected B cells 
(Jenh et al., 2001) occurs without eliciting a measurable calcium flux.  
Interestingly, we observed that actin polymerization was independent of 
CXCL11-induced [Ca2+]i. In contrast, the presence of cytosolic Ca2+ was 
essential for actin polymerization. After depletion of free intracellular Ca2+ with 
BAPTA-AM F-actin levels were markedly lowered in non-stimulated cells, 
indicating that the intracellular [Ca2+] plays a role in the maintenance of the 
cytoskeleton. CXCL11-induced actin polymerization response was strongly 
decreased in BAPTA-AM treated cells, however not completely abolished. 
Calcium-dependence of the actin cytoskeletal organization was further 
demonstrated by the increased levels of F-actin after treatment of T cells with 
thapsigargin. Conversely, in Ca2+-free medium basal F-actin levels were 
increased in non-stimulated cells and agonist-induced actin polymerization 
was enhanced. Thus, although Ca2+ is necessary for the maintenance and 
reorganization of the actin cytoskeleton, these data suggest that the [Ca2+]i is 
not involved in the initiation of CXCR3-mediated actin polymerization. In 
conclusion, CXCL11-induced T cell migration, but not actin polymerization was 
dependent on [Ca2+]i. Importantly, Ca2+ release from intracellular stores is 
sufficient for these responses, rendering Ca2+ entry from the extracellular 
environment via SOC channels superfluous (See also figure 6).  
Agonist binding to CXCR3 results in the phosphorylation of Akt which can be 
partially prevented by inhibition of PI3K (Smit et al., 2003). We here 
demonstrate that phosphorylation of Akt is dependent on intracellular Ca2+. 
CXCL11-induced Akt phosphorylation was decreased when intracellular 
calcium was chelated with BAPTA-AM. Absence of extracellular Ca2+ did not 
affect Akt phosphorylation, indicating that intracellular Ca2+ was sufficient for 
an optimal response. On the contrary, induction of [Ca2+]i in T cells with 
thapsigargin had no effect on Akt phosphorylation. One possible effect of Ca2+ 
after chemokine signaling may be the regulation of PI3K activity, however, 
this property of PI3K has not been described before. Agonist-induced receptor 
activation may also activate Ca2+ dependent kinases that can activate Akt [e. 
g. Ca2+-calmodulin dependent kinase (CaMK) (Yano et al., 1998) and CaMK 
kinase (CaMKK) (Soderling, 1999)]. For example, in human neutrophils 
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inhibition of calmodulin attenuated fMLP-induced Akt phosphorylation 
(Verploegen et al., 2002). We tested the effect of the calmodulin inhibitor W7 
on the migration and actin polymerization of human activated T cells. 
However, in our hands this compound was toxic for T cells at active 
concentrations (50 mM) (Verploegen et al., 2002; Zahalka et al., 2003). Taken 
together, our results suggest that CXCL11-induced phosphorylation of Akt 
occurs via both a PI3K-dependent pathway and a Ca2+-dependent pathway 
(figure 6).  
Phosphorylation of p44/p42 is known to be induced by increase in intracellular 
[Ca2+]. Both thapsigargin and the Ca2+-ionophore ionomycin are often used as 
a positive control for p44/42 phosphorylation (Anborgh et al., 1999). Indeed, 
thapsigargin induced the phosphorylation of this kinase in human primary T 
cells. Chelation of extracellular Ca2+, but not of intracellular Ca2+, completely 
abolished the response. These results suggest that for thapsigargin-induced 
activation of p44/42 the influx of Ca2+ across the plasma membrane, is crucial. 
In BAPTA-AM loaded cells the Ca2+ influx might still be activated by the 
processes induced by the Ca2+ release from intracellular stores.  
In contrast to thapsigargin-induced phosphorylation, activation of p44/p42 by 
agonist binding to CXCR3 was almost completely independent of both 
intracellular and extracellular Ca2+. The same phenomenon was found by 
Fierro et al. for TCR-crosslinking in T cells (Fierro et al., 2004). The 
discrepancy between Ca2+ dependent phosphorylation of p44/p42 by 
thapsigargin and Ca2+-independent phosphorylation of the same kinases by 
CXCL11 may be explained by the multiple ways in which the Raf/Mek/p44/p42 
pathway can be activated (Chong et al., 2003). Many different kinases can be 
activated in T cells following receptor triggering, some of which are dependent 
on Ca2+ [such as PKCβ (Carnevale and Cathcart, 2003), Pyk2 (Di, V et al., 
2004; Rodriguez-Fernandez et al., 2002), CAMK1 (Schmitt et al., 2004)], while 
others are independent of Ca2+ [such as PKCδ (Shah and Catt, 2002), Ras 
(Jimenez-Sainz et al., 2003; Olson and Marais, 2000), Src pathway (Korade-
Mirnics and Corey, 2000), PI3K (Sasaki et al., 2000)]. The dominant 
mechanism of MAP kinase activation varies significantly between receptor and 
cell type. Moreover, the mechanism of MAP kinase activation has a substantial 
impact on MAP kinase function and its location of action (Luttrell, 2003; DeFea 
et al., 2000). Thus, CXCL11 may trigger signal transduction routes that 
activate kinases, such as p44/p42, in a way that is specific for receptor and 
cell type, resulting in the desired effects, such as, in the case of CXCR3, 
cytokine production and proliferation (Luttrell, 2003; DeFea et al., 2000; 
Whiting et al., 2004). Which pathways determine the CXCL11-induced 
phosphorylation of p44/p42 and the functions of p44/p42 in CXCR3-stimulated 
cells are as yet unclear (figure 6).  
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Recent studies have pointed towards a role of receptor internalization and β-
arrestin in MAP kinase activation. Several reports point to the requirement of 
endocytosis for the activation of MAPK, such as p44/p42 (Della Rocca et al., 
1999; Daaka et al., 1998; DeFea et al., 2000; Kranenburg et al., 1999), while 
others contradict this (Blaukat et al., 1999; Schramm and Limbird, 1999; Budd 
et al., 1999). We show that in activated human T cells CXCR3 internalization is 
not essential for MEK1/2 activity since disruption of the actin cytoskeleton had 
no effect on the phosphorylation of p44/p42 in activated human T cells 
following stimulation with CXCL11, known to internalize CXCR3 (Sauty et al., 
2001). This means either that complex formation of the receptor with β-
arrestin is sufficient to activate MEK1/2-p44/p42 or that these kinases are 
activated through an β-arrestin independent alternative route, which is 
independent of internalization.  
In monocytes, migration towards CCL2 (MCP-1) was dependent on the Ca2+-
dependent PKCβ (Carnevale and Cathcart, 2003). Similarly, CXCR4-mediated 
migration was prevented by inhibition of PKC (Wang et al., 2000). As CXCR3-
mediated actin polymerization was PLC dependent (Smit et al., 2003) but 
independent of CXCR3-mediated [Ca2+]i, we studied the involvement of PKC in 
CXCR3–mediated actin polymerization and T cell migration. We show here 
that CXCR3-mediated actin polymerization and migration are independent of 
PKC. In conclusion, CXCR3-mediated actin polymerization and T cell migration 
both are independent of PKC.  
In conclusion, CXCL11-induced [Ca2+]i occurred in CHO cells transfected with 
human CXCR3 via store operated calcium influx. However, biological 
responses following CXCL11-stimulation of human peripheral T cells, such as 
actin polymerization, chemotaxis and phosphorylation of downstream kinases, 
were independent of influx of extracellular Ca2+. Importantly, T cell migration 
was completely dependent on the chemokine-induced release of calcium from 
the intracellular store. In addition, actin polymerization and chemotaxis were 
severely diminished or abolished in the complete absence of intracellular Ca2+. 
Also phosphorylation of the downstream kinase Akt, but not p44/p42, was 
decreased after chelation of intracellular Ca2+.  
Furthermore, we showed that CXCR3 signaling is distinct from other 
chemokine receptors: CXCR3-mediated Ca2+ mobilization in CHO cells, in 
contrast to other chemokine receptors, was independent of PI3K and not 
affected by disruption of the cytoskeleton. In addition, PKC was not involved 
in CXCR3-mediated calcium mobilization, actin polymerization and migration of 
human primary T cells. Also CXCL11-induced p44/p42 phosphorylation was 
not mediated via receptor internalization. Taken together, our results 
demonstrate that the repertoire of signal transduction proteins and 
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mechanisms involved in chemokine receptor signaling is highly dependent on 
the type of receptor and the cellular context.  
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Abstract 
CXCR3-ligands CXCL9 (monokine induced by IFN-γ; MIG), CXCL10 (IFN-γ-
inducible protein 10; IP10) and CXCL11 (IFN-γ-inducible T cell α-
chemoattractant; ITAC) are inducible cytokines and are produced in response 
to exposure to interferon-γ (IFN-γ). Infiltration of CXCR3+ cells and increased 
expression of CXCR3-ligands have been demonstrated in a number of type 1 
inflammatory diseases, including rheumatoid arthritis, multiple sclerosis, 
hepatitis C–infected liver, artherosclerosis, delayed-type hypersensitivity skin 
reactions, and chronic skin inflammations. Its association with a wide variety 
of diseases makes CXCR3 an attractive target for therapeutic applications. 
Two small molecule CXCR3 antagonists containing a 3-phenyl-3H-quinazolin-4-
one nucleus, have been reported (Schall et al., 2001). To attain antagonists 
with increased affinity for CXCR3, analogues were synthesized based on this 
scaffold, and tested in radioligand binding and functional assays. Of all 
analogues tested VUF5834 had the highest binding affinity for CXCR3. In 
functional assays with CXCR3-expressing cells, VUF5834 efficiently inhibited 
CXCR3 induced phospholipase C activity and calcium mobilization. Moreover, 
in CXCR3-expressing human primary T cells VUF5834 completely abrogated 
CXCR3-mediated actin polymerization and chemotaxis, while migration 
towards CXCR4-ligand CXCL12 was not affected. Thus, the small molecule 
VUF5834 specifically antagonizes CXCR3-mediated responses via interaction 
with the receptor. VUF5834 may serve as a lead to obtain a compound with 
improved affinity and potency for therapeutic applications and exploration of 
the role of CXCR3+ T cells in type 1 inflammatory disorders.  
Introduction 
Chemokines are small proteins involved in the recruitment and homing of 
leukocytes. Chemokines are produced by tissue cells and leukocytes and are 
subdivided into four classes based on the relative position of conserved 
cysteine residues: CC, CXC, CXXXC, and XCL (Murphy et al., 2000). They act 
through corresponding groups of CCR, CXCR, CX3CR and XCR receptors that 
belong to the seven-transmembrane, G protein-coupled receptor family. The 
chemotactic function of chemokines can be classified into two categories: 
constitutive and inducible. Constitutive chemokines are involved in the 
development of lymphatic tissues, basal leukocyte trafficking and immune 
surveillance. Inducible chemokines are produced upon infection or other stress 
signals and regulate the recruitment of leukocytes to sites of inflammation 
(Zlotnik et al., 1999). For example exposure of tissue cells to interferon γ 
(IFN-γ) induced the production of the CXCR3-ligands CXCL9 (monokine 
induced by IFN-γ; MIG), CXCL10 (IFN-γ-inducible protein 10; IP10) and 
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CXCL11 (IP-9/IFN-γ-inducible T cell α-chemoattractant; ITAC). Secretion of 
these chemokines then results in the recruitment CXCR3-expressing 
leukocytes to the site of inflammation (Kupper and Fuhlbrigge, 2004). CXCR3 
is expressed mainly on activated T cells (both CD4+ and CD8+ T cells), but can 
also be found on B cell plasmablasts and NK cells (Inngjerdingen et al., 2001; 
Loetscher et al., 1998). Increased expression of CXCR3 on CD4+ T cells is 
associated with a Th1 phenotype (Kim et al., 2001). Infiltration of CXCR3+ 
cells and increased expression of CXCR3-ligands have been demonstrated in a 
number of type 1 inflammatory diseases, including rheumatoid arthritis (Qin et 
al., 1998; Patel et al., 2001), multiple sclerosis (Balashov et al., 1999), 
hepatitis C–infected liver (Shields et al., 1999), artherosclerosis (Mach et al., 
1999), delayed-type hypersensitivity skin reactions, and chronic skin 
inflammations (Tensen et al., 1999; Flier et al., 1999; Flier et al., 2001; 
Tokuriki et al., 2002). Moreover, infiltration of CXCR3+ cells is associated with 
graft rejection (Hancock et al., 2001). The association of CXCR3 with a wide 
range of immune disorders makes it an attractive target for therapeutic 
applications.  
So far only two small molecule CXCR3 antagonists containing a 3-phenyl-3H-
quinazolin-4-one nucleus, have been reported (Schall et al., 2001). Based on 
this scaffold, analogues were synthesized and tested in radioligand binding 
and functional assays. Of all analogues, VUF5834 had the highest affinity for 
CXCR3. Preincubation with VUF5834 efficiently abrogated CXCR3-mediated 
PLC activation and Ca2+ mobilization in CXCR3 expressing COS-7-cells and 
blocked CXCR3-mediated actin polymerization and chemotaxis in human 
activated T cells in a dose-dependent manner. This novel small molecule 
CXCR3-antagonist may serve as an important tool to further unravel the role 
of CXCR3 in autoimmune and inflammatory diseases, and may serve as a lead 
to the development of therapeutic agents.  
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Materials and Methods 
Cells and reagents 
COS-7 cells transfected with the human CXCR3 (Smit et al., 2003) and 
HEK293 cells stably expressing CXCR3 (Dijkstra et al., 2004) were cultured as 
described previously. Human primary activated T cells (> 95% CXCR3+) were 
isolated and cultures as described by Verdijk et al. 2004 (Chapter 5). 3-
Phenyl-3H-quinazolin-4-one derivatives, analogues of the small molecular 
antagonist for CXCR3 reported by Schall et al. (WO 01/16144 A2), were 
synthesized by the Leiden/Amsterdam Center for Drug Research (LACDR). 
125I-labeled CXCL1O (2200 Ci/mmol) was obtained from Perkin-Elmer Life 
Sciences (Boston, Mass.). CXCL10 was obtained from PeproTech (Rocky Hill, 
N.J.). CXCL11 was purchased from R&D Systems, Inc. (Minneapolis, Minn.). 
Poly-L-Lysine was from Sigma (St. Louis, Mo.). 
Radioligand binding assay 
In competition experiments, HEK293-CXCR3 cells were seeded in poly-L-
Lysine-coated 48-well plates. After 24 hours the cells were incubated with 125I-
labeled CXCL10 in binding buffer (50 mM HEPES [pH 7.4], 1 mM CaCl2, 5 mM 
MgCl2, 0.5% BSA) containing increasing concentrations of the indicated 
compounds for 4 h at 4°C. After incubation, cells were washed three times 
with ice-cold binding buffer supplemented with 0.5 M NaCl. Subsequently, cells 
were lysed and counted in a Wallac Compugamma counter. 
[3H]Inositol phosphate production 
COS-7 cells were transfected with CXCR3 and Gqi5 chimeric protein (Coward 
et al., 1999). 24 h after transfection cells were labeled overnight in inositol-
free medium (modified Eagle's medium with Earle's salts) supplemented with 
2 mM L-glutamine, L-cysteine, L-leucine, L-methionine, L-arginine, glucose, 
0.2% bovine serum albumin, and 2 µCi/ml myo-[2-3H]inositol (Amersham 
Pharmacia Biotech, Roosendaal, The Netherlands). Subsequently, the labeling 
medium was aspirated, cells were washed for 10 min with Dulbecco's modified 
Eagle's medium containing 25 mM HEPES (pH 7.4) and 20 mM LiCl. Cells were 
preincubated for 10 minutes with/or without 3-Phenyl-3H-quinazolin-4-one 
derivatives and incubated for 2 h in the same medium in the absence or 
presence of 10 nM CXCL11 or 30 nM CXCL10. The incubation was stopped by 
aspiration of the medium and addition of cold 10 mM formic acid. After 90 min 




chromatography (Dowex AG1-X8 columns, Bio-Rad) and counted by liquid 
scintillation. 
Ca2+ measurements 
CXCL11-stimulated increases in [Ca2+]i were quantified by monitoring the 
fluorescence of Fluo-4 AM-loaded HEK293-CXCR3 cells, using an automated 
NOVOstar microplate reader (BMG Labtech GmbH, Offenburg, Germany). Cells 
were loaded in Hanks’ balanced salt solution containing 20 mM HEPES, 2.5 
mM Probenecid, 2 µM Fluo-4 AM and 0.02 % Pluronic F-127, pH = 7.4. Cells 
were washed three times and fluorescence was measured (1 data 
point/second, excitation 485 nm, emission 520 nm) for 10 seconds to 
calculate the mean basal value. Cells were preincubated for 10 min with the 
indicated compounds (1 µM). After injection of the agonist CXCL11 (30 nM) 
fluorescence was recorded for 50 seconds. Changes induced by Triton X-100 
(0.25% [v/v]) injection were recorded for further 10 seconds to determine the 
maximal fluorescence of the system. Basal and maximal values determined for 
each well were used to normalize the data. Results were expressed as percent 
age of the maximal stimulation induced by Triton X-100.  
Actin polymerization assay 
Cells were resuspended in RPMI-1640 with 0.25% BSA [BSA, fraction V, 
Sigma]) in a concentration of 4 × 106 cells/ml. 3-Phenyl-3H-quinazolin-4-one 
derivatives were added 10 minutes prior to the stimulation. Chemokines was 
added in a concentration of 10 nM. At indicated time points, 25 ml of cell 
suspension was transferred to 25 ml of fixation solution (4 % 
paraformaldehyde; PFA). Cells were fixed for at least 15 minutes. Thereafter, 
cells were washed and resuspended in 50 ml of permeabilization reagent 
(0.1% Triton-X 100). After 10 minutes, cells were washed, blocked with 1% 
BSA (5 min), washed and incubated with 0.5 mM rhodamine-phalloidin 
(Molecular Probes, Leiden, The Netherlands) to visualize filamentous actin (F-
actin). After 45 minutes, cells were centrifuged and resuspended in PBS with 
0.25% BSA. Mean fluorescence intensity was measured by FACS analysis.  
Chemotaxis assays  
The assay for chemotaxis was performed in 24 well plates (Costar, Cambridge, 
MA) carrying Transwell permeable supports with 5 µm pore size polycarbonate 
membrane. T cells were cultured overnight at 4 × 106 cells/ml in RPMI-1640 
containing 0.25% BSA. Cells were incubated with 3-Phenyl-3H-quinazolin-4-
one derivatives for 10 minutes. Medium alone or supplemented with 
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chemokine and/or 3-Phenyl-3H-quinazolin-4-one derivatives was placed in the 
lower compartment, and cells were loaded onto the inserts at 0.4 × 106/100 
µl. Chambers were incubated for 120 minutes in a 5% CO2, humidified 
incubator at 37°C. After the incubation period, numbers of T cells migrating to 
the lower chamber were counted under a microscope using a hemocytometer. 
Viability was checked with trypan blue exclusion. All conditions were tested in 




Results and discussion 
VUF5834 binds with high affinity to CXCR3 
To attain a CXCR3 antagonist with increased affinity, various 3-Phenyl-3H-
quinazolin-4-one derivatives, analogues of the small molecular antagonist for 
CXCR3 reported by Schall et al. (WO 01/16144 A2; compound 1c, figure 1A) 
were synthesized and there affinity for CXCR3 and ability to inhibit CXCR3-
mediated signaling were determined. Variations were introduced in the adduct 
to the phenyl ring (X) and by removing or replacing the decanoyl chain with 
other groups (R) (Table 1). Radioligand binding assays using HEK293-cells 
heterologously expressing the human CXCR3 revealed that the decanoyl group 
was essential for binding to CXCR3. Removal or substitution of the decanoyl 
group resulted in a total loss of activity (Table 1). Varying the position and/or 
the nature of the phenyl ring adduct altered the affinity of the compound to 
the receptor (Table 1). Most effective was the replacement of the F at position 
4 (4-F) of the lead compound by a cyano group (4-CN). Compound 1b 
(VUF5834: X = 4-CN, R = decanoyl, figure 1B) possessed the highest affinity 
for CXCR3 in the radioligand binding assay (pIC50: 6.04 ± 0.09) and was 




























Figure 1: Molecular structure of A. the lead compound (Schall et al.; compound 1c), B. 
compound 1b (VUF5834) and C. compound 2b (VUF5833).  
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Compound  R  X  pIC50   
1a decanoyl H 4.85 ± 0.15  
1b decanoyl   4-CN  6.04 ± 0.09  VUF5834 
1c decanoyl  4-F  5.51 ± 0.13  Schall et al.  
1d decanoyl  4-OCH3  5.51. ± 0.15  
1e decanoyl  4-OH  3.94 ± 0.27  
1f decanoyl  4-CH3  5.54 ± 0.15  
1g decanoyl  4-CF3 < 4  
1h decanoyl  3-CN  5.24 ± 0.05  
1i decanoyl  2-CN  4.99 ± 0.08  
1j cyclohexanoyl 4-CN < 4  
1k benzoyl 4-CN < 4  
1l naphtoyl 4-F  < 4  
2a H H < 4  
2b H 4-CN < 4  VUF5833 
Table 1: Binding affinity of the different modifications of the reported scaffold. 
The binding experiments were carried out on HEK293 cells expressing the human CXCR3 
receptor. The compounds were tested for their ability to displace [125I]CXCL10. Compound 
1c represents the lead compound described by Schall et al. Compounds 1b and 2b were 









VUF5834 abrogates CXCL11-induced Ca2+ mobilization and PI 
turnover in CXCR3-expressing COS-7 cells 
The effect of VUF5834 on CXCL11- and CXCL10-mediated processes was 
studied in different signaling assays in human CXCR3 expressing cells and its 
effects were compared to a non-binding analogue (compound 2b/VUF5833: X 
= 4-CN, R = H, figure 1B). Agonist binding to CXCR3 results in the activation 
of PLC via Gi (Smit et al., 2003). The effect of VUF5834 on CXCL11-induced 
PLC activity was determined by measuring the production of IPx in COS-7-
CXCR3 cells. A 10 minute preincubation of COS-7-CXCR3 with VUF5834 
inhibited CXCR3–mediated PI turnover in a dose-dependent manner (IC50 [10 
nM CXCL11]: 6 uM), while the non-binding analogue had no effect (figure 2A-
B). IP3, one of the products of PLC activity, induces an increase in intracellular 
Ca2+ concentrations, by mobilizing Ca2+ from intracellular stores and activating 
the influx of Ca2+ from the extracellular environment (Loetscher et al., 1996; 
Tensen et al., 1999; Rabin et al., 1999) and Verdijk et al. 2004, Chapter 5). 
Incubation of HEK293-CXCR3 cells with 1 µM of VUF5834, 10 minutes prior to 
chemokine stimulation completely abrogated the CXCR3-induced Ca2+ 
increase, while the non-binding analogue had no effect (figure 2C). These 
results demonstrate that VUF5834 efficiently blocks the CXCL11-induced PI 
turnover and subsequent Ca2+ mobilization interaction with CXCR3.  
VUF5834 inhibits CXCR3-mediated actin polymerization and 
migration of human primary T cells 
Agonist binding to CXCR3 on human T cells induces a rapid and transient 
increase in filamentous actin (F-actin) and chemotaxis towards the 
chemotactic gradient (Tensen et al., 1999; Smit et al., 2003). The fast and 
transient increase in F-actin content is one of the earliest measurable 
biological responses following binding of chemoattractants to their receptor 
and is considered as an early sign of lymphocyte migration (Voermans et al., 
2001; Tenscher et al., 1997; Elsner et al., 1998). We investigated the effect of 
VUF5834 on both CXCR3-induced actin polymerization and migration of 
human activated T cells. Human peripheral blood T cells were isolated from 
healthy donors, activated with PHA and expanded in the presence of 
recombinant human IL2 as described previously, resulting in >95% 
CXCR3+/CD3+ cells (Tensen et al., 1999; Loetscher et al., 1996; Qin et al., 
1998). CXCR3-induced increase in actin filaments was completely abrogated in 
the presence of 1 µM of VUF5834 (figure 4). Its non-binding analogue 
counterpart VUF5833 had no effect on CXCR3-agonist induced actin 
polymerization, indicating that inhibition was dependent on receptor binding.  
 
































































































Figure 2: VUF5834 abrogates CXCR3-mediated IP3 production and [Ca2+]i. A-B. 
Effect of VUF5834 and its non-binding analogue VUF5833 on CXCR3-mediated PLC activity 
by CXCL10 (A) and CXCL11 (B). PLC activity was measured by the production of [3H]IPx 
from radioactive labeled inositol in COS-7-CXCR3. C. Ca2+ mobilization in response to 30 nM 
CXCL11 in HEK283-CXCR3 in the presence or absence of 1 µM of VUF5834 or the non-
binding analogue VUF5833. Error bars show standard error of the mean. 
We then investigated the effect of both compounds on CXCR3-mediated 
chemotaxis. Migration of activated T cells towards CXCR3-ligands CXCL11 and 
CXCL10 was dose-dependently inhibited by preincubation with VUF5834, but 
not with VUF5833 (figure 3 B, C). VUF5834 inhibited T cell migration induced 
by 30 nM CXCL11 with an IC50 of 0.5 µM. Viability of the cells in the presence 
of VUF5834 was determined by trypan blue exclusion and was not affected by 
concentrations up to 1 µM.  
To confirm that the antagonistic action of VUF5834 on CXCR3-mediated 
processes occurred via binding to CXCR3, we studied its effect on T cell-
migration towards CXCR4-ligand CXCL12 (formerly known as SDF-1a; 30 nM). 
In human peripheral blood the percentage of CXCR4+ T cells is approximately 
40%, which is increased to up to 80% upon culturing with PHA or IL2 (Bleul 
et al., 1997). VUF5834 did not affect the migration of activated T cells to 
CXCR4-agonist CXCL12 (figure 3C), indicating that VUF5834 acts specifically 
on CXCR3-mediated migration. Basal migration in the absence of 
chemoattractants was not changed by VUF5834, demonstrating that motility 
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Figure 3: VUF5834 inhibits CXCR3-mediated actin polymerization and 
chemotaxis of human T cells. Human T cells were isolated form peripheral blood and 
activated with PHA and IL-2. A. Actin polymerization in response to CXCL11 was measured 
in the presence or absence of 1 µM of VUF5834 or its VUF5833. Results are representative 
for 3 donors. Error bars show the standard error of the mean. B-C. Chemotaxis of activated 
T cells towards CXCR3-ligands. B. Dose-response effect of VUF5834 and VUF5833 on 
chemotaxis of activated T cells induced by 30 nM of CXCL11. C. Dose-response effect of 
VUF5834 on CXCL11-, CXCL10- and CXCL12-induced chemotaxis (all 30 nM) of activated T 
cells. Results are representative for 3 donors. Error bars show the standard deviation.  
Conclusion 
In conclusion, binding of 3-Phenyl-3H-quinazolin-4-one derivatives to CXCR3 is 
determined by the decanoyl-group and the adduct on position 4 on the 
phenyl-ring. VUF5834 (X=4-CN, R= decanoyl) bound to CXCR3 with the 
highest affinity. Binding of VUF5834 to CXCR3 on COS-7-cells expressing the 
human CXCR3 inhibited activation of PLC and the mobilization of Ca2+. 
Moreover, 1 µM of VUF5834 abrogated both CXCR3-mediated actin 
polymerization and chemotaxis. At this concentration no signs of toxicity were 
detected. Inhibition of CXCR3-signaling was dependent on receptor-binding, 
which was demonstrated by the lack of inhibition by the non-binding analogue 
VUF5833. The antagonistic effect of VUF5834 was specific for CXCR3, as 
CXCR4-mediated chemotaxis was not affected. All together VUF5834 may 
serve as a lead to obtain a compound with improved affinity and potency for 
therapeutic applications and exploration of the role of CXCR3+ T cells in type 1 
inflammatory disorders.  
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Summary and general discussion 
The immune system is a complex and well-organized organ. Knowledge of its 
function is crucial, not only for the treatment of infectious diseases and 
allergies, but also for many other disorders, such as autoimmunity and cancer, 
and for organ transplantation. In the skin, excessive infiltration of leukocytes 
are found in many inflammatory diseases. Two major players involved in 
acquired immune responses are the dendritic cell and the T cell. This thesis 
will focus on two aspects of this system; the maturation of DC and its antigen-
presenting function and the trafficking of T cells, which can be considered as 
crucial steps in directing the acquired immune system.  
The actin binding protein cofilin is dephosphorylated during DC 
maturation 
The principal task of dendritic cells is to specifically direct T cells that are 
reactive with the antigens the DC has encountered and presents on its cell 
surface. In this process, the maturation state of the DC is of critical 
importance for T cell activation as it determines the outcome of the interaction 
between the DC with the T cell: activation or tolerance. The aim of the study 
described in chapter 2 was to identify novel proteins involved in DC 
maturation that may have a role in T cell activation.  
To accomplish this, total protein expression profiles of immature and mature 
DC were compared by the combined use of two-dimensional gel-
electrophoresis (2DE) and mass spectrometry (MS). Although both 2DE and 
MS are no new techniques, recent advances in the technology and software 
make it an attractive and promising methodology for the identification of 
differentially expressed proteins. 2DE is based in the separation of proteins 
first on their iso-electric point and then on their molecular weight. 
Commercially available gel strips used for the first dimension make 2DE less 
time-consuming and more reproducible. Furthermore, the resolution and 
sensitivity of the latest generation of mass-spectrometers has greatly 
increased. New software programs and the availability of advanced protein 
databases on the internet have facilitate the analysis of the results. The value 
of 2DE lies in the detection of differences in both protein expression levels and 
protein modifications. Protein expression profiles are more informative than 
mRNA expression profiles, as mRNA levels not always reflect protein levels. 
Moreover, many processes in the cell are not regulated by protein expression 
levels, but by modulation of the protein activity. The bulk of protein 
modifications result either in a shift in mass or iso-electric point, or both and 
can be visualized by 2DE and identified with MS.  
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The proteome of a cell is very complex; the number of proteins expressed at 
the same time in a given cell type is estimated at 6000, which in addition can 
exist in different forms as a result of post-translational processing and 
chemical modifications. By 2DE only a proportion of proteins from total cell 
lysates can be identified. As a result of the low solubility of most proteins 
greater than approximately 100 kDa, the failure to resolve and separate most 
membrane proteins and the resolution of the gel (Mann et al., 2001; 
Hatzimanikatis et al., 1999), mainly soluble and high abundant, low molecular 
weight proteins will be detected with this technique. Prefractioning of the 
samples or the use of multiple first dimension gel strips with distinct, narrow 
pH ranges may increase the yield of this technique.  
In spite of these shortcomings, the differential modification of an actin-binding 
protein during (cofilin) DC maturation was identified by proteomic profiling 
using 2DE and MS, and is described in chapter 2. Cofilin is a small protein of 
18 kD, which is inactive when phosphorylated on its serine on position 3 and 
is involved in cytoskeletal rearrangements. During maturation the protein spot 
identified as phosphorylated cofilin by MS, was strongly reduced. Western blot 
analysis confirmed a gradual loss of cofilin phosphorylation during LPS-
induced maturation. In addition, cofilin was translocated towards the plasma 
membrane, where the actin cytoskeleton is located. Cofilin dephosphorylation 
correlated with an increase in filamentous actin (F-actin) and the development 
of veils. These data suggest involvement of cofilin in the formation of veils 
that are characteristic for mature DC.  
Activation of cofilin results in an increased turnover of F-actin, thereby 
enhancing cytoskeletal rearrangements and increasing cell motility 
(Lappalainen and Drubin, 1997; Moon and Drubin, 1995; Chen et al., 2000). 
Furthermore, through its severing capacity it can promote actin polymerization 
by increasing the number of filament ends (Ichetovkin et al., 2002). In 
addition, cofilin has been demonstrated to promote actin-bundling (Pfannstiel 
et al., 2001). Cofilin is most likely not the only player involved in the 
cytoskeletal rearrangements leading to the appearance of veils on mature DC. 
Expression of the actin-bundling protein Fascin has been demonstrated in 
mature, but not immature DC. Also the ARP2/3 complex may be important for 
the dendritic appearance of DC, through its capacity to initiate and nucleate 
new actin filaments, as deficiency in Wiscott-Aldrich syndrome protein 
(WASp), the activator of Arp2/3, prevents the formation of podosomes in DC 
(Binks et al., 1998; Burns et al., 2001). Moreover, mRNA levels encoding a 
cross-linker of F-actin, MARCK, were elevated early during DC maturation. 
Also the microtubular network might be involved, as mRNA levels for β-tubulin 
and dynein light chain were up-regulated (Huang et al., 2001). Other proteins 
that may be regulated during maturation are anchoring (ezrin/radixin/moesin, 
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α-actinin), actin-bundling (α-actinin) and severing (gelsolin) proteins (Otey 
and Carpen, 2004; Takubo et al., 1999; Barreiro et al., 2002; Chou et al., 
2002).  
The formation of veils by DC may be of great importance for its antigen-
presenting function. First, the enlarged cell surface enables the expression of 
high levels of peptide-MHC complexes and costimulatory molecules. Second, 
the chance to encounter and interact with antigen-specific T cells is increased. 
And most importantly, when DC-T cells contact is established it may increase 
the contact area between DC and T cells and thereby strengthen the 
activation signal that is delivered to the T cell. In other leukocytes, cofilin has 
been demonstrated to be involved in migration (Matsui et al., 2001; 
Konakahara et al., 2004; Nishita et al., 2002) and phagocytosis (Matsui et al., 
2002). It remains to be established whether cofilin plays a similar role in 
migration and endocytosis of dendritic cells.  
A mutation in the carbohydrate recognition domain of Langerin 
protein prevents Langerin-induced formation of Birbeck granules 
The Langerhans cell (LC) is the dendritic cell of the epidermis and 
distinguishes itself from dermal and other DC by the expression of Birbeck 
granules. The type II C-type lectin Langerin, which is uniquely expressed in 
LC, has been shown to induce the formation of Birbeck granules when 
heterologously expressed in murine fibroblasts (Valladeau et al., 2000). The 
function of Birbeck granules is still poorly understood, but many data now 
suggest a role for Langerin in the processing and presentation of exogenous 
antigens. Understanding their ontogenisis may give clues for the function of 
these organelles. In 1994 the department of Dermatology in Leiden, the 
Netherlands, encountered a healthy individual (E. N.) whose LC completely 
lacked Birbeck granules (Mommaas et al., 1994). The aim of the work 
described in chapter 3 was to identify possible genetic defects underlying the 
deficiency in Birbeck granules.  
Sequence analysis the Langerin gene of E. N. revealed a mutation in exon 5 in 
one of the Langerin alleles. This mutation was located in the area encoding 
the carbohydrate recognition domain (CRD) of Langerin and resulted in the 
replacement of a tryptophane at position 264 for an arginine residue (W264R) 
in a region that is highly conserved among related type II C-type lectins and 
among different species. Heterologous expression of the W264R form in 
human fibroblasts did not result in the formation of Birbeck granules, in 
contrast to the wildtype Langerin. The mutant Langerin could not be detected 
by the anti-Langerin monoclonal antibody DCGM4. However, linking green 
fluorescent protein (GFP) to the N-terminus of Langerin enabled the 
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visualization of the protein in transfected cells with an anti-GFP antibody. 
Although no Birbeck granules were formed in GFP-W264R Langerin 
transfected cells, GFP-W264R Langerin was detected in irregular tubular 
membrane structures. Recently, a mutation in mouse Langerin cDNA resulting 
from a cloning artifact was described, which gave rise to the same phenotype 
when transfected in fibroblasts (Valladeau et al., 2002). Interestingly, this 
mutation was also located in the region encoding the CRD domain. Together, 
these data indicate an important role of the CRD of Langerin in the formation 
of Birbeck granules.  
Anti-GFP staining of cells expressing GFP-wildtype Langerin revealed a regular 
repetitive pattern of GFP-Langerin along the Birbeck granules. In contrast, 
staining with anti-DCGM4 resulted in a much lower labeling of Birbeck 
granules, suggesting that the epitope for DCGM4 is engaged in the formation 
of the Birbeck granules and therefore not available for antibody binding. In 
cells transfected with GFP-W264R Langerin, staining with anti-GFP revealed 
the absence of a repetitive pattern of Langerin expression. Conversely, GFP-
W264R Langerin transfected cells demonstrated a tubule-like structure highly 
positive for GFP, that was reminiscent of cored tubules (Hopkins et al., 1994; 
McDermott et al., 2002; Valladeau et al., 2000). The spatial organization of 
Langerin in the Birbeck granule implicates an active role for Langerin in the 
ontogenesis of the typical zipper like structure and suggests that Birbeck 
granules arise through the interaction of Langerin molecules with one another 
and/or ligands, possibly via its CRD. This was also proposed by Mc Dermott et 
al, who described the formation of Birbeck granules like structures at sites 
where Langerin accumulates. They hypothesize that a ''minimal zipping 
concentration" of these molecules is necessary in combination with preexisting 
tubular structure where close membrane apposition exists, like in the 
endosomal recycling compartment (Geissmann et al., 2002). This hypothesis is 
further strengthened by the observation that Langerin can bind mammalian 
high-mannosylated (endogenous) glycoproteins as well as glycoconjugates of 
microorganisms (Stambach and Taylor, 2003). This indicated that either 
Langerin interacts with high mannose structures on opposite Langerin 
molecules or opposite Langerin molecules might interact with the same 
glycosylated ligand that is present in cored tubules or the endosomal recycling 
compartment. A mutation in the CRD likely prevents the binding of 
glycoconjugates and thereby the zipping that is typical for the Birbeck like 
structures.  
The next question was whether this mutation was unique or that it occurred 
more frequently in the population. The identified mutation could be detected 
with a simple assay consisting of PCR amplification of a small fragment of the 
Langerin gene followed by digestion with a restriction enzyme, specific for the 
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mutated allele. Using this method, 3 additional persons in a total of 219 
screened were detected. Like the index person, genomic DNA of all three 
encoded for both wildtype and W264R-Langerin (unpublished data). From one 
of these persons a skin biopsy was obtained and analyzed for the presence of 
Birbeck granules. However, in contrast to E. N., the Langerhans cells of this 
person (M) did contain Birbeck granules in normal numbers (unpublished 
data).  
These data suggest that heterozygosity for W264R Langerin is not correlated 
with the absence of Birbeck granules per se. The phenotype (Birbeck granules 
or not) may be influenced by other factors, such as mRNA expression levels, 
the translation of mRNA into protein or protein degradation. The Langerhans 
cells of E. N. not only lacked Birbeck granules, but were also negative for anti-
Langerin staining (Mommaas et al., 1994). It is thus unclear, whether one or 
both Langerin alleles are expressed on the protein level in the LC. 
Alternatively, the level of Langerin expression and/or the ratio of W264R- and 
wildtype Langerin expression may differ between both persons. If equal levels 
of mutant and wild type Langerin are expressed, the minimal zipping 
concentration of functional Langerin molecules, hypothesized by Mc Dermott 
et al. may not be reached (McDermott et al., 2002). However, if the total 
expression level of Langerin is increased or if wildtype Langerin expression 
exceeds the expression of the mutant, the minimal zipping concentration 
needed for the formation of Birbeck granules may still be reached and Birbeck 
granules may be formed despite the presence of the mutant Langerin protein 
in the cell.  
The functional significance of the lack of Birbeck granules can be questioned, 
as the Birbeck granule deficient person was healthy and showed normal mixed 
lymphocyte reactions (Mommaas et al., 1994). Moreover, no function has 
been discovered for Birbeck granules as yet. For the function of Langerhans 
cells the expression of functional Langerin may be of greater importance than 
the presence of Birbeck granules itself. The zipper-like conformation of Birbeck 
granules may only be a 'side effect' of the accumulation of Langerin in tubular 
structures and have no specific function in itself. Langerin has been associated 
with the uptake of glycolipids and the presentation of these antigens via CD1a 
(Hunger et al., 2004) to T cells. This way, Langerin may play a crucial role in 
the directing of immune responses via non-peptide antigens derived from 
invading pathogens.  
Involvement of different signal transduction pathways in CXCR3 
signaling and their role in T cell chemotaxis 
After activation, T cells have to find their way to the site of pathogen invasion 
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or tissue trauma. Locally produced chemokines specifically direct leukocytes to 
distinct tissues and to sites of inflammation. In type 1 inflammatory responses 
of the skin CXCR3-ligands are involved in the recruitment of activated T cells. 
Many inflammatory disorders in the skin and throughout the body are 
associated with an excessive production of CXCR3-ligands and a massive 
infiltration of CXCR3+ T cells. Therefore, CXCR3 is an attractive target for the 
development of intervention therapies. For the evaluation and development of 
specific therapies intervening in CXCR3-mediated processes it is of importance 
to unravel the signal transduction pathways used by the receptor and their 
functional importance. The aim of the studies described in chapter 4 and 5 
was to elucidate the pathways involved in CXCR3-mediated signaling and their 
functional importance for T cell migration and actin polymerization.  
Beig typical for most Gi protein-coupled receptors, chemokine receptor 
triggering leads to an increase in intracellular calcium concentrations ([Ca2+]i). 
Chapter 5 demonstrates that [Ca2+]i in CXCR3-transfected CHO cells consists 
of the mobilization of Ca2+ from intracellular stores and the influx of 
extracellular Ca2+, the latter making up the major part of the calcium signal. 
Although essential for T cell migration, [Ca2+]i was not was needed for actin 
polymerization in T cells. Remarkably, CXCR3-mediated actin polymerization 
and T cell migration occurred completely independent of the influx of calcium 
into the cells, meaning that intracellular Ca2+ mobilization suffices for T cell 
migration. In experiments in T cells in which intracellular Ca2+ is depleted both 
T cell migration and actin polymerization were dependent on the presence of 
intracellular calcium and appeared to be regulated in a Ca2+-dependent 
manner, both in resting and in activated cells. In conclusion, CXCR3-induced T 
cell migration is independent of Ca2+ influx, but is dependent on Ca2+ 
concentrations in the cell and CXCR3-induced mobilization of intracellular Ca2+.  
Receptor-mediated Ca2+ influx in T cells occurs predominantly via so-called 
store-operated calcium channels (SOC), which are activated through depletion 
of Ca2+ from intracellular Ca2+ stores. In T cells the only known SOC channel is 
the calcium release activated calcium (CRAC) channel. Ca2+ entry through 
CRAC channels is essential for T-cell activation and activation associated gene 
expression (IL-2 and -5 and IFN-γ) and proliferation (Ishikawa et al., 2003; 
Zitt et al., 2004; Fanger et al., 1995; Fischer et al., 2001). Voltage dependent 
Ca2+ channels (VDCC) were reported to be involved in T cell activation and 
proliferation (Kotturi et al., 2003) and in CX3CL1-induced [Ca2+]i in CHO cells 
expressing CX3CR1 (Kansra et al., 2001). In CXCR3-mediated T cell migration, 
however, calcium channels whether CRAC or VDCC have no apparent function. 
Nonetheless, it is still unclear whether influx of calcium is essential for 
chemokine-mediated activities other than migration, actin polymerization and 
kinase activation, such as integrin activation, gene transcription, or T cell 
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proliferation (van Kooyk et al., 1991; Cinamon et al., 2001a; Cinamon et al., 
2001b; Whiting et al., 2004; Lauffenburger and Horwitz, 1996).  
In both chapter 4 and 5 the involvement of different kinases in CXCR3-
induced signaling was investigated. All three ligands of CXCR3 (CXCL9-11) 
were capable of activating the PI3K/Akt and MEK/p44/42 pathway in a dose-
dependent manner in both activated T cells and COS-7 cells expressing human 
CXCR3, CXCL11 being the most potent. All CXCR3-induced processes were 
mediated via Gαi. CXCL11-induced phosphorylation of p44/p42 did not need a 
functional cytoskeleton, suggesting that receptor internalization was not 
involved in activation of this kinase. Activation of p44/p42 by CXCR3 relied 
completely on MEK, partially on PI3K and not on Ca2+. Also Akt was partially 
regulated by PI3K and was decreased in the absence of intracellular calcium. 
Both CXCR3-mediated T cell migration and actin polymerization depended on 
PLC-linked signal transduction pathways. Furthermore, in contrast to several 
other reports describing chemokine signaling, PI3K, MEK (chapter 4), and 
PKC (chapter 5) were not involved in CXCR3-induced chemotaxis.  
Until recently, PI3K was thought to be indispensable for chemoattractant-
induced migration (Bonacchi et al., 2001; Knall et al., 1997; Sotsios et al., 
1999; Sullivan et al., 1999; Turner et al., 1998; Vicente-Manzanares et al., 
1999; Wain et al., 2002; Wang et al., 2000). However, more recently it has 
become clear that PI3K dependence is not universal for all chemokine 
receptors. Several reports describe migration of leukocytes that is either 
completely (Cinamon et al., 2001b; Cronshaw et al., 2004; Heit et al., 2002; 
Scandella et al., 2002; Verploegen et al., 2002; Fine et al., 2001; Ward, 2004) 
or partially independent (Wain et al., 2002; Reif et al., 2004) of PI3K. Heit et 
al. suggested that signaling via PI3K depends on the receptor responding to 
either intermediary chemoattractants or end target chemoattractants. 
Neutrophil migration towards intermediary chemoattractants depended on 
PI3K/Akt activity, whereas end target chemoattractants induced migration 
occurred via p38. Moreover, 'end target' chemokines were dominant over 
'intermediary' chemokines (Heit et al., 2002). The notion that CXCR3 mediated 
migration is independent of PI3K fits in this theory. However, CCR4-medated 
migration (Cronshaw et al., 2004) and PBL transendothelial migration 
(Cinamon et al., 2001b) that occur independently of PI3K do not fit in this 
description of 'end targeting'. Perhaps, dividing chemokines in dominant and 
weak is a more appropriate classification. Strikingly, Bonnacchi et al report 
that CXCR3-mediated migration is dependent on PI3K (Bonacchi et al., 2001). 
However, these results were obtained from pericytes and not T cells, 
indicating that chemokine receptor signaling not only depends on the type of 
receptor, but also on the cell type in which they are expressed. Also on MEK 
and PKC involvement in leukocyte migration contradictory reports exist, 
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stating that chemokine induced chemotaxis is either independent or 
dependent on these kinases [MEK independency: (Stein et al., 2003; Knall et 
al., 1997; Bardi et al., 2003), PKC independency (Scandella et al., 2002; Fine 
et al., 2001; Choi et al., 2003); MEK dependency: (Hii et al., 1999; Sullivan et 
al., 1999), PKC dependency (Ko et al., 2002; Choi et al., 2003; Wang et al., 
2000; Carnevale and Cathcart, 2003)]. These results indicate once more that 
receptor signaling may differ per chemokine receptor and cell type.  
Thus, although different receptors may use the same components of signal 
transduction pathways, the exact combination and the repertoire of kinases 
differ per receptor and probably also per cell type. It is likely that distinct 
signaling pathways are involved in the diverse effects of chemokine triggering 
(chemotaxis, gene transcription and proliferation), which may also differ per 
receptor and cell type. Also, triggering of chemokine receptors by different 
ligands may result in diverse effects. For example, binding by CCR2 of CCL2 
and the CCR3-ligand CCL11 both induce the activation of p44/p42, although 
via different pathways. However, where CCL2 mediates chemotaxis, CCL11 
prevents CCL2-induced migration (Ogilvie et al., 2004). Unraveling all signal 
transduction routes and their effects on cell activity and cell signaling, will be 
indispensable for the evaluation of new pharmaceutics that target chemokine 
receptors.  
The biological activity of a small-molecule CXCR3 antagonist 
To study the role of CXCR3+ infiltrating T cells in type 1 inflammatory 
disorders, specific CXCR3-antagonists may prove to be a valuable tool. In 
addition, the identification of high affinity CXCR3-antagonists may eventually 
lead to the development of intervening therapies. The aim of chapter 6 was 
to synthesize a small molecule CXCR3-antagonist with high affinity that blocks 
CXCR3-ligand-mediated signal transduction and human T cell migration.  
The design of small molecule antagonists may lead to compounds with higher 
stability than peptidic agents and may be suitable for oral administration. In 
addition, small molecule antagonist may be able to penetrate through the skin 
and be used for local administration. Recently, it was demonstrated that a 
small molecule that was originally designed as a murine CCR4-antagonist also 
antagonizes murine CXCR3 (Yang et al., 2002). For the human CXCR3, only 
two antagonistic small-molecules have been described with a moderate 
binding affinity (Schall et al., 2001). Chapter 6 describes the modification of 
one of these compounds to increase its affinity to CXCR3. At the Department 
of Pharmacochemistry (Free University, Amsterdam), different compounds 
were synthesized based on the lead compound (Schall., et al. 2001) and 
tested in radio-ligand binding assays. Compound VUF5834 demonstrated the 
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highest affinity for CXCR3 and effectively prevented CXCR3-ligand-induced 
activation of phospholipase C and CXCR3-mediated [Ca2+]i in cells transfected 
with the human CXCR3. Moreover, in T cells, 1 µM of VUF5834 completely 
abrogated CXCR3-mediated actin polymerization and T cell migration. This 
effect was specifically mediated via binding to CXCR3, as VUF5834 did not 
inhibit CXCR4-mediated T cell migration and a non-binding analogue of 
VUF5834 had no effect on CXCR3-mediated signaling and T cell migration. In 
conclusion, the small molecule VUF5834 specifically antagonizes CXCR3 via 
interaction with the receptor.  
VUF5834 did not affect T cell chemotaxis induced by CXCR4-ligand CXCL12, 
indicating that the action of this antagonist is limited to CXCR3. Nevertheless, 
cross-reactivity of VUF5823 with other chemokine receptors remains to be 
determined, in particular with CCR3 and CCR5. Recently, the three ligands of 
CXCR3 were discovered to act as antagonists for CCR3 (Xanthou et al., 2003). 
In addition, CXCL11 is a natural antagonist of CCR5 (Petkovic et al., 2004). 
CXCR3 antagonist may therefore not only bind to CXCR3 but also to CCR3 and 
CCR5. Already, the murine CCR5 antagonist TAK-779 was shown to 
antagonize both CCR5 and CXCR3 (Yang et al., 2002).  
For future studies on the in vivo effect of VUF5834 test animals will be 
indispensable. First, to asses toxicity and assemble information on the route of 
administration and bioavailability. Secondly, to study its effect on in vivo 
trafficking of CXCR3+ T cells. In this respect, it would be preferable that the 
antagonist not only binds to the human receptor but also antagonizes CXCR3 
of mammalian test-animals. The murine and human CXCR3 and their ligands 
share a high homology with each other. Murine CXCL11 also triggers human 
CXCR3, although with lower potency (Meyer et al., 2001). However, human 
CXCL11 does not activate the murine CXCR3 (unpublished data). In case mice 
are selected for in vivo experiments, the binding affinity of VUF5834 for the 
murine CXCR3 and its capacity to antagonize murine CXCR3 ligands should be 
determined.  
For therapeutic applications, the route of administration may determine the 
effect of antagonists. Oral or intravenous administration will result in total 
body availability of the antagonist. If inhibition is complete this will prevent 
the recruitment of all CXCR3+ T cells to site of inflammation producing CXCR3-
ligands. Local administration, for example local injection or via penetration of 
the skin, will likely not prevent the initial recruitment of CXCR3+ T cells, but 
may attenuate the immune response, by preventing the local activation of 
CXCR3+ T cells (IFN-γ production and proliferation). Depending on the type of 
inflammatory disease either complete inhibition or attenuation of CXCR3+ T-
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Basale aspecten van verworven immuniteit: 







Het lichaam wordt op verschillende manieren beschermd tegen infecties met 
ziekteverwekkers (pathogenen) zoals virussen, bacteriën en schimmels. Ten 
eerste belemmeren fysieke barrieres het binnentreden van pathogenen. Een 
voorbeeld hiervan vormt de huid; een haast ondoordringbare schild dat vocht 
en warmte van het lichaam binnenhoudt en vuil en pathogenen buiten. Als er 
toch op een of andere manier indringers binnen weten te komen, komt het 
immuunsysteem in actie. Het immuunsysteem is een zeer complexe 
organisatie, die door het hele lichaam heen vertegenwoordigd is. Hieraan 
doen ook weefselcellen mee (bijv. keratinocyten in de huid) door de productie 
van eiwitten die een antibacteriële of een signaalwerking hebben. De 
signaalstoffen activeren op hun beurt cellen die de bestrijding van infecties als 
hoofdfunctie hebben, zoals macrofagen, granulocyten, “natural killer” (NK) 
cellen en dendritische cellen. Deze reacties zijn niet-specifiek en vallen onder 
de eerste lijn van de verdediging, de aangeboren immuniteit. De tweede lijn 
wordt gevormd door de verworven immuniteit en bestaat uit T en B cellen. 
Deze cellen herkennen de pathogeen juist heel specifiek. Voor elke 
ziekteverwekker wordt een aparte set van cellen actief, die alleen reageert op 
die specifieke indringer. Een andere belangrijke eigenschap van de verworven 
immuniteit is dat het een geheugen ontwikkelt. Als het lichaam voor de 
tweede (of derde enz.) keer geïnfecteerd wordt met dezelfde bacterie of 
hetzelfde virus, zal het immuunsysteem veel sneller en effectiever kunnen 
reageren, waardoor het lichaam beter beschermd is. 
Zoals gezegd zijn de T- en B cellen onderdeel van de verworven immuniteit. B 
cellen zijn verantwoordelijk voor de productie van antilichamen (antistoffen) 
tegen pathogenen. Antilichamen binden aan de ziekteverwekker, zodat deze 
herkenbaar wordt voor andere componenten van het immuunsysteem en 
opgeruimd kan worden. T cellen zijn er in verschillende soorten: ‘killer’ T 
cellen, die geïnfecteerde cellen kunnen herkennen en onschadelijk maken, 
helper T cellen, die o.a. de activatie van killer T cellen en B cellen helpen en 
het geheugen stimuleren en regulatoire T cellen, die ongewenste 
immuunreacties kunnen onderdrukken.  
Dendritische cellen 
Een belangrijke schakel tussen het eerste en het tweede leger is de 
dendritische cel (DC). Dendritische cellen hebben namelijk als hoofdtaak het 
activeren van naïeve T cellen (T cellen die nog niet eerder in aanraking zijn 
geweest met deeltjes van pathogenen [antigenen]) in geval van een infectie. 
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In weefsels die een barriere vormen tussen het lichaam en de buitenwereld, 
zoals de huid, de longen en de darmen, bevinden zich dendritische cellen. De 
eigenschappen van de DCs hangen af van het stadium waarin ze verkeren. In 
de weefsels zijn de DCs onrijp en zijn ze heel goed in het opnemen van alles 
wat in hun omgeving komt (antigenen). De opgenomen antigenen worden 
door de DCs in specifieke organellen (=orgaan van een cel) verwerkt om in 
kleine stukjes gepresenteerd te worden aan T cellen. Het presenteren van 
antigenen aan T cellen is een eigenschap van rijpe DCs. De rijping (maturatie) 
van DCs vindt plaats in reactie op een infectie. Tijdens de maturatie neemt de 
capaciteit om antigen op te nemen af en neemt de presentatie van antigenen 
sterk toe met als doel de activatie van specifieke T cellen. Tegelijkertijd 
migreren de DCs vanuit het weefsel via de lymfevaten naar de dichtstbijzijnde 
lymfeklier. Ook verandert het uiterlijk van de cel. Onrijpe DCs hebben een vrij 
rond uiterlijk, maar na maturatie vertonen ze op uitgebreide schaal dunne en 
langwerpige uitstulpingen als een soort sluier. Dit uiterlijk is nodig om zoveel 
mogelijk contact te kunnen maken met T cellen.  
De lymfeklier is de ontmoetingsplaats voor dendritische cellen, T- en B cellen. 
Hier komen de DCs in aanraking met een heleboel T cellen. Elke T cell heeft 
echter een specifieke en heel eigen T cel receptor, waarmee hij unieke stukjes 
eiwit kan herkennen. Alleen de T cellen die een stukje herkennen dat 
gepresenteerd wordt door de DCs, worden geactiveerd. Een deel van de 
geactiveerde cellen zal achterblijven in de lymfklier om zich te ontwikkelen tot 
een geheugencel, maar het overgrote deel zal de klier verlaten en op zoek 
gaan naar de plaats van de infectie. 
Migratie en chemokines 
Het doel waar immuuncellen naartoe migreren wordt gereguleerd door 
eiwitten op het oppervlak van de immuuncellen en door eiwitten die daaraan 
binden en die gemaakt worden door weefselcellen. Een belangrijk onderdeel 
daarvan is het chemokine-receptor systeem. Chemokines zijn kleine eiwitten 
die als een soort lokstof dienen om bepaalde cellen aan te trekken. Welke 
cellen aangetrokken worden hangt af van het soort receptoren die de cel op 
zijn oppervlak heeft. Cellen die de juiste receptor hebben zullen in de richting 
van de hoogste concentratie van dat chemokine migreren. Op die manier 
kunnen cellen heel gericht naar de plaats van infectie migreren omdat daar de 
juiste chemokines gemaakt worden. 
Dit proefschrift 
In de hoofdstukken 2 tot en met 6 van dit proefschrift worden verschillende 
aspecten van verworven immuniteit belicht. Als eerste wordt de dendritische 
cel bestudeerd die zo’n belangrijke rol speelt bij de activatie van T cellen. In 
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hoofdstuk 2 worden de verschillen tussen de maturatiestadia van de DCs 
bestudeerd, terwijl hoofdstuk 3 zich richt op een speciale dendritische cel, 
namelijk de Langerhans cel. Als tweede wordt aandacht geschonken aan de 
migratie van T cellen en met name hoe chemokines via een bepaalde receptor 
inwerken op de geactiveerde T cel. In de hoofdstukken 4 en 5 wordt de 
manier waarop de T cel op chemokines reageert onderzocht. In hoofdstuk 6 
wordt onderzocht of de werking van chemokines op de bijbehorende 
chemokinereceptor op T cellen geblokkeerd kan worden. Dit kan interessant 
zijn voor de ontwikkeling van nieuwe behandelmethodes voor een breed scala 
aan immuunziektes, waarbij een overmatige activiteit van geactiveerde T 




In hoofdstuk 2 wordt de maturatie van DCs nader onderzocht. Er is al veel 
bekend over hoe een DC een T cel activeert, maar sommige aspecten zijn nog 
onderbelicht. In hoofdstuk 2 is gezocht naar verschillen tussen onrijpe en rijpe 
DCs in de eiwiten de ze aanmaken. Het aantal verschillende eiwitten dat een 
cel aanmaakt (eiwitexpressie) wordt geschat op rond de 6000. Eiwitten zijn 
opgebouwd uit aminozuren, waarvan er 20 verschillende bestaan, en bevatten 
soms ook suikers. De volgorde van de aminozuren bepalen de eigenschappen 
van het eiwit. Een groot aantal eiwitten kan in verschillende vormen 
voorkomen. Er kunnen bijvoorbeeld groepen, zoals fosfaat, aangehangen of 
verwijderd worden die de werking van het eiwit beinvloeden. Door de vorm 
van een eiwit te veranderen kunnen functies van een cel gereguleerd worden. 
Al deze aanpassingen leveren een een enorme variatie op. Om verschillen te 
kunnen vinden in het eiwitrepertoire in verschillende celstadia, moeten de 
eiwitten van elkaar gescheiden worden. Dit is mogelijk door gelelectroforese. 
Met deze methode kunnen eiwitten gescheiden worden op basis van hun 
eigenschappen. Om een zo groot mogelijke scheiding te krijgen, werden 
eiwitten eerst op basis van hun grootte en vervolgens op basis van hun 
zuurtegraad (pH) gescheiden. Daarna werden de eiwitten aangetoond met 
een zilverkleuring, waardoor een 2-dimensionaal patroon ontstaat. Van de 
eiwitten van zowel onrijpe als rijpe DCs zijn twee-dimensionele plaatjes 
gemaakt, die vervolgens met elkaar vergeleken werden. Hieruit kwam naar 
voren dat een van de eiwitten die verschilt tussen onrijpe en rijpe DCs Cofiline 
is. Dit eiwit was in beide celstadia in evengrote hoeveelheden aanwezig, 
echter in een andere vorm. Dit verschil in vorm zorgt ervoor dat in de rijpe cel 
veel meer cofiline actief is dan in de onrijpe cel. Cofiline speelt een belangrijke 
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rol in het skelet van een cel en daarmee in de vorm die een cel aanneemt. De 
verhoogde cofiline activiteit in rijpe DCs is waarschijnlijk belangrijk voor de 
verandering in vorm die waargenomen wordt tijdens de maturatie van DCs.  
Hoofdstuk 3 
Een speciaal type DC is de Langerhans cel. De Langerhans cel (LC) bevindt 
zich in de opperhuid en strekt lange tentakels uit tussen de huidcellen. 
Hiermee kan de LC de omgeving in de gaten houden en controlen op de 
invasie van ziekteverwekkers. Wat LCs onderscheidt van alle andere DCs is 
een organel (orgaan in een cel) dat de Birbeck granule genoemd wordt. De 
functie van dit organel is nog vrij onbekend, maar heeft mogelijk te maken 
met de presentatie van antigenen. Tien jaar geleden was bij toeval bij iemand 
vastgesteld dat deze persoon geen Birbeck granula had in zijn LCs. Deze 
indexpersoon was volkomen gezond en er konden geen afwijkingen gevonden 
worden in testen van verschillende immuunreacties. Onlangs is gebleken dat 
een bepaald eiwit dat alleen in Langerhans cellen voorkomt, genaamd 
Langerine, verantwoordelijk is voor de vorming van deze granula. Als dit eiwit 
kunstmatig in andere cellen die nooit Birbeck granula maken wordt gebracht, 
vertonen deze cellen ook Birbeck granula. Wij hebben onderzocht of er 
misschien een foutje zit in het DNA van de indexpersoon dat codeert voor 
Langerine, dat de afwezigheid van de Birbeck granula veroorzaakt. Wij hebben 
inderdaad een mutatie gevonden in het Langerine DNA, wat resulteerde in 
verandering van één aminozuur in het eiwit. Deze mutatie zat op een plaats in 
het eiwit met een belangrijke functie en is mogelijk de oorzaak van de 
afwezigheid van Birbeck granula in de indexpersoon. We hebben 
gecontroleerd of deze mutatie ook de aanmaak van Birbeck granula voorkomt. 
Daarvoor hebben we het DNA met en zonder de mutatie in cellen gezet en 
naar het effect gekeken. In cellen met het normale Langerine DNA ontstonden 
Birbeck granula. Echter in cellen met Langerine DNA met een mutatie 
gebeurde dat niet. Dit wijst erop dat deze mutatie inderdaad effect heeft op 
de vorming van Birbeck granula. 
T cel migratie 
Zoals boven vermeld, zijn chemokines kleine eiwitten die cellen kunnen 
aantrekken. De chemokines kunnen binden aan receptoren op het oppervlak 
van een cel. In de cel wordt daarop een signaal doorgegeven 
(signaaltransductie), dat verteld dat de cel zich moet gaan bewegen in de 
richting van de hoogste concentratie van dat chemokine. Er zijn veel 
verschillende receptoren en nog veel meer verschillende chemokines. Door 
middel van het selectief maken van chemokine receptoren kunnen 
immuuncellen zoals T cellen specifiek geleid worden naar verschillende 
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weefsels en zelfs nog specifieker, naar de plaats van de ontsteking. In de huid 
bijvoorbeeld worden onder invloed van bepaalde signaalstoffen de liganden 
(stoffen die aan een receptor binden en die activeren) van chemokinereceptor 
CXCR3 geproduceerd: CXCL9, CXCL10 en CXCL11. De receptor CXCR3 komt 
op een groot deel van alle geactiveerde T cellen tot expressie. Deze expressie 
van CXCR3 op T cellen en CXCL9-11 in de huid speelt waarschijnlijk een 
belangrijke rol bij een aantal huidziektes. Wanneer je in wilt grijpen op een 
bepaald mechanisme is het van belang alle betrokken processen en hun 
functie te kennen. In hoofdstukken 4 en 5 wordt daarom de signaaltransductie 
van CXCR3 in de T cel bestudeerd. In hoofdstuk 6 wordt vervolgens gezocht 
naar een stofje dat de binding van de chemokines CXCL9-11 aan CXCR3 kan 
blokkeren. Dit kan uiteindelijk leiden tot de ontwikkeling van een medicijn dat 
ziekteverschijnselen kan remmen in een groot aantal aandoeningen die 
gekenmerkt worden door een overmatige infiltratie van geactiveerde CXCR3-
positieve T cellen. 
Hoofdstuk 4 en 5  
Wanneer een signaalstof als een chemokine bindt aan een cel, moet de cel 
deze informatie omzetten in actie. Dit proces wordt gereguleerd door een een 
verzameling eiwitten en andere moleculen, die op een of andere manier 
geactiveerd of juist geïnactiveerd moeten worden. Wanneer het chemokine 
aan zijn receptor op het oppervlak van de cel bindt, vindt er in de cel een 
cascade van reacties plaats die ervoor zorgen dat de benodigde eiwitten en 
moleculen in actie komen. De signalen hiervoor kunnen op heel veel manieren 
doorgegeven worden. Welke eiwitten en moleculen daarbij betrokken zijn, is 
afhankelijk van de receptor en het celtype. In hoofdstuk 4 en 5 wordt 
onderzocht welke signaal routes van belang zijn voor migratie van T cellen na 
stimulatie van de CXCR3-receptor.  
In hoofdstuk 4 worden de betrokkenheid van verschillende eiwitten uitgetest 
door het toedienen van remmers. Hierbij werd gebruik gemaakt van zowel 
humane T cellen geïsoleerd uit bloed met de CXCR3-receptor op hun 
oppervlak, als cellijnen waar kunstmatig de CXCR3-receptor ingezet is. Uit de 
experimenten bleek dat het eiwit phospholipase C een cruciale rol heeft in de 
activatie van T celmigratie, maar dat de andere geteste eiwitten niet van 
belang zijn voor dit proces. Tevens werd aangetoond dat activatie van 
migratie niet in alle cellen en niet met alle chemokinereceptoren op dezelfde 
manier gaat. Een van de eiwitten, PI3K (fosfatidylinositol-3-kinase), waarvan 
door veel onderzoekers beschreven wordt dat het essentieel is voor migratie 
van cellen, bleek niet betrokken te zijn bij de migratie van T cellen na 
stimulatie van CXCR3. Ook werd bevestigd dat van de drie liganden het 
chemokine CXCL11 de beste activator van T cellen is in vergelijking met 
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CXCL9 en CXCL10.  
In hoofdstuk 5 werd verder ingegaan op de rol van fosfolipase C in de signaal 
transductie van T cellen na stimulatie van CXCR3. Fosfolipase C zet een 
signaal route aan waardoor de concentratie van vrije calciumionen in de cel 
stijgt. Dit kan weer een reeks van processen activeren, maar het is nog niet 
duidelijk welke. Wij bestudeerden de rol van calcium in T cel migratie. Hieruit 
werd duidelijk dat cellen wel calcium nodig hebben, maar dat er daarvoor 
geen calcium vanuit de omgeving nodig is. Het calcium dat opgeslagen is in 
de cel is voldoende om de cel te laten migreren. Het is mogelijk dat de cel de 
signalering via calcium nodig hebben om de richting te bepalen waarin ze 
moeten migreren. 
Hoofdstuk 6 
In hoofdstuk 6 wordt onderzocht of de CXCR3-gedreven T cel migratie CXCR3 
is af te remmen. Een aantal huidziekten wordt namelijk in verband gebracht 
met een verhoogde concentratie van CXCR3-dragende T cellen. Door een 
teveel aan actieve T cellen op een bepaalde plaats kunnen ongewenste 
reacties optreden. Daarnaast is gebleken dat CXCR3-dragende cellen een rol 
spelen in de afstoting van transplantaten (zoals hart en nier). Door middel van 
het blokkeren van de CXCR3-receptor, zou een chronische ontsteking verzacht 
of genezen kunnen worden doordat minder actieve T cellen naar de plaats van 
ontsteking worden aangetrokken. Door blokkade van de CXCR3-receptor bij 
transplantaties zou bovendien voorkomen kunnen worden dat afstoting 
plaatsvindt doordat actieve CXCR3-positieve T cellen naar het transplantaat 
migreren en de lichaamsvreemde cellen aanvallen. Voor verschillende 
chemokinereceptoren worden momenteel kleine moleculen ontwikkeld die 
binden aan de receptor en daardoor voorkomen dat de chemokines zelf 
binden en de cel activeren (antagonisten). Voor de CXCR3-receptor is onlangs 
een klein molecuul gemaakt dat deze functie heeft.  
De afdeling Farmacochemie van de Vrije Universiteit van Amsterdam heeft 
deze antagonist zodanig weten te veranderen dat de binding aan de CXCR3-
receptor verbeterd is en een mogelijke toepassing in de kliniek dichterbij 
komt. Met verschillende functionele test werd het effect op de cel bestudeerd. 
Hieruit bleek dat de antagonist de werking van chemokines op de cel kon 
blokkeren. In aanwezigheid van de antagonist reageerden de cellen niet op de 
relevante chemokines. De cellen migreerden niet naar de CXCR3-chemokines 
CXCL10 en -11, maar wel naar een ligand (CXCL12) van een andere 
chemokine receptor (CXCR4). Deze antagonist remt dus specifiek de migratie 
van T cellen die via CXCR3 gestimuleerd worden en niet via andere chemokine 
receptoren. Dit stofje is dus een aantrekkelijke kandidaat voor toepassing in 
de kliniek. Voordat deze antagonist als medicijn gebruikt kan worden is echter 
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nog veel aanvullend onderzoek nodig, bijvoorbeeld naar de toxiciteit. Als de 
studies uitwijzen dat het veilig is, kan een medicijn gemaakt worden dat 
bijvoorbeeld chronische ontstekingen verzacht of geneest of de acceptatie van 
transplantaten bevordert.  
Conclusie 
De verschillende hoofdstukken laten enkele aspecten zien van het 
immuunsysteem die onderling met elkaar verbonden zijn. De beschreven 
bevindingen zijn slecht kleine facetten van een complex systeem. Elk stukje 
nieuw opgedane kennis is echter waardevol voor een beter begrip van de 
werking van het immuunsysteem en betere behandelmethodes voor ziektes 
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